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Summary
While metabolite profiling has been carried out for decades, the scope for metabo-
lite analysis have recently been broadened to aim at all metabolites in a living
organism – also referred to as the metabolome. This is a great challenge, which
requires versatile analytical technologies that are highly sensitive and specific,
and to undertake this challenge mass spectrometry (MS) is among the best can-
didates. Along with analysis of the metabolome the research area of metabolomics
has evolved. Metabolomics combines metabolite profiles, data mining and bio-
chemistry and aims at understanding the interplay between metabolites. In this
thesis, different topics have been addressed and discussed with the aim of advanc-
ing metabolomics to explore the concept in a physiological context.
The metabolome comprises a wide variety of chemical compounds that act dif-
ferently upon sample preparation, and therefore sample preparation is critical for
metabolome analysis. The three major steps in sample preparation for metabo-
lite analysis are sampling, extraction and concentration. These three steps were
evaluated for the yeast Saccharomyces cerevisiae with primary focus on analysis
of a large number of metabolites by one method. The results highlighted that
there were discrepancies between different methods.
To increase the throughput of cultivation, S. cerevisiae was grown in microti-
tier plates (MTPs), and the growth was found to be comparable with cultivations
in shake flasks. The carbon source was either glucose, galactose or ethanol, and
metabolic footprinting by mass spectrometry was used to study the influence of
carbon source on the extracellular metabolites. The results showed that footprints
clustered according to the carbon source.
Advances in technologies for analytical chemistry have mediated increased
amounts of data generated in high resolution. One major limitation though is the
digestion of data coverting the information into a format that can be interpreted
in a biological context and take metabolomics beyond the principle of guilt-by-
association. To analyze the data there is a general need for databases that contain
metabolite specific information, which will speed up the identification of profiled
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metabolites. To address the capabilities of electrospray ionization (ESI)-MS in
detecting the metabolome of S. cerevisiae, the in silico metabolome of this or-
ganism was used as a template to present a theoretical metabolome. This showed
that in combination with the specificity of MS up to 84% of the metabolites can
be identified in a high-accuracy ESI-spectrum. A total of 66 metabolites were
systematically analyzed by positive and negative ESI-MS/MS with the aim of
initiating a spectral library for ESI of microbial metabolites. This systematic
analysis gave insight into the ionization and fragmentation characteristics of the
different metabolites. With this insight, a small study of metabolic footprint-
ing with ESI-MS demonstrated that biological information can be extracted from
footprinting spectra. Statistical analysis of the footprinting data revealed dis-
criminating ions, which could be assigned using the in silico metabolome. By this
approach metabolic footprinting can advance from a classification method that
is used to derive biological information based on guilt-by-association, to a tool
for extraction of metabolic differences, which can guide new targeted biological
experiments.
Dansk sammenfatning
Analyse af metabolitter og sammenligning af profiler af disse har været udført
i a˚rtier, og inden for de senest a˚r er der kommet fornyet fokus p˚a denne disci-
plin, hvor man nu ønsker at m˚ale samtlige metabolitter i en celle — ogs˚a kaldet
metabolomet. Det er en betydelig udfordring at analysere metabolomet, og det
stiller store krav til analysemetoderne, der skal besidde stor følsomhed og speci-
ficitet. Der er et begrænset antal analyseteknikker til r˚adighed for at klare denne
udfordring og heriblandt ma˚ massespektrometri anses for en af de bedre mu-
ligheder. H˚and i h˚and med analysen af metabolomet er der opst˚aet et forskn-
ingsomr˚ade kaldet metabolomics, hvor metabolitprofiler, dataanalyse og biokemi
kombineres for at opn˚a en helhedsforst˚aelse af metabolitternes sammenspil. I
denne afhandling diskuteres forskellige emner inden for metabolomics med hen-
blik p˚a at bringe metabolomics et skridt videre i forst˚aelse af, hvordan det kan
bruges i en fysiologisk sammenhæng.
Metabolomet er sammensat af en lang række kemisk forskellige forbindelser
og prøveforberedelse er derfor kristisk for metabolomanalyse. De tre primære trin
i prøveforberedelse er prøveudtagning, ekstraktion og opkoncentrering. Disse tre
trin er blevet undersøgt for gæren Saccharomyces cerevisiae med henblik p˚a at
m˚ale s˚a mange metabolitter s˚a muligt p˚a en gang. Forsøgene understregede at de
forskellige metoder gav forskellige resultater.
Med henblik p˚a at kunne gennemføre flere forsøg blev S. cerevisiae dyrket
i mikrotiterplader, og væksten synes at være sammenlignelig med vækst i en
rysteflaske. Som en del af forsøget blev der brugt 3 forskellige kulstofkilder:
glukose, galactose og ethanol og kulturvæsken blev analyseret for ekstracellulære
metabolitter ved metabolic footprinting. Data blev opn˚aet ved massespektrometri,
og dataanalysen viste, at det var muligt at skelne prøverne, efter hvilken kulstofk-
ilde der var brugt.
Inden for analytisk kemi sker der store tekniske fremskridt, og det har bl.a.
betydet at data bliver generet i stadig højere opløsning. Dette kræver en effektiv
fortolkning af data, s˚aledes at det bliver muligt at ekstrahere biologisk informa-
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tion. Denne fortolkning kan assisteres af databaser, der indeholder reference-
data, og disse databaser vil kunne effektivisere dataanalysen og identifikationen
af metabolitter. For at belyse muligheden for at bruge elektrosprayionisering-
massespektrometri (ESI-MS) til detektion af hele metabolomet for S. cerevisiae
blev der taget udgangspunkt i in silico metabolomet af denne organisme. Det
viste sig, at med specificiteten fra massespektrometri var det muligt at skelne
mellem op til 84% af metabolitterne i et massespektrum. Yderligere blev der
indsamlet data fra 66 metabolitter med henblik p˚a at lave en database med ESI-
MS spektre for mikrobielle metabolitter. Data blev systematisk genereret, og
med udgangspunkt i disse data har det været muligt at forbedre fortolkningen af
metabolomdata opn˚aet ved massespektrometri. Som et eksempel herp˚a var det
muligt at udlede biologisk information p˚a baggrund af metabolic footprinting.
Normalt bruges metabolic footprinting til klassifikation, men med udgangspunkt
i massespektrene blev det muligt at tage metabolic footprinting skridtet videre
og udlede fysiologiske forskelle.
Preface
The present thesis concludes 3 years research started in March 2003 at Cen-
ter for Microbial Biotechnology resided at the department Sysmtems Biology at
Technical University of Denmark (DTU). The work has been carried out under
supervision by Professor Jens Nielsen and co-supervision by Associated Professor
Jørn Smedsgaard.
The thesis comprises the primary work of several distinct projects aiming at ad-
vancing metabolomics to explore the concept in a physiological context. The
research has been a journey within bioanalytical chemistry spiced with microbial
physiology and informatics. Mass spectrometry has had a central position in the
work, which is reflected in the thesis.
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Chapter 1
Introduction
In the 1990’ies major advances were made in genomic research. Automated gene
sequencing seeded the initiation of several sequencing programs with the objec-
tive to sequence whole genomes. In 1996 the whole genome for baker’s yeast Sac-
charomyces cerevisiae was published as the first fungal genome and also the first
genome of a eukaryotic organism (Goffeau et al., 1996). At present (January 2008)
708 complete genome sequences are published (http://www.genomesonline.org)
and the number is rapidly increasing. Genome sequences have provided substan-
tial biological information, which has led to comparative studies across species
to decode the four-letter code in the genetic material. This has been one of the
major driving forces in initiation of systems biology, since the genomic sequence
(genotype) sets the theoretical boundaries for the cellular capabilities. However,
based on the genome sequence alone it is not possible to predict all resulting phe-
notypes; although the genome provides the code for life and in other words forms
the basis for phenotypic behavior. The genetic information flow in a cell starts by
transcription of the genes to mRNA that is further translated to proteins (Figure
1.1). The proteins interact with present small molecules (metabolites) that react
and form a metabolic network. On top of this the environment and a wide range of
regulatory mechanisms play a role through interactions – everything contributing
to the phenotype.
To undertake the challenge of predicting phenotypes we must take a holistic
approach inspecting the whole cell or organism as a system – moving away from
the reductionistic approach that has been widely applied in biology (Stephanopou-
los et al., 2004). To face this challenge of global biology a variety of techniques
have been developed that allow high-throughput, multi-parallel analysis of bio-
logical systems, e.g. hybridization arrays (Fodor et al., 1993; Schena et al., 1995;
de Saizieu et al., 1998), LC-MS/MS protein analysis (Gygi et al., 1999; Washburn
1
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genes mRNA protein metabolites
transcription translation metabolic uxes
GENOTYPE
PHENOTYPE
Figure 1.1 The central dogma of biology including metabolites. The genes give the po-
tential of an organism (genotype) and provide the boundaries for the metabolic capabilities,
whereas proteins and especially metabolites reflect the actual activities under a given set of
conditions (phenotype) as they assemble the functional metabolic network.
et al., 2001), metabolite profiling platforms (Fiehn et al., 2000; Raamsdonk et al.,
2001) and interaction assays (Fields and Song, 1989; Uetz et al., 2000). The abil-
ity to generate high-throughput data have reversed research strategies towards
data-driven approaches where new hypothesis are generated based on data (Kell
and Oliver, 2004). This is in contrast to hypothesis-driven research that bases
the experimental design on a hypothesis.
1.1 Metabolite profiles
Metabolite profiling studies have been carried out for decades, but recently metabo-
lite profiling has attracted increased attention as a tool in functional genomics
and systems biology (Fiehn et al., 2000; Raamsdonk et al., 2001; Roessner et al.,
2001; Trethewey, 2001; Weckwerth and Fiehn, 2002; Weckwerth, 2003). The term
metabolome has been coined to describe the complete pool of metabolites in a
cell, and the metabolome is basically the sum of all metabolites in analogy to
the terms genome, transcriptome and proteome (see Table 1.1 for definitions). It
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Table 1.1 Definitions used in this thesis in relation to metabolites analysis
Term Definition
Metabolite A low-molecular-weight chemical compound that is re-
lated to metabolism, but not directly derived from the
genome and nor structurally bound in the cell
Metabolome The complete set of metabolites associated with a
cell/organism at any given time. The metabolome is sub-
divided into the endo- and exo-metabolome that cover the
intra- and extra-cellular metabolites, respectively
Metabolite profiling Chemical analysis of numerous metabolites
Metabolic fingerprinting A chemical signature or snapshot of (intracellular) meta-
bolites in crude extracts. The fingerprints are mainly used
for classification and biomarker discovery
Metabolic footprinting Metabolic footprinting is equivalent to metabolic finger-
printing, but covers analysis of extracellular metabolites.
The term is primarily used in microbial metabolomics
Metabolomics The research field focussing on comprehensive chemi-
cal analysis of the metabolome and integration of data
through data mining and biochemistry (Figure 1.2)
covers the comprehensive set of all low-molecular-weight molecules (metabolites)
associated with a cell at any given time. The metabolome can be divided into
the endo- and the exo-metabolome that cover the metabolites inside and outside
the cell, respectively. In these sub-metabolomes some metabolites are present in
both the endo- and the exo-metabolome, since they are transported across the
cell membrane. A major part of the metabolome (the primary metabolites in the
central metabolism) is conserved across species, and this property makes it pos-
sible to develop generic analytical techniques that can be applied across species
even when the genome sequence is unknown.
The central dogma in biology hierarchically links genes, transcripts and pro-
teins, but as such the metabolites cannot be characterized as a direct product of
proteins (Figure 1.1). Nevertheless, proteins catalyze the conversion of metabo-
lites, which make metabolite profiles an imprint of physiological states. The cat-
alytic activity of enzymes is a prerequisite for metabolic reactions, and metabo-
lites are therefore indirectly a downstream product of gene expression (Fiehn,
2002; Schmidt, 2004; Nielsen and Oliver, 2005; Schreiber, 2005). Metabolites are
the intermediates of biochemical reactions that are parts of metabolic pathways.
These pathways are interconnected and hereby constitute a metabolic network
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that is the functional machinery in a living cell. Metabolite concentrations are
determined by the enzyme kinetics of the different pathways that produce and
consume the metabolites, and hence the metabolite concentrations are indirectly
influenced by gene transcription, mRNA translation, protein-DNA interactions,
protein-protein interaction, posttranslational modifications etc.
The metabolic network of S. cerevisiae has recently been reconstructed in silico
(Forster et al., 2003). The model represents the current knowledge of the major
biochemical reactions present in S. cerevisiae and consist of approximately 1,200
reactions involving around 600 metabolites. Using this model the connectivity
of the metabolic network can be inspected using graph theory, which results in
a very compact graph (Nielsen, 2003; Nielsen and Oliver, 2005). The metabolic
reactions are incorporated in the graph by connecting the reaction substrates to
the catalyzing enzyme and further on the reaction products. This way the web
of metabolic reactions are represented in a bipartite graph consisting of both
metabolites and enzymes as nodes. Analysis of this graph shows that more than
70% of the metabolites are participating in more than just two metabolic reactions
and thus indicating the compact and highly connected structure of the graph.
Given this fact, it is evident that only a minor perturbation of the metabolic
network will result in a global response in the metabolite pools. This can be seen
as both an advantage and disadvantage. The advantage is that the metabolite
levels are very likely to reflect a change in e.g. the genome, but on the other hand
it is difficult to locate the reason for the change due to the wide-spread effects it
might have.
Metabolite concentrations are the variables that to some extend control the
metabolic fluxes. From the theory of metabolic control analysis (MCA)1 it is
known that changes in enzyme activities might have a little effect on the related
fluxes, whereas they are very likely to have significant effects on the concentrations
of metabolites. Teusink et al. (1998) applied MCA to theoretically investigate
a metabolic network perturbation. Specifically, mutants of the 2,6-bisphospho-
fructokinase encoded by PFK26 and PFK27 in the glycolytic EMP pathway
were investigated. The theoretical results of the MCA showed that steady-state
metabolite concentrations of the pathway would be affected by the mutation and
this was later experimentally confirmed by Raamsdonk et al. (2001). In addition
to this Raamsdonk et al. (2001) introduced a functional genomic approach by
1H-NMR (nuclear magnetic resonance spectroscopy, see Section 3.1.2) analysis of
metabolite extracts and solely based on the NMR data it was possible to clus-
ter the different mutants. And even analysis of extracellular metabolites using
direct infusion mass spectrometry (MS) proves to allow discrimination of various
1MCA is the sensitivity analysis of metabolic fluxes and metabolite concentrations in
metabolic pathways.
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mutants (Allen et al., 2003).
Metabolite quantities provide integrative information of the many different
processes operating in a living cell, and therefore they are very likely to be re-
porters of developmental, genetic and environmental changes, which to some de-
gree is complementary to the genetic information (Oliver et al., 1998; Raamsdonk
et al., 2001; Allen et al., 2003, 2004).
1.2 Metabolomics
The definition of metabolomics and related terms are still a matter of some debate,
and to enlighten the definitions Table 1.1 contains a list of the definitions used
in this thesis. Metabolomics has been defined as the quantitative analysis of
the complete metabolome (Fiehn, 2002), which is equivalent to global metabolite
profiling. I argue that there is more to metabolomics than just comprehensive
metabolite profiles. Metabolomics should be considered as a research area rather
than an analytical approach as already discussed by Villas-Boas et al. (2005).
Of course comprehensive chemical analysis of the metabolite pools (metabolite
profiling) is a prerequisite for metabolomics research to give global metabolic
states; but along with this, data mining and biochemistry will have a major impact
on the interpretation of data, which is required for metabolomics to succeed. In
Figure 1.2 the three major components of metabolomics: chemical analysis, data
mining and biochemistry are integrated.
Metabolomics covers an integrated approach, which includes the functional
level of metabolites in a cell. Genome-scale models of metabolic networks can be
constructed through combination of genome sequences, biochemistry and litera-
ture (Borodina and Nielsen, 2005; Edwards et al., 1999; Palsson, 2000), and these
comprehensive models represent the scaffold for the metabolome and opens up for
integration of upstream functional levels like proteins, mRNAs and genes. The
genome-scale models contain a large number of metabolites and these metabolites
can serve as templates driving the metabolome analysis.
A major challenge at present is to fully access the metabolome and there is
still some way to go to be able to completely cover the full metabolic network. A
number of analytical techniques has to come into play to measure the metabolome.
MS has for many years had a central position in metabolite analysis, and MS is
expected to be one of the primary technologies for analysis of the metabolome,
since MS has the sensitivity and specificity required for metabolome analysis.
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BiochemistryData miningChemical analysis
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Metabolic networks
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Figure 1.2 Metabolomics is comprehensive metabolite profiling in combination with data
mining, which can be structured by biochemistry. Both metabolite data and biochemistry
has to be combined and integrated in the data mining.
1.3 Thesis overview
The aim of the research, which is presented and discussed in this thesis, has
been to explore strategies to pursue metabolites as genetic markers, since there
is an increasing interest for metabolites as functional markers. The potential
is large and the power of comprehensive metabolite profiling has already been
shown. While the degree of insight gained from the metabolite profiles is still
limited, this thesis communicates different concepts that have been investigated
to improve the interpretation of metabolome data with focus on MS.
The thesis composes eight chapters, which can be read independently. After
this introductory chapter, the following three chapters present background infor-
mation and discuss aspects of MS, metabolite profiling and data analysis with
emphasis on metabolomics. Chapter 2 provides some basics of MS in relation to
metabolite profiling and is primarily devoted to technological descriptions. Then
Chapter 3 proceeds by reviewing different approaches for metabolite profiling
with emphasis on mass spectrometry associated techniques and a few examples
of nuclear magnetic resonance spectroscopy (NMR) – another powerful technique
for metabolomics. The chapter is partly adapted from Publication 4. Hereafter,
Chapter 4 outlines considerations regarding data handling and analysis with spe-
cific emphasis on MS data.
A considerable part of chemical analysis of metabolites is sample preparation
and Chapter 5 deals with sample preparation protocols for the yeast S. cerevisiae.
This work results from a collaboration with former PhD student Silas G. Villas-
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Boˆas and the chapter corresponds to Publication 1.
Chapter 6 describes the growth of Saccharomyces cerevisiae in microtiter
plates, which potentially can ease the handling of many samples. The results
emphasize the potential of using different carbon sources. The experimental work
was assisted by visiting student Nicolas Moreau.
The next chapter, Chapter 7, is a submitted manuscript (Publication 2), which
is addressing the capabilities of electrospray ionization MS for detection of the
yeast metabolome. Furthermore, the manuscript is an initiation of construction
of a spectral library containing tandem mass spectra of primary metabolites. The
metabolites are analyzed by electrospray MS in both positive and negative mode.
It is a considerable task to cover the full metabolome and at present data for
66 metabolites are contained in the library. The application of the list of yeast
metabolites is then used to deduce biological information for metabolic footprint
of S. cerevisiae.
Finally, the thesis is concluded in Chapter 8 by discussion of the presented
results in Chapters 5–7. Further the concept of dynamic footprinting is presented
with some preliminary results arising from a collaboration with Sandrine Mas and
Michael Edberg Hansen. Dynamic footprinting extends the metabolic footprinting
approach by investigating the dynamics in metabolic footprinting during the time
course of a batch cultivation.
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Chapter 2
Mass spectrometry for
metabolomics
Comprehensive metabolite profiling requires sensitive and specific methods that
can determine a wide range of chemical compounds varying in polarity and con-
centration range. Mass spectrometry (MS) fulfills these requirements to a large
extent and development of biological MS has been one of the major driving forces
in the development of metabolomics. MS presents a versatile technology and mass
spectrometers can be used to resolve complex samples either on its own or in con-
nection with separation techniques (Chapter 3). The mass spectrometer provides
high sensitivity and at the same time structural and chemical information.
The basic function of a mass spectrometer is to determine the mass-to-charge
ratio (m/z) of charged compounds, where m is the ion mass measured in daltons1
(Da) and z is the number of elementary charges. To do this, the mass spectrometer
needs an ion source, where the ions are formed; a mass analyzer in which the ions
are separated bym/z; and a detector quantifying the ion abundance by measuring
the ion current or count. Between the ion source and the mass analyzer there are
a series of ion lenses and ion optics that focuses and guides the ion beam to the
mass analyzer situated in the high vacuum envelope of the mass spectrometer. A
schematic overview of the mass spectrometer is shown in Figure 2.1.
In this section, some basics on MS technologies within the field of metabolite
profiling will be presented by mainly describing ionization techniques and mass
analyzers.
1The mass unit dalton (Da) is defined to be 1/12 of the mass of one 12C atom equal to
12 × 10−3 kg mol−1, thus 1 Da = 1× 10−3 kg mol−1/NA = 1.661 × 10−27 kg, where NA =
6.022× 1023 mol−1 is Avogadro’s constant.
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Figure 2.1 Schematic overview of a mass spectrometer. The mass spectrometer consists
of an ion source where the compounds are ionized, and a series of ion lenses and ion optics
that guides the ions to the mass analyzer and the detector in vacuo. A series of vacuum and
turbo pumps maintain the vacuum.
2.1 Ionization processes
To measure the mass by MS, it requires a charged molecule, an ion, present in
the gas phase. There are multiple ways to produce ions for mass spectrometric
detection; however, for metabolite profiling electron impact ionization (EI) and
electrospray ionization (ESI) are predominantly used when connected to gas and
liquid chromatography, respectively.
2.1.1 Electron impact ionization
EI is a classical ionization technique and is used in connection with gas chromatog-
raphy (GC). The EI process takes place in vacuo where the analyte molecule is
ionized by passing a beam of energized electrons emitted from a heated filament.
The electrons are accelerated to an energy of 70 eV (electron volts). When an
electron hits the molecule, it may knock of another electron and hereby ionize the
molecule by production of a positively charged radical ion (Equation 2.1). The
radical ion (M•+) is called the molecular ion and has the same molecular mass as
the molecule (except the mass of an electron2).
M + e− −→ M•+ + 2e− (2.1)
2The mass of an electron is me = 5.486× 10−4 Da.
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The impact with energetic electrons at 70 eV leaves some of the molecular
ions with excess energy that is sufficient to mediate bond breakage and subse-
quent production of smaller fragment ions (Equation 2.2). The ionization energy
of 70 eV is high compared to the energy of a covalent bound (typically 3–7 eV),
and therefore the EI process is considered as a hard ionization process. By EI,
most ions produced are single charged and therefore the m/z determined by MS
conveniently corresponds the m of the (fragment) ion. However, due to the rela-
tively high ionization energy the molecular ion is predominantly fragmented and
therefore not always present in the spectrum to reveal the molecular mass.
M•+ −→ M+1 +M•2
M+3 +M4
↗
M+1 −→ M+5 +M6 (2.2)
↘
M+7 +M8
...
etc.
The fragmentation pattern (relative occurrence of fragment ions) will be char-
acteristic for the molecule and comparable to a molecular fingerprint well suited
for identification. The ionization energy of 70 eV is the standard energy for EI and
the ionization has proven to be very robust and give reproducible fragmentation
patterns over time and for different instruments. This has allowed compilation
of comprehensive spectral databases/libraries enabling confident identification of
compounds (Halket et al., 2005).
2.1.2 Electrospray ionization
For many years, coupling of liquid chromatography (LC) to MS was hindered by
the incompatibility of liquid flows at atmospheric pressure and vacuum in the mass
spectrometer. Simple injection of liquid into vacuum induces an extensive volume
expansion and results in collapse of vacuum. Introduction of atmospheric pressure
ionization (API) techniques in the mid 1980’ies came around these obstacles and
revolutionized the mass spectrometric analysis of biomolecules, because it enabled
ionization from a liquid phase and an easy coupling of LC to MS.
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The most popular API technique is ESI, which is frequently used in biological
mass spectrometry. In ESI, high voltage (2–5 kV) is applied to a conducting cap-
illary through which a liquid solution is pumped and electrospray occurs from the
tip of the capillary. The mechanism underlying ESI is still a matter of some debate
and not fully understood, but there is a general consensus that the ESI combine
three major processes: i) the production of charged droplets from solvent contain-
ing electrolytes, ii) droplet shrinkage by solvent evaporation and repeated droplet
disintegration (fission) leading to highly charged droplet from which iii) gas-phase
ions are produced (Kebarle and Tang, 1993).
The electrical potential at the tip of the capillary partly separates negative
and positive ions in the solution by electrophoretic movement. In positive mode,
positive ions are enriched at the liquid surface at the capillary exit. The over-
representation of positive charge at the surface mediates repulsion and along with
the pull of the electrical field, the liquid elongates into filaments – referred to as
the Taylor cone. At a certain point the force of charge repulsion and attraction to
the counter-electrode exceeds the surface tension and small droplet are emitted
from the tip of the Taylor cone as illustrated in Figure 2.2. This produces a fine
spray of droplets with a surplus of positive charge. The droplet size is dependent
on the liquid composition, the flow rate, the viscosity and ionic strength in the
liquid. Mostly, the droplet diameter is around 1–2 µm, when spraying from normal
size capillaries around 0.1–0.2 mm in inner diameter (Kebarle, 2000; Cole, 2000;
Cech and Enke, 2001). In nano-electrospray very small needles less than 10 µm
in outer diameter produces droplets with diameters in the nm-range.
The droplets shrink in size due to solvent evaporation and consequently the
charge density increases, which leads to Coulomb fission at 70%–80% of the
Rayleigh limit3. The Coulomb fission produce tiny off-spring droplets from a
”tail” (Taylor cone) of larger non-spherical droplets (Gomez and Tang, 1994) as
illustrated in Figure 2.2. The process repeats for the smaller droplets and ul-
timately, highly charged and very small droplets of few nanometers in size are
formed from which gas-phase ions are produced. The actual mechanism for pro-
duction of gas-phase ions from tiny charged droplets is still not fully understood,
but there seems to be two models describing the process, the ion evaporation
model and the charge residue model. In brief, 1) the ion evaporation model pro-
poses emission of single gas-phase ions directly from tiny charged droplets when
these reach a certain diameter, and 2) the charge residue model proposes that
ultimately only one charged residue is left in the droplet and hence after evap-
oration of the final solvent the charged residue (ion) is present in the gas phase
(Cole, 2000; Kebarle and Tang, 1993; Kebarle, 2000).
3The Rayleigh limit is the droplet radius at which the force of electrostatic repulsion equals
the surface tension force.
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While the positive charges emerge from the Taylor cone at the tip of the
capillary, oxidation processes releasing electrons occur at the interface between
the capillary and solution. E.g. in aqueous solutions, the oxidation of water
releases H+ that can affect the pH and subsequently the mass spectrum through
changed ionization properties.
The ESI mechanisms are less studied in negative mode and at present also
less frequently used than positive mode. For simplicity only the mechanism has
been described for positive ESI, but the fundamental mechanism is the same in
negative mode just with opposite charges, i.e. in negative mode the electrophoretic
movement will be reversed, so that the negative ions will accumulate on the surface
of the liquid filament and reduction reactions will occur at the capillary wall.
Many factors influence electrospray and do have an impact on the spray, e.g.
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Figure 2.2 Electrospray ionization is performed by applying high voltage to a conducting
capillary through which a solution is flowing. Through formation of a liquid filament called
the Taylor cone the liquid emerge into fine charged droplets that ultimately yield ions in the
gas phase. The figure summarizes the overall ESI process in positive mode. The circle in
the top illustrates the generation of off-spring droplets from a tail of a larger, non-spherical
droplet by Coulomb fission (Gomez and Tang, 1994).
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the organic solvent content in the liquid, modifiers, the surface activity of the
analyte, the ionic species, the ionic strength etc. To obtain electrospray and
formation of the Taylor cone it is required to have electrolytes (ions) present in
the solvent, but the ionization is matrix dependent and one molecule does not
necessarily yield a unique mass spectrum, which makes ESI spectra less robust
compared to EI for application of database searches for identification. E.g. trace
amounts of sodium ions can suddenly result in increased sodium adduct forma-
tion in ESI. As a rule-of-thumb volatile acids improve the ionization in positive
mode by providing excess of protons to charge the compounds. For negative ESI,
Wu et al. (2004) studied the influence of different modifiers on the negative elec-
trospray ionization and found that weak acids can have a favorable effect on the
ionization efficiency.
The ESI process depends strongly on the composition of the solution, the
so-called matrix effects, that can change the ionization efficiency and lead to sup-
pression or amplification of the ionization. One major reason for these phenomena
is changes in the ionic strength and surface tension in liquid that will affect the
charge distribution in the droplet and on its surface caused by modifiers or co-
eluting substances (Matuszewski et al., 2003; Taylor, 2005). High concentrations
of buffers and especially non-volatile buffers are incompatible with ESI and will
leave you with low signal, if any at all. The buffer will simply snatch the charge
from the molecules of interest. Application of volatile buffers consisting of e.g.
formic or acidic acid and ammonia is however a way to reduce the ion suppres-
sion caused by buffers (McCalley, 2003). A recommended concentration range of
electrolytes for ESI is around 10−5–10−3 M (Kebarle, 2000).
The ionization can be obtained by protonation [M + H]+ or deprotonation
[M−H]−, but adduct formation with e.g. Na+, NH+4 or Cl− is common. Solvent
adducts may also appear, e.g. [M + CH3CN + H]+, [M + CH3CN + Na]+ and
[M+CH3OH+H]+, and more complicated ions like [2M+H]+ and [M−H+2Na]+
are also found. The latter may indicate the presence of a carboxylic acid group,
where the carboxylic acid group is dissociated and binds a sodium ion apart from
the whole molecule forms a sodium adduct. For larger biomolecules like peptides
and proteins multiple charged ions [M + nH]n+ are very common.
2.2 Mass analyzers
After production of the ions by ionization in the ion source the ions enter the mass
analyzer. The mass-to-charge ratios of the ions are determined by guiding the
ions through a mass analyzer to a detector, where a computer is used to acquire
the mass spectrum by summarizing the ion statistics. There are several mass
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Figure 2.3 The quadrupole is constructed of four metal rods with an DC and RF voltage
applied. The ion path through the quadrupole is determined by the DC and RF voltage
applied to the rods. The resonating (stable) ions will follow a fluctuating trajectory through
the rods of quadrupole and hereafter reach the detector as illustrated by the dashed line.
Unstable ions will collide with the rods and not reach the detector.
analyzer technologies available for separation of ions prior to detection and in this
section the quadrupole, the ion trap and the time-of-flight (TOF) technologies are
described. A summarizing overview of the mass analyzers are given in Table 2.1
in the end of the section.
2.2.1 Quadrupole
The quadrupole is one of the technically simpler mass analyzers available and
it presents a versatile and robust technology that is fairly easy to operate. The
quadrupole acts as a mass filter that allows passage of ions with a set mass-to-
charge ratio to reach the detector. By scanning the filter mass, spectra covering
an m/z range from 2 Da/e up to about 4000 Da/e can be recorded. For a stan-
dard instrument, unit mass resolution allows mass determination within 0.3 Da,
but in the recent years high-resolution quadrupole instruments have also become
available.
The quadrupole is constructed of four parallel metal rods arranged as illus-
trated in Figure 2.3. The two sets of diametric rods are electrically connected and
a radio frequency (RF) voltage V cos(ωt) and an off-set (DC) voltage U (elec-
trical potential) is applied across the two pairs (Figure 2.3). Before entering the
quadrupole, the ions are accelerated to the same translational energy and they
enter the quadrupole through a hole that determines the width of the ion beam.
In the quadrupole, the ions start to fluctuate in the xy-plane (Figure 2.3), while
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the movement along the z-axis is ideally unaffected by the quadrupole field and
determined by the acceleration voltage applied before the quadrupole entrance.
The trajectory of the ion flight path through the four rods is given by the ampli-
tude of the oscillating RF potential and the constant DC potential; and depending
on the m/z of the ion, it will either resonate and pass through the quadrupole for
detection or collide with one of the rods (Steel and Henchman, 1998).
The quadrupole can be operated as mass analyzer in two modes referred to a
selected ion mode (SIM) and scan mode. In SIM, the U and V are kept constant
and tuned to allow transmission of a specific m/z. This results in very sensitive
and specific detection of the selected ion as all the analysis time is spend to
monitor this particular ion. No spectrum is recorded and thus no identification
and structure elucidation is possible. Therefore, SIM is primarily used for targeted
analysis or trace analysis, where maximal sensitivity is required. To record a mass
spectrum, the quadrupole is scanned (scan mode) by ramping the DC and RF
voltages, while maintaining the ratio between those (U/V ) constant. Hereby
a m/z range can be covered and combined into a mass spectrum. The larger
the mass range the longer the scan time, which decreases the sensitivity because
relatively less time is used on measuring the individual masses.
2.2.2 Ion trap
The ion trap is comparable to the quadrupole and can be described as a three-
dimensional quadrupole that traps the ions in a potential well, formed by a three-
dimensional electrical field. To be more correct the ion trap is actually named
a quadrupole ion trap (QIT). In contrast to the quadrupole that continuously
transmits resonating ions the QIT works by first trapping the ions in the potential
well and then ejecting the ions to reach the detector. Hence, the full duty cycle of
a QIT consists of ion injection, ion trapping, and finally ion ejection for detection.
The QIT is constructed of a ring electrode and two end-caps that form a
cavity in the center of which the ions can be trapped (Figure 2.4). A DC and
RF potential U + V cos(ωt) is applied to the ring electrode and the end-caps are
grounded (March, 1997). The potentials define the ion trajectories and in regions
of stable ion trajectories, the ions will be trapped and move in a complex saddle-
form fashion within the trap (Forbes et al., 1999). The maximum mass range
for trapped ion is obtained by only applying the RF potential and leaving the
DC potential at 0 V (March, 1997). The trapped ions can then be ejected from
the trap for acquisition of a mass spectra. The ion trajectories are destabilized
by increasing amplitude of the RF voltage, which will lead to ejection of ions
to the detector in ascending order according to m/z. The ejection is caused by
destabilization in the direction of the end-caps and the ions are ejected through
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Figure 2.4 The (quadrupole) ion trap is constructed of a ring electrode and two end-caps
that form a cavity in which ions can be trapped. The ions arrive from the ion source and
are trapped in stable cloud in presence of helium (small white dots) to decrease the kinetic
energy of the ions (black circles). By manipulation of the electrical field in the trap the ions
are ejected to the detector in an ascending order according to mass-to-charge ratio.
holes in the end-caps (March, 1997).
Helium gas is present in the ion trap at around 0.13 Pa to reduce the kinetic
energy and stabilizing the ions in the trap. The helium gas helps dapping the
motion of ions by low-energy collisions and concentrate them in the center of the
trap, which allows a faster duty cycle for trapping and ejection.
A strong feature of the QIT is its ability to perform multiple fragmentation cy-
cles (MSn). The ion of interest is isolated in the QIT and by increasing the kinetic
energy, fragmentation is induced by collision of the ion with the helium already
present in the trap. After collision-induced fragmentation, the QIT contains the
daughter ions that can be ejected to the detector giving a tandem mass spectrum.
This cycle can be repeated and thus enabling MSn (Jonscher and Yates, 1997;
March, 1997).
2.2.3 Time-of-flight
The TOF analyzer is far more intuitive and easy to understand than quadrupole
and QIT. The ions are directed into a flight tube of a certain length and hence
the flight time can be related to the m/z of the ions. There are no complicated
trajectories that arise from electrical or magnetic fields constraining the ions in
the flight tube. After acceleration, they follow at simple flight path at constant
velocity.
Ions carrying a charge of q = z e with z being the number of elementary
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Figure 2.5 The time-of-flight (TOF) mass analyzer determines the mass-to-charge ratio
of ions by measuring the time it takes the ions to fly along an evacuated flight tube. The
pusher pushes the ions into the flight tube and when they reach the reflectron in the end of
the flight tube they are reversed and directed to the detector. The reflectron functions as an
electric mirror that reduces dispersion in energy and improves mass resolution by lengthening
the flight path.
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charges and e the elementary charge of an electron, are accelerated through an
electric potential (U) to obtain the translational energy (Eacc) of
Eacc = q U = z e U, (2.3)
which equals the kinetic energy relating the mass m and velocity v as
Ekin =
1
2
m v2. (2.4)
After acceleration, the velocity is constant in vacuo and it can simply be deter-
mined by measuring the time of flight (t) of the ion in an evacuated flight tube of
constant length (d):
d = v t. (2.5)
Combining Equations 2.3, 2.4 and 2.5 gives the relation between the mass-to-
charge ratio (m/z) and time of flight:
m/z =
2 e U
d2
t2, (2.6)
where it is found that m/z is proportional with the squared flight time. Thus,
there is higher spacial resolution between lighter ions compared to heavier ions.
Instruments tuning is important for optimal performance of mass analyzers.
During tuning of TOF instruments, the ion optics are optimized to transmit ions
from the ion source to the mass analyzer in a narrow beam – the narrower (and
thereby less disperse) a beam is the higher the mass resolution. The beam enters a
pusher that by an instantaneous electric pulse pushes an ion package orthogonal to
the beam direction (Figure 2.5). The pusher potential determines the acceleration
that ideally should give ions the same energy (Eacc) and hence, ions with the same
m/z should obtain the same velocity and reach the detector at the same time.
However, in reality the velocity varies and some equivalent ions are slower and
some faster, which eventually will affect the mass resolving power. To correct for
the variation in energy a reflectron can be inserted in the end of the flight tube.
The reflectron acts like an electric mirror that doubles the flight path (and time)
and at the same time also evens out velocity variation for equal mass ions. The
reflectron reverses the ion movement and the reflection is obtained by repulsion in
a series of increasing electrical fields. The faster the ion the earlier the ion reaches
the reflectron and also the deeper the ion penetrates into the electrical fields and
vice versa for the slower ions. Thus, the flight distance gets adjusted according
to the actual ion energy to compensate for energetic dispersion, and consequently
the ions are focussed resulting in higher mass resolution.
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From each pusher impulse, all ions are pushed into the flight tube and the
flight time for ions of 1000 Da/e is typically less than 50 µs, thus next push
events can proceed right after all ions has reached the detector. From each push
a mass spectrum can be assembled and summarizing several push events into one
mass spectrum improves the ion statistics and reduces the noise level (and the
required disc space on the computer). The fast push events make it possible to
acquire spectra with short time intervals, which is ideal in combination with fast
separation techniques. Unlike the quadrupole, there is no advantages of using
SIM since all ions are pushed into the flight tube and needs to reach the detector
before the next push event.
2.3 Ion identification
The power of mass spectrometry is that it produces compound specific informa-
tion related to the elementary composition of the ion, and fragmentation reflects
compound structures. This does not only make detection by MS highly specific,
but can provide molecular information about unknown compounds (Fiehn et al.,
2000; McLafferty and Turecek, 1993).
All mass spectrometers have sufficient mass resolution to separate isotopes
(at least in the mass range of metabolites) and therefore they do not measure
the average molecular weight of ions, but rather the monoisotopic masses and
distinguish the different isotopes. For this purpose Table A.1 in Appendix A lists
the accurate mass and isotopes of the typical atoms in biomolecules.
Multiple charged ions can be identified from the isotope masses. If there is
less than one mass unit between the isotopes, then the ion is multiple charged,
e.g. if an ion is double charged the isotopes are separated by half of a mass unit.
Compounds containing an odd number of nitrogen atoms have a resulting
odd molecular mass. This is referred to as the nitrogen rule and can be helpful to
indicate the presence of nitrogen. Furthermore, high-resolution MS gives accurate
mass and makes it possible to determine candidates for the molecular composition
by searching the combinatorial space of molecular compositions in a narrow mass
range determined by the mass accuracy. This is indeed valuable information
in relation to identification of unknown components. The existence of different
isotopes of the same atom gives rise to isotope patterns that can support the
composition of a given ion in the mass spectrum. Thus, not only the mass, but
also the relative abundances of the isotope masses can be used to confirm the
actual ion composition (Kind and Fiehn, 2006; McLafferty and Turecek, 1993).
Especially, chloride, bromide and sulfur have characteristic isotope patterns.
As already mentioned in Section 2.1.2, ESI produces different adducts. Ta-
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Table 2.2 Typical adduct and fragment ions produced from electrospray ionization
(ESI) of primary metabolites
Positive ESI Negative ESI
Ion composition Mass change Ion composition Mass change
Adducts [M + H]+ + 1 [M−H]− − 1
[M + Li]+ + 7 [M + Cl]− + 35a
[M + NH4]+ + 18 [M + CHOO]− + 45
[M + Na]+ + 23 [M + CH3COO]− + 59
[M +K]+ + 39 [M + HSO4]− + 97a
[M−H+ 2Na]+ + 45 [M + H2PO4]− + 97
[M− 2H + 3Na]+ + 67
[M− 3H + 4Na]+ + 89
Fragments [M−NH3 +H]+ − 16 [M−H2O−H]− − 19
[M−H2O+H]+ − 17 [M−H3PO4 −H]− − 99
[M− CO+H]+ − 27
[M− CO2 +H]+ − 43
Multimers [2M + H]+ + M+ 1 [2M−H]− + M− 1
[2M + Na]+ + M+ 23
a Adduct ions have characteristic isotope pattern according to the adduct molecule
ble 2.2 summarizes the most frequent adducts and lists some of the common
fragments that can be used for ion identification and help to derive the molecular
mass.
2.4 Mass spectral data
For processing of data this section will give a brief overview of formats of mass
spectral data and considerations regarding comparison of multiple spectra. Mass
spectral data come in two forms: continuum or centroid. Continuum data cor-
respond to what is acquired by the mass spectrometer and centroid data are a
processed and compressed form that contains the centroid masses as illustrated
in Figure 2.6. The centroid data contain the primary information from the con-
tinuum data and efficiently save disc space on the computer.
For automatic comparison of two mass spectra binning is used to align data.
In order to bin the data a mass grid is defined and then the ions from the mass
spectrum are assigned to the corresponding mass bins (Figure 2.6). This way mass
spectrum is converted from a continuous scale to discrete bins which can easily be
aligned and organized into a matrix for several spectra. If more than one ion falls
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Figure 2.6 Mass spectra can be presented in two formats continuum (raw data) and cen-
troid (compressed data). The continuum spectrum contains the maximum information and
corresponds to the raw data, but takes up considerable storage space. The centroid spec-
trum is a compact and a processed variant of the continuum spectrum, which captures the
major spectral information. Binning of centroid data is used to align spectra. Here examples
of nominel (left) and high-resolution (right) data are shown. Taken from Smedsgaard and
Nielsen (2005).
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in the same bin, the binning will result in loss of information. For nominal mass
spectra a bin width of 1 Da is appropriate, otherwise the bins can be designed
using a priori knowledge about mass precision and data type (Smedsgaard and
Nielsen, 2005).
When comparing multiple mass spectra the data need to be brought to the
same scale by normalization in order to properly compare the data. There are
varies ways of doing this. Sum normalization is done by dividing the intensity of
the individual ions in the mass spectrum by the total sum of intensity. Alterna-
tively, the maximum peak (base peak4) can be used to scale the spectrum. In
case an internal standard or a marker is present in the spectra, its corresponding
intensity can also be used for normalization.
From a series of mass spectra, e.g. obtained from a chromatographical run,
the data are three-dimensional (time, mass and intensity), and different (two-
dimensional) chromatograms can be extracted from the data:
Total ion chromatogram (TIC) is the sum of all ion intensities in each mass
spectrum as a function of time
Base peak chromatogram (BPC) is the intensity of the base peak in each
mass spectrum as a function of time
Extracted ion chromatogram (EIC) is the intensity of a specified ion as a
function of time
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Chapter 3
Metabolite profiling
platforms in metabolomics
The degree of chemical heterogeneity increases from DNA to metabolites. DNA
and RNA are polymers of 5 nucleotides and proteins are composed of 22 amino
acids. Indeed proteins are much more diverse than DNA and RNA, but anyhow
much more homogenous than metabolites. Particularly, when they are digested
to peptides. Metabolites vary in chemical and physical properties from ionic and
hydrophilic to lipophilic. This makes it challenging to cover the complete set of
metabolites in one go.
This chapter will give an overview of metabolite analysis techniques in metabol-
omics. The emphasis will be on applications based on MS and a short introduction
of nuclear magnetic resonance spectroscopy (NMR) is included, since NMR along
with mass spectrometry (MS) are the two most prominent candidates to under-
take the analytical challenges in metabolomics.
3.1 Fingerprinting
The principle of fingerprinting is to capture a snapshot of a metabolic extract and
the fingerprinting technique is used to obtain a metabolic fingerprint (or foot-
print; see Table 1.1 for definitions). It is comparable with a picture developed
from physical properties of the metabolites, e.g. mass, nuclear spin, bond vibra-
tion, light absorption etc. The data acquisition is fast and data can be reduced to
a 2-dimensional space representing the physical property orthogonal to the mag-
nitude. Some qualitative and quantitative information might be present in the
data, but this is not a prerequisite for fingerprinting.
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3.1.1 Direct infusion MS
Direct infusion MS is a mass spectral fingerprint of a sample injected directly into
the ion source of a mass spectrometer. Some metabolites from the sample are
ionized and enter the mass analyzer, in which they are separated according to
mass (Chapter 2). The outcome of the analysis is a mass spectrum comprising
the metabolite sample composition to a certain extend. The analysis time is short
typically lies in the range of three to five minutes.
Direct infusion MS has successfully been used in different classification stud-
ies. Smedsgaard and colleagues (Smedsgaard, 1997; Smedsgaard et al., 2004;
Smedsgaard and Nielsen, 2005) have used direct infusion MS to profile secondary
metabolites from filamentous fungi for chemotaxonomy, where closely related
species of Penicillium were classified. From the mass spectral data several sec-
ondary metabolites could be identified based on masses and isotope patterns.
Similarly, direct infusion MS was used for identification of bacteria by analysis
of crude cell extracts (Vaidyanathan et al., 2002). Here, five bacterial strains
were studied and the predominant biomakers from the analysis were found to be
phospholipids, glycolipids and proteins. In a functional genomic context, Allen
et al. (2003) analyzed the extracellular metabolite profiles (footprints) of single
knock-out strains of the yeast Saccharomyces cerevisiae by direct infusion MS.
The results proved that mutants with related genotypes express similar extracel-
lular metabolite profiles and the concept was applicable for assignment of gene
functions by guilt-by-association. Extension of this strategy demonstrated that
metabolic footprinting also can be used to determine mode-of-action of antifungal
compounds (Allen et al., 2004).
Matrix effects may cause interference during direct infusion MS analysis as
discussed in Section 2.1.2, and there is a risk of favoring metabolites with high
ionization efficiency, since all metabolites are ionized together. However, samples
obtained from similar chemical conditions can provide information about changes
in metabolic states as discussed in Chapter 8. Quantitative analysis by direct
infusion MS is rare, but Nagy et al. (2003) analyzed amino acids in blood spots by
direct infusion tandem MS, where addition of isotope-labeled internal standards
allowed quantification of 19 native amino acids.
Application of high resolution mass spectrometers can increase the chemical
information from direct infusion MS, since they make it possible to determine the
accurate mass of compounds. Even compositional different compounds that have
the same unit mass can be separated on the mass scale, e.g. lysine (C6H14N2O2;
M = 146.1055 Da) and glutamine (C5H10N2O3; M = 146.0691 Da), and from
the accurate mass measurement the elemental composition can be directly com-
puted (Smedsgaard and Nielsen, 2005; Aharoni et al., 2002; Sleno et al., 2005).
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Conformational isomers can not be resolved by MS alone simply because they
will have the same mass, but tandem MS or coupling of separation techniques in
front of the MS can help this out. Combination of separation techniques with MS
tremendously improves the resolution of complex samples, see Section 3.2.
3.1.2 Nuclear magnetic resonance spectroscopy
NMR is a versatile technology and probably the technique of choice when it comes
to detailed structure elucidation of purified metabolites, but NMR is also widely
applied for metabolic fingerprinting. NMR relies on the nuclear spin of atomic
nuclei. The nuclear spin is posed by unpaired protons and neutrons and makes the
nuclei act like small magnets and thus e.g. 1H, 13C, 15N and 31P can be analyzed
by NMR.
The sensitivity is not as high as for MS; however, NMR does not discriminate
between metabolites in the samples and thereby present an unbiased technique for
metabolite fingerprinting that is quantitative even in complex mixtures. Nichol-
son and co-workers have pioneered the application of NMR for metabolite finger-
printing (Bollard et al., 2005; Lindon et al., 2003). In particular, they analyzed
urine and blood by NMR and successfully identified biomarkers for diagnostics.
Fingerprinting by 1H-NMR of a metabolite extracts from yeast was proposed
for assignment of unknown gene functions. The analysis of six yeast knock-out
strains proved to classify and relate the genotypes by multivariate statistics, which
potentially can be applied for functional genomics (Raamsdonk et al., 2001).
NMR is non-destructive and therefore in vivo analysis is also possible. Inser-
tion of a special probe into the NMR instrument makes it possible to grow micro-
bial cell in suspension and hereby perform non-invasive studies of the metabolite
concentrations in a dynamic state (Gmati et al., 2005; Gonzalez et al., 2000; Neves
et al., 2005; Weuster-Botz and de Graaf, 1996).
3.2 Metabolite profiling
Adding separation in time to the detection method brings us to metabolite profil-
ing. This strategy provides increased resolution in comparison with fingerprinting,
and the metabolites will be at least partly separated and detected individually.
This adds another dimension to the data and the combination of a separation tech-
nology and MS gives a 2-dimensional separation in time and mass as illustrated
in Figure 3.1 with intensity then being the third dimension.
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Figure 3.1 The combination of a separation technique and mass spectrometry provides a
very powerful platform that enables high resolution and sensitive detection
3.2.1 Gas chromatography coupled to MS
Any chromatographic technique is based on distribution between a stationary
phase and a mobile phase. In gas chromatography (GC), the mobile phase is a
gas and therefore the molecules that are to be analyzed are required to be volatile
enough to be evaporated to the mobil carrier, which normally is helium. GC can
be used to analyze the volatile part of the metabolome and although this part
might often be neglected, it does provide insight into metabolism and taxonomy
(Larsen and Frisvad, 1994; Karlshoj and Larsen, 2005). On the other hand, many
metabolites are small polar molecules that are not readily evaporated into the gas
phase. This can be overcome by derivatization that converts the functional polar
groups in the molecule into non-polar groups.
A classical derivatization reaction is silylation, where active hydrogen atoms
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from hydroxyl, amine, thiol and carboxylic acid groups are substituted by silyl
groups, e.g. trimethylsilyl [−Si(CH3)3] or tert-butyldimethylsilyl [−Si(CH3)2C4H9].
The reactions proceed under strictly anhydrous conditions at slightly elevated
temperature and produces derivates that are generally less polar, more volatile,
and thermally more stable than the parent compound. The derivatization reac-
tion is very versatile and covers most primary metabolite although not all of them
will end up being volatile (Halket and Zaikin, 2003; Koek et al., 2006; Roessner
et al., 2000). Alternatively, alkylation can be used for derivatization of functional
group with acidic or basic hydrogen atoms, e.g. carboxylic acids, and primary
and secondary amines (Halket and Zaikin, 2004). Chloroformates is used for alky-
lation and have been suggested as a good alternative for silylation. They have
successfully been applied in analysis of amino and organic acids in blood (Husek,
1995, 1998) and metabolite extracts (Villas-Boas et al., 2003, 2005). One of the
major advantages of the chloroformate reaction is that it can be performed un-
der partly aqueous conditions and at room temperature, but it does not enable
analysis of sugars and sugar derived compounds as these are not derivatized. One
thing to keep in mind is that the derivatization reaction rarely results in a single
product, but multiple byproducts may be formed. This complicates the chro-
matograms and makes the data analysis more cumbersome, since one peak does
not necessarily correspond to one metabolite.
Coupling of capillary GC to MS combines two strong technologies. GC of-
fers high separation efficiency between even similar compounds whereas MS pro-
duces compound-specific mass spectra that may resolve co-eluting compounds.
Metabolite profiling of plants has significantly contributed to the field of metabo-
lite profiling by GC-MS (Fiehn et al., 2000; Roessner et al., 2000, 2001) and
the methodologies can readily be transferred to microbial metabolite profiling
(Strelkov et al., 2004). Recently, two-dimensional GC (GC×GC)-TOF-MS in-
struments have been applied for metabolite profiling and this is currently the
most comprehensive GC-based technology available. Two-dimensional GC en-
ables very high chromatographic resolution and high scan rates from the TOF
mass spectrometer makes it possible to resolve very complex samples with high
sensitivity (Kell et al., 2005; Jover et al., 2005; Adahchour et al., 2006). The data
are further resolved compared to conventional GC-MS and GC×GC-MS can be
considered as 4D-data.
3.2.2 Liquid chromatography coupled to MS
Introduction of atmospheric pressure ionization (API) techniques opened up new
possibilities for metabolite profiling. The coupling of liquid chromatography (LC)
to MS became reality and LC-MS instruments are nowadays standard equipment
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in many labs. Till today the major applications of LC-MS have been within
environmental analysis, analysis of pharmaceuticals, and profiling of biofluids.
Although LC-MS has yet not been as widely used for primary metabolite profiling,
it has a major potential to complement GC-MS. Derivatization is not required and
low separation temperatures compared to GC-MS reduces the risk of degradation
of heat labile compounds.
Separation of highly polar and ionic metabolites can be achieved by ion-
exchange chromatography that includes gradient elution at high salt concentra-
tions. This is not readily compatible with ESI, but insertion of a desalting device
in between the LC and the MS is a solution for improved sensitivity and robust-
ness. Reversed phase ion-pair chromatography is another option for separation
of ionic metabolites. The only requirement is that the counter-ion used for ion-
pairing should be volatile e.g. alkyl amines and perfluoro-carboxylic acids, even
though these might still present a problem with contamination of the ion-source.
Matrix effects in the ESI process (Section 2.1.2) are especially critical for quan-
titative studies. Although tandem MS allows highly specific and sensitive detec-
tion of metabolites, matrix effects during ionization are obstructive for quantifica-
tion. Addition of isotopic-labeled internal standards can overcome the discrimina-
tion observed during ionization and extend the dynamic range for quantification.
The labeled standard is ionized together with the compound of interest and the
ions will be separated by the mass spectrometer (Stokvis et al., 2005). The only
drawback is that only a limited number of labeled metabolites are commercially
available and they tend to be expensive; but in vivo synthesis by feeding labeled
substrates is an option (Birkemeyer et al., 2005; Mashego et al., 2004; Wu et al.,
2005).
Metabolites from the central carbon metabolism can be directly analyzed by
LC-MS (Buchholz et al., 2001; van Dam et al., 2002; Huck et al., 2003) and
also nucleotides (Coulier et al., 2006; Xing et al., 2004). Lu et al. (2006) has
developed a LC-MS method for quantitative analysis of nitrogen-containing com-
pound covering 90 metabolites and using this method it was possible to quantify
36 metabolites from Salmonella enterica. The continuing development of new
stationary phases for LC columns are promising and will pose new possibilities
through novel stationary phases with improved resolution. One of the most recent
technologies is ultrahigh pressure liquid chromatography. Here reduction of the
particle size of the column material to sub-2 µm and high linear flow rates have
significantly improved the chromatographic resolution to levels previously only
seen for GC (Plumb et al., 2004).
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3.2.3 Capillary electrophoresis coupled to MS
A third separation technique is capillary electrophoresis (CE). Separation by CE
relies on differential migration of ions in an electrical field and is performed in
a buffer-filled capillary of fused silica. The capillary is placed in two separate
buffer reservoirs with a potential difference of up to 30 kV. The potential over
the capillary mediates an electroosmotic flow that carries the analytes along while
they are separated by differential migration. The electroosmotic flow can be varied
by changing the applied potential and the ion strength in the buffer, but the flow
is typically in the range of nL/min. The migration velocity is determined by the
charge-to-volume ratio of the ion and the overall migration velocity will be a sum
of the electroosmostic flow and the migration of the individual ions.
CE offers high separation efficiencies, which makes it powerful for analysis of
complex samples (Ramautar et al., 2006) although sensitivity might be limited
by fairly small injection volumes in the range of nL. Coupling of CE to mass
spectrometry is possible, but currently not that widespread. Due to the low flow
rates the ionization is mostly performed by ESI, and the interface between the CE
instrument and the ESI source often includes a coaxial sheath flow to maintain a
stable spray (Schmitt-Kopplin and Frommberger, 2003).
CE is ideal for separation of ionic metabolites. There is no requirement for
derivatization and many different compound classes can be analyzed e.g. organic
acids, amino acids, nucleotides and carbohydrates with indirect UV detection
(Soga and Imaizumi, 2001). Soga et al. (2002) coupled the CE to MS which
enabled analysis of 32 central anionic metabolites from glycolysis and TCA cycle.
Later, a combination of three different CE-MS methods was used to cover the
cationic metabolites, the anionic metabolites, and nucleotides and coenzymes,
respectively, which enabled detection of more than 1,500 compounds from a Bacil-
lus subtilis extract. Of these compounds, 150 were identified based analysis of 352
metabolite standards, and 83 unknown compounds were assigned (Soga et al.,
2003).
References
M. Adahchour, J. Beens, R. J. J. Vreuls, and U. A. T. Brinkman. Recent developments
in comprehensive two-dimensional gas chromatography (GC×GC) I. Introduction and
instrumental set-up. Trends Anal. Chem., 25(5):438–454, 2006.
A. Aharoni, C. H. R. de Vos, H. A. Verhoeven, C. A. Maliepaard, G. Kruppa, R. Bino,
and D. B. Goodenowe. Nontargeted metabolome analysis by use of fourier transform
ion cyclotron mass spectrometry. OMICS, 6(3):217–234, 2002.
36 REFERENCES
J. Allen, H. M. Davey, D. Broadhurst, J. K. Heald, J. J. Rowland, S. G. Oliver, and
D. B. Kell. High-throughput classification of yeast mutants for functional genomics
using metabolic footprinting. Nat. Biotechnol., 21(6):692–696, 2003.
J. Allen, H. M. Davey, D. Broadhurst, J. J. Rowland, S. G. Oliver, and D. B. Kell.
Discrimination of modes of action of antifungal substances by use of metabolic foot-
printing. Appl. Environ. Microbiol., 70(10):6157–6165, 2004.
C. Birkemeyer, A. Luedemann, C. Wagner, A. Erban, and J. Kopka. Metabolome
analysis: the potential of in vivo labeling with stable isotopes for metabolite profiling.
Trends Biotechnol., 23(1):28–33, 2005.
M. E. Bollard, E. G. Stanley, J. C. Lindon, J. K. Nicholson, and E. Holmes. NMR-based
metabonomic approaches for evaluating physiological influences on biofluid composi-
tion. NMR Biomed., 18(3):143–162, 2005.
A. Buchholz, R. Takors, and C. Wandrey. Quantification of intracellular metabolites
in Escherichia coli K12 using liquid chromatographic-electrospray ionization tandem
mass spectrometric techniques. Anal. Biochem., 295(2):129–137, 2001.
L. Coulier, R. Bas, S. Jespersen, E. Verheij, M. J. van der Werf, and T. Hankemeier. Si-
multaneous quantitative analysis of metabolites using ion-pair liquid chromatography-
electrospray ionization mass spectrometry. Anal. Chem., 78(18):6573–6582, 2006.
O. Fiehn, J. Kopka, P. Dormann, T. Altmann, R. N. Trethewey, and L. Willmitzer.
Metabolite profiling for plant functional genomics. Nat. Biotechnol., 18(11):1157–
1161, 2000.
D. Gmati, J. K. Chen, and M. Jolicoeur. Development of a small-scale bioreactor:
Application to in vivo NMR measurement. Biotechnol. Bioeng., 89(2):138–147, 2005.
B. Gonzalez, A. de Graaf, M. Renaud, and H. Sahm. Dynamic in vivo P-31 nuclear
magnetic resonance study of Saccharomyces cerevisiae in glucose-limited chemostat
culture during the aerobic-anaerobic shift. Yeast, 16(6):483–497, 2000.
J. M. Halket and V. G. Zaikin. Derivatization in mass spectrometry – 1. Silylation. Eur.
J. Mass Spectrom., 9(1):1–21, 2003.
J. M. Halket and V. G. Zaikin. Derivatization in mass spectrometry – 3. Alkylation
(arylation). Eur. J. Mass Spectrom., 10(1):1–19, 2004.
J. H. Huck, E. A. Struys, N. M. Verhoeven, C. Jakobs, and M. S. van der Knaap.
Profiling of pentose phosphate pathway intermediates in blood spots by tandem mass
spectrometry: application to transaldolase deficiency. Clin. Chem., 49(8):1375–1380,
2003.
P. Husek. Simultaneous profile analysis of plasma amino and organic acids by capillary
gas chromatography. J. Chromatogr. B, 669(2):352–357, 1995.
REFERENCES 37
P. Husek. Chloroformates in gas chromatography as general purpose derivatizing agents.
J. Chromatogr. B, 717(1-2):57–91, 1998.
E. Jover, M. Adahchour, J. M. Bayona, R. J. J. Vreuls, and U. A. T. Brinkman. Char-
acterization of lipids in complex samples using comprehensive two-dimensional gas
chromatography with time-of-flight mass spectrometry. J. Chromatogr. A, 1086(1-2):
2–11, 2005.
K. Karlshoj and T. O. Larsen. Differentiation of species from the Penicillium roqueforti
group by volatile metabolite profiling. Journal of Agricultural and Food Chemistry,
53(3):708–715, 2005.
D. B. Kell, M. Brown, H. M. Davey, W. B. Dunn, I. Spasic, and S. G. Oliver. Metabolic
footprinting and systems biology: The medium is the message. Nat. Rev. Microbiol.,
3(7):557–565, 2005.
M. M. Koek, B. Muilwijk, M. J. van der Werf, and T. Hankemeier. Microbial
metabolomics with gas chromatography/mass spectrometry. Anal. Chem., 78(4):
1272–1281, 2006.
T. O. Larsen and J. C. Frisvad. A simple method for collection of volatile metabolites
from fungi based on diffusive sampling from petri dishes. J. Microbiol. Meth., 19(4):
297–305, 1994.
J. C. Lindon, E. Holmes, and J. K. Nicholson. So whats the deal with metabonomics?
Metabonomics measures the fingerprint of biochemical perturbations caused by dis-
ease, drugs, and toxins. Anal. Chem., 75(17):384A–391A, 2003.
W. Lu, E. Kimball, and J. D. Rabinowitz. A high-performance liquid chromatography-
tandem mass spectrometry method for quantitation of nitrogen-containing intracellu-
lar metabolites. J. Am. Soc. Mass Spectrom., 17:37–50, 2006.
M. R. Mashego, L. Wu, J. C. van Dam, C. Ras, J. L. Vinke, W. A. van Winden,
W. M. van Gulik, and J. J. Heijnen. MIRACLE: mass isotopomer ratio analysis
of U-13C-labeled extracts. A new method for accurate quantification of changes in
concentrations of intracellular metabolites. Biotechnol. Bioeng., 85(6):620–628, 2004.
K. Nagy, Z. Takats, F. Pollreisz, T. Szabo, and K. Vekey. Direct tandem mass spectro-
metric analysis of amino acids in dried blood spots without chemical derivatization
for neonatal screening. Rapid Commun. Mass Spectrom., 17(9):983–990, 2003.
A. R. Neves, W. A. Pool, J. Kok, O. P. Kuipers, and H. Santos. Overview on sugar
metabolism and its control in Lactococcus lactis - The input from in vivo NMR. FEMS
Microbiol. Rev., 29(3):531–554, 2005.
R. Plumb, J. Castro-Perez, J. Granger, I. Beattie, K. Joncour, and A. Wright. Ultra-
performance liquid chromatography coupled to quadrupole-orthogonal time-of-flight
mass spectrometry. Rapid Commun. Mass Spectrom., 18(19):2331–2337, 2004.
38 REFERENCES
L. M. Raamsdonk, B. Teusink, D. Broadhurst, N. Zhang, A. Hayes, M. C. Walsh, J. A.
Berden, K. M. Brindle, D. B. Kell, J. J. Rowland, H. V. Westerhoff, K. van Dam, and
S. G. Oliver. A functional genomics strategy that uses metabolome data to reveal the
phenotype of silent mutations. Nat. Biotechnol., 19(1):45–50, 2001.
R. Ramautar, A. Demirci, and G. J. de Jong. Capillary electrophoresis in metabolomics.
Trends Anal. Chem., 25(5):455–466, 2006.
U. Roessner, C. Wagner, J. Kopka, R. N. Trethewey, and L. Willmitzer. Simultaneous
analysis of metabolites in potato tuber by gas chromatography-mass spectrometry.
Plant J., 23(1):131–142, 2000.
U. Roessner, A. Luedemann, D. Brust, O. Fiehn, T. Linke, L. Willmitzer, and A. Fernie.
Metabolic profiling allows comprehensive phenotyping of genetically or environmen-
tally modified plant systems. Plant Cell, 13(1):11–29, 2001.
P. Schmitt-Kopplin and M. Frommberger. Capillary electrophoresis - mass spectrome-
try: 15 years of developments and applications. Electrophoresis, 24(22-23):3837–3867,
2003.
L. Sleno, D. A. Volmer, and A. G. Marshall. Assigning product ions from complex
MS/MS spectra: The importance of mass uncertainty and resolving power. J. Am.
Soc. Mass Spectrom., 16(2):183–198, 2005.
J. Smedsgaard. Micro-scale extraction procedure for standardized screening of fungal
metabolite production in cultures. J. Chromatogr. A, 760(2):264–270, 1997.
J. Smedsgaard and J. Nielsen. Metabolite profiling of fungi and yeast: from phenotype
to metabolome by MS and informatics. J. Exp. Bot., 56(410):273–286, 2005.
J. Smedsgaard, M. E. Hansen, and J. C. Frisvad. Classification of terverticillate Penicillia
by electrospray mass spectrometric profiling. Stud. Mycol., 49:243–251, 2004.
T. Soga and M. Imaizumi. Capillary electrophoresis method for the analysis of inorganic
anions, organic acids, amino acids, nucleotides, carbohydrates and other anionic com-
pounds. Electrophoresis, 22(16):3418–3425, 2001.
T. Soga, Y. Ueno, H. Naraoka, Y. Ohashi, M. Tomita, and T. Nishiokat. Simultaneous
determination of anionic intermediates for Bacillus subtilis metabolic pathways by
capillary electrophoresis electrospray ionization mass spectrometry. Anal. Chem., 74
(10):2233–2239, 2002.
T. Soga, Y. Ohashi, Y. Ueno, H. Naraoka, M. Tomita, and T. Nishioka. Quantitative
metabolome analysis using capillary electrophoresis mass spectrometry. J. Proteome
Res., 2(5):488–494, 2003.
E. Stokvis, H. Rosing, and J. H. Beijnen. Stable isotopically labeled internal standards
in quantitative bioanalysis using liquid chromatography/mass spectrometry: necessity
or not? Rapid Commun. Mass Spectrom., 19(3):401–407, 2005.
REFERENCES 39
S. Strelkov, M. von Elstermann, and D. Schomburg. Comprehensive analysis of metabo-
lites in Corynebacterium glutamicum by gas chromatography/mass spectrometry.
Biol. Chem., 385(9):853–861, 2004.
S. Vaidyanathan, D. B. Kell, and R. Goodacre. Flow-injection electrospray ionization
mass spectrometry of crude cell extracts for high-throughput bacterial identification.
J. Am. Soc. Mass Spectrom., 13(2):118–128, 2002.
J. C. van Dam, M. R. Eman, J. Frank, H. C. Lange, G. W. van Dedem, and S. J.
Heijnen. Analysis of glycolytic intermediates in Saccharomyces cerevisiae using anion
exchange chromatography and electrospray ionization with tandem mass spectromet-
ric detection. Anal. Chim. Acta, 460:209–218, 2002.
S. G. Villas-Boas, D. G. Delicado, M. Akesson, and J. Nielsen. Simultaneous analysis
of amino and nonamino organic acids as methyl chloroformate derivatives using gas
chromatography-mass spectrometry. Anal. Biochem., 322(1):134–138, 2003.
S. G. Villas-Boas, J. F. Moxley, M. Akesson, G. Stephanopoulos, and J. Nielsen. High-
throughput metabolic state analysis: the missing link in integrated functional ge-
nomics of yeasts. Biochem. J., 388:669–677, 2005.
D. Weuster-Botz and A. A. de Graaf. Reaction engineering methods to study intracellu-
lar metabolite concentrations. In Advances in Biochemical Engineering/Biotechnology,
volume 54, pages 75–108. Springer Berlin/Heidelberg, 1996.
L. Wu, M. R. Mashego, J. C. van Dam, A. M. Proell, J. L. Vinke, C. Ras, W. A. van
Winden, W. M. van Gulik, and J. J. Heijnen. Quantitative analysis of the microbial
metabolome by isotope dilution mass spectrometry using uniformly C-13-labeled cell
extracts as internal standards. Anal. Biochem., 336(2):164–171, 2005.
J. Xing, A. Apedo, A. Tymiak, and N. Zhao. Liquid chromatographic analysis of nucleo-
sides and their mono-, di- and triphosphates using porous graphitic carbon stationary
phase coupled with electrospray mass spectrometry. Rapid Commun. Mass Spectrom.,
18(14):1599–1606, 2004.

Chapter 4
Data analysis tools
From metabolite profiling, ideally all metabolites should be quantified. This
gives – for yeast at least – 600 or so metabolites corresponding to 600 mea-
surements/variables per sample point placing the sample in a hyper-dimensional
space. Among the multiple variables probably only a few are needed to describe
the investigated case adequately. Thus, the major challenge is how to pick out
and identify these few variables of importance.
The pipeline for data analysis can be divided in three stages (Brown et al.,
2005):
1. Preprocessing
2. Data reduction
3. Data analysis
First, the raw data need to be preprocessed and converted into a suitable
form, e.g. improvement of signal-to-noise (S/N), normalization, deconvolution
and feature extraction. For most multivariate data mining techniques, the data
need to be aligned and conveniently organized into a matrix or an array. In
a matrix-format the n rows will contain the samples and the m columns the
variables resulting in a n×m-matrix. Likewise, the metadata associated with the
samples can be organized into a similar matrix containing n rows of samples and a
number of columns representing the metadata. The metadata could correspond to
experimental conditions like carbon source, group information, genotype, strain,
sampling time etc.
The data reduction stage aims at qualifying the data for further analysis. Here,
outliers are detected and excluded, and replicate samples are used to confirm that
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features/variables are conserved within the replicates. A selection of variables for
description of group information can be done through statistical testing to identify
the presence of group characteristics. Student’s t-test and one-way analysis of
variance (ANOVA) are common candidates for selection of variables that describe
group differences. The tests return a p-value1, which will indicate the ability of
the variable to describe group differences.
Finally, the data analysis should reveal data patterns that represent biological
information and can be used to generate hypotheses for further studies.
4.1 Metrics for mass spectral comparison
A binned mass spectrum (see Section 2.4) can be represented as a vector con-
taining the spectral ion intensities ordered according to the mass scale. Distance
(or the inverse similarity) metrics can then be used for comparison of mass spec-
tra. Stein and Scott (1994) compared five search algorithms for identification of
compounds from mass spectral libraries. From the study, Stein and Scott (1994)
concluded that the dot-product algorithm performed best for identification of
compounds in GC-MS data. Later, Stein (1999) published the algorithm under-
lying AMDIS (automated mass spectral deconvolution and identification system)
for analysis GC-MS data. Here the dot-product was also applied for measure
of spectral similarity. Mathematically, the normalized dot-product is computed
according to Equation 4.1 including weighting by the ion mass (m) and scaling of
intensity/abundance by the power of 12 (Stein, 1999). Equation 4.1 takes values
from 0 to 100, where 100 corresponds to the similarity between identical spectra.
similarity index = 100
(∑
imi [Au,iAr,i]
1
2
)2
∑
iAu,imi
∑
iAr,imi
(4.1)
where Au,i and Ar,i are the abundances of the ith ion in the user and the reference
spectrum, respectively, and mi is the mass of the ith ion.
The method described above rely on aligned and binned data. For accurate
mass data, binning of mass spectra for alignment results in loss of information,
since the accurate mass is no longer preserved in the data structure and adjacent
ions with mass differences within bin width might be confounded as they can fall
in the same bin. Hansen and Smedsgaard (2004) solved this problem by defining
a distance for accurate mass spectra on a continuous scale. The distance measure
is computed between two spectra by first pairing the ions with the same mass
1The p-value is the probability of obtaining a samples that is at least as extreme/”impressive”
as that obtained, assuming that the null hypothesis is true, so that the finding was the result
of chance alone.
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Figure 4.1 Principal component analysis (PCA) is a spacial rotation of the data space
in order to present maximum data variation derived from covariation. For illustration, a
2-dimensional data set (A) is rotated by PCA, which results in the score-plot (rotated space)
in B. The red and green line represent the first and second principal component (PC),
respectively. It is illustrated that the major variation is captured by the first PC.
between the spectra and then calculating the pairwise distance of these by the
Jeffreys-Matusitas distance. Combining these pairwise distances and weighting
them according to relative number of paired ions give the accurate mass spec-
trum distance between two spectra. The performance of the algorithm was tested
against existing library search algorithms, and it was found to perform at least
as good as these (Hansen and Smedsgaard, 2004).
4.2 Reduction of dimensionality
Reduction of dimensionality is applied in order to get an overview and visualiza-
tion of the data. It is a common scenario in biology that the number of samples is
relatively low compared to the number of variables available and sometimes the
variables are also highly correlated2.
Principal component analysis (PCA) is a popular method for visualization
of metabolome data through reduction of dimensionality. The method is unsu-
pervised which means that no sample information (metadata) is included in the
analysis. In principle, the PCA is a spacial rotation by linear transformation of
2Specifically for mass spectrometry, the presence of isotopes gives rise to redundant infor-
mation in mass data, because the intensity of the isotope ions is strictly correlated due to the
natural isotope abundances.
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Figure 4.2 Principal component analysis (PCA) is affected by noise, which can impact the
ability of the analysis to separate groups even though group information is available in the
data. Using two variables segregating three group, PCA efficiently separates the two groups
by the first principal component (A). The performance of PCA is weakened when adding
noise by including 25 variables with random values in addition to the two variables. Then
the PCA is no longer capable of clearly separating the groups (B).
the variable space in such way that it represents the maximum variation in the
data set. The computed principal components (PCs) are organized in such way
that the first PC accounts for the maximum variation, the second PC describes
the second most variation etc. (Figure 4.1). All PCs are orthogonal to each other
and the maximum number of PCs being the smaller of n−1 and m. This way, the
PCs describing the major variation, e.g. 95% or 99%, can be selected to represent
the data in a lower dimensional space.
Before PCA, the data matrix is normally centered and scaled (Bro and Smilde,
2003) although Allen et al. (2003) stated that this can cloud the underlying sta-
tistical trends, but the variables in the data are not corrected for magnitude by
omitting this step. The PCA can be done by eigenvalue decomposition of the data
covariance matrix or by singular value decomposition of the centered and scaled
data matrix. This way the unit eigenvectors (or singular vectors) correspond to
the PCs, which are numbered according to descending eigenvalue. In relation to
PCA the PCs are referred to as loadings and represent the weights of the orig-
inal variables in the linear transformation. Multiplication of the loading matrix
and the data matrix will give the scores, which are the coordinates in the new
projection space that give the transformation illustrated in Figure 4.1 (Jolliffe,
2002).
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Figure 4.3 Fisher discriminant analysis (FDA) of the same noisy data as were used for the
PCA score plot in Figure 4.2B.
The widespread use of PCA is probably mediated by the easy implementation
of the algorithm that needs no parameters. For PCA to be successful in pattern
visualization, the major variation should capture the group segregation; however,
the objective of variance maximization does not always correspond to information.
The PCA is affected by noisy variables, which blur the analysis when identification
of group information is intended (Halouska and Powers, 2006). This is also illus-
trated in Figure 4.2, where two variables are describing differences between three
groups. Applying the PCA on the data matrix containing the two variables yields
a spacial rotation where the three groups are separated (Figure 4.2A). Adding
another 25 variables with random values to the data matrix and performing a
PCA gives a more blurred picture (Figure 4.2B). This is simply because the PCA
maximizes variation and does not consider group information.
Similar to the PCA is Fisher (or linear) discriminant analysis (FDA) that also
is used to project data into a lower dimensional space. Where PCA maximizes
variation, the FDA instead maximizes between-group variation while minimizing
the within-group variation. Hereby turning FDA into a supervised method that
uses group information (metadata) to compute the between- and within-group
variation. FDA is better at overcoming noise in data, since it uses group infor-
mation for the projection. In Figure 4.3 FDA is applied on the same data set as
was used to obtain the PCA score plot in Figure 4.2B. Here, it is evident that
the FDA is capable of capturing the group information and neglecting the noise.
The FDA score plot (Figure 4.3) corresponds well to the PCA score plot in Fig-
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ure 4.2A with the two variable describing the three groups. Actually, the FDA
seems to give slightly less disperse clusters, which most likely is because FDA has
a tendency of over-fitting the data when the group size is small compared the
number of variables. Therefore it is always recommended to use cross-validation
for FDA models or any other supervised methods.
Stephanopoulos et al. (2002) demonstrated the use of FDA in combination
with ANOVA for microarray data analysis, and Raamsdonk et al. (2001) and Allen
et al. (2003) applied the FDA in combination with PCA for metabolic finger- and
footprinting data. Raamsdonk et al. (2001) and Allen et al. (2003) first aimed
at reducing the variable space to describe 95% of the data variation by PCA and
then the reduced space was subjected to discriminant analysis. This resulted in
clustering of similar mutants of Saccharomyces cerevisiae. The only downside
of the PCA-FDA approach is that it is difficult to backtrack and interpret the
influence and loadings of the original variables.
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Abstract
Sample preparation is considered one of the limiting steps in microbial metabolome
analysis. Eukaryotes and prokaryotes behave very differently during the several steps
of classical sample preparation methods for analysis of metabolites. Even within the
eukaryote kingdom there is a vast diversity of cell structures that make it imprudent
to blindly adopt protocols that were designed for a specific group of microorganisms.
We have therefore reviewed and evaluated the whole sample preparation procedures
for analysis of yeast metabolites. Our focus has been on the current needs in
metabolome analysis, which is the analysis of a large number of metabolites with
very diverse chemical and physical properties. This work reports the leakage of
intracellular metabolites observed during quenching yeast cells with cold methanol
solution, the efficacy of six different methods for the extraction of intracellular
metabolites, and the losses noticed during sample concentration by lyophilization
and solvent evaporation. A more reliable procedure is suggested for quenching yeast
cells with cold methanol solution, followed by extraction of intracellular metabolites
by pure methanol. The method can be combined with reduced pressure solvent
evaporation and therefore represents an attractive sample preparation procedure
for high-throughput metabolome analysis of yeasts. Copyright  2005 John Wiley &
Sons, Ltd.
Keywords: extraction; metabolome; metabolomics; quenching; sample preparation;
freeze-drying
Introduction
Metabolomics and metabolome analysis is a
broadly used term for analysis of a large number of
metabolites from a single organism. In metabolome
analysis of microbial cells the separation of intra-
and extracellular metabolites is often required
to gain insight into the control of metabolic
pathways. Therefore, it is important to determine
the intracellular levels of metabolites accurately,
which requires efficient and reliable methods for
sample preparation. There have been considerable
efforts to develop sensitive and accurate methods
for detection of metabolites (Buchholz et al., 2002;
Soga et al., 2002; van Dam et al., 2002; Mashego
et al., 2004; Villas-Boˆas et al., 2005; and others)
and to improve the efficiency of data mining
and data analysis (Goodacre et al., 2004; Kell,
2004; van der Greef et al., 2004) but relative little
attention has been given to sample preparation
procedures.
Figure 1 summarizes the main steps in sample
preparation for metabolome analysis. Since the
metabolite levels reflect the ultimate response of
a biological system to genetic or environmental
changes, rapid stopping (quenching) of the cell
metabolism and extracellular enzymatic activity is
the first step for such methods. Metabolite con-
centrations are very prone to changes induced by
(unnoticed) variation in the environment of the cell
(de Koning and van Dam, 1992). The quenching
procedure aims to stop cellular metabolism and
prevent the turnover of metabolites, maintaining
the in vivo metabolite concentrations at a constant
Copyright  2005 John Wiley & Sons, Ltd.
50 CHAPTER 5. SAMPLE PREPARATION
1156 S. G. Villas-Boˆas et al.
Biomass
Intracellular metabolites
Sample preparation
Medium
Extracellular metabolites
Quenching
Cold methanol
Concentration
Freeze-drying
Solvent evaporation
Extraction
Chloroform:methanol:buffer (CMB)
Boiling ethanol (BE)
Perchloric acid (PCA)
Potassium hydroxide (KOH)
Methanol:water (MW)
Pure methanol (PM)
Figure 1. The main steps in sample preparation in connection with metabolome analysis of microorganisms. Grey squares
show the steps evaluated in this work, listing the different methods examined
level. A rapid stop of metabolism is usually
achieved through fast changes in temperature or
pH. A limitation for quenching a microbial cell cul-
ture is the inherently associated dilution of the sam-
ple, which is due to the unfavourable ratio between
biomass and the aqueous medium. The commonly
used method is based on rapid sampling into a
cold aqueous methanol solution, as proposed by de
Koning and van Dam (1992). This method is pre-
ferred in microbial research because it is currently
the only method that enables a reliable separation
of intra- and extracellular metabolites while stop-
ping cell metabolism. The cells are usually sepa-
rated from the quenching mixture by centrifugation,
requiring sample handling at low temperatures to
eliminate or at least minimize turnover of metabo-
lites prior to cell extraction.
A key question in connection with quenching
yeast cell metabolism with cold methanol solution
is whether it causes leakage of metabolites from
the cells. Gonzalez et al. (1997) found significant
amounts of glucose 6-phosphate, ATP and NAD+
in the supernatant from methanol-quenched cells.
However, the amount of these metabolites was
roughly equal to those found in the culture medium.
Hans et al. (2001) could not detect any amino acids
in the supernatant of methanol-quenched yeast
cells. In contrast to yeast cells, the intracellular
metabolites from bacterial cells leak from the
cells when these are brought into contact with
cold methanol solution (60% v/v) and several
intracellular metabolites have been found in the
medium after the quenching process (Jensen et al.,
1999; Letisse and Lindley, 2000; Wittmann et al.,
2004).
Following quenching, the second step in the sam-
ple preparation is the separation of the extracellu-
lar metabolites from the biomass and subsequent
extraction of the intracellular metabolites, achiev-
ing minimal losses by degradation and avoiding
further biochemical reactions. The extraction step
aims to induce complete leakage of the intracel-
lular metabolites from the cells — and to some
extent from its sub-compartments — into a liq-
uid solution. Cell extraction makes the intracel-
lular metabolites accessible to the different ana-
lytical methods employed. However, it is virtu-
ally impossible to avoid losses, mainly due to the
diverse chemistry plus physical properties of the
metabolome.
Again, de Koning and van Dam (1992) adapted
a methodology originally designed for extraction
of total lipids from animal tissues (Folch et al.,
1957), based on buffered methanol–water mixture
and chloroform, to extract polar metabolites from
a yeast cell suspension. Their method has recently
been applied for intracellular metabolite analysis
of microorganisms (Cremin et al., 1995; Ruijter
and Visser, 1996; Smits et al., 1998; Jensen et al.,
1999; Zaldivar et al., 2002; Maharjan and Ferenci,
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2003) and animal tissues (Le Belle et al., 2002).
The method presents good recovery of phosphory-
lated compounds (Smits et al., 1998; Jensen et al.,
1999). However, the recovery for other classes of
metabolites has not been reported so far. In addi-
tion, this method is considered tedious and time-
consuming, and uses chloroform, an undesirable
solvent due to its toxic and carcinogenic effects.
Another popular extraction method for intracel-
lular metabolites of yeast is based on the use of
boiling ethanol as first described by Entian et al.
(1977) and later revised by Gonzalez et al. (1997).
It is widely used for the extraction of intracel-
lular metabolites of microorganisms (Tweeddale
et al., 1998; Hans et al., 2001; Lange et al., 2001;
Visser et al., 2002; Castrillo et al., 2003). Accord-
ing to Gonzalez et al. (1997), the method is simple,
fast, accurate and reliable. Glucose 6-phosphate,
ATP, pyruvate, NAD+ and NADH seem to be very
stable in buffered boiling ethanol, presenting an
excellent recovery after extraction. However, for
metabolome analysis, this method is not free of
problems, since not all metabolites are stable at the
high temperature applied (Maharjan and Ferenci,
2003).
Recently, Maharjan and Ferenci (2003) proposed
a method where extraction of intracellular metabo-
lites from bacterial cells was achieved in cold
methanol solution (50% v/v) after one freeze–thaw
cycle in dry ice. It seems to present all the advan-
tages of the boiling ethanol extraction method, in
addition to preventing thermodegradation of the
heat-labile compounds. However, this method has
not been applied to metabolite extraction of organ-
isms other than bacteria.
Classical acidic and alkalinic extraction meth-
ods are commonly used for the extraction of acid
and alkaline stable compounds, respectively. These
methods have been widely used in the extrac-
tion of metabolites from animal and plant tis-
sues (Shryock et al., 1986; Kopka et al., 1995;
Chen et al., 1998; Adams et al., 1999; Bouchereau
et al., 2000; Conneely et al., 2002) and microor-
ganisms (Cordeiro and Freire, 1996; Weuster-Botz,
1997; Hajjaj et al., 1998; Schaefer et al., 1999;
Vaseghi et al., 1999; Letisse and Lindley, 2000;
Martins et al., 2001; Buchholz et al., 2002; Buziol
et al., 2002; Maharjan and Ferenci, 2003). Acidic
extraction is commonly used for the extraction of
nucleotides and water-soluble metabolites (Vaseghi
et al., 1999; Martins et al., 2001; Buchholz et al.,
2002), but for metabolome studies it is evident that
not all metabolites are stable at the extreme pH, and
destruction of some nucleotides has been reported
during acidic extractions (Hajjaj et al., 1998).
Furthermore, most of the extraction methods
result in a high degree of sample dilution, thus
further diluting the already low concentration of
some intracellular metabolites. Very often a third
step in sample preparation is required, the concen-
tration of the extract (Figure 1). Lyophilization, or
freeze-drying, is commonly used to remove water
from aqueous samples in order to concentrate and
avoid thermal degradation. This method combines
the advantage of both deep-freezing and dehydra-
tion. Alternatively, non-aqueous extracts can be
concentrated by solvent evaporation. It should be
noted, however, that both methods are unsuitable
for volatile metabolites.
Therefore, this work aimed to evaluate the main
steps in samples preparation for metabolome anal-
ysis of yeasts. We first examined the possible vari-
ations in the quenching step, using both buffered
and non-buffered cold methanol solution in order
to determine whether or not intracellular metabolite
leakage takes place during this process. Second, we
checked the efficiency of the six different extrac-
tion methods for intracellular metabolites as listed
in Figure 1, in regard to metabolite recovery and
reproducibility, and we determined the recovery of
different classes of metabolites during the sample
concentration step by using two mild techniques,
lyophilization and reduced-pressure solvent evapo-
ration.
Materials and methods
Strain and cultivation
The Saccharomyces cerevisiae strain CEN.PK113-
7D (MAT a MAL2-8 c SUC2 ) was used for the
experiments. The strain was cultivated aerobically
in shake flasks, using a rotary shaker at 150 r.p.m.
and 30 ◦C. Each shake flask contained 150 ml
medium composed of glucose (20 g/l), (NH4)2SO4
(5.0 g/l), MgSO4 · 7H2O (0.5 g/l), KH2PO4(3.0 g/l), vitamins and trace elements (Verduyn
et al., 1992).
Chemicals
Methanol and chloroform were obtained from LAB
SCAN Analytical Sciences (Dublin, Ireland). All
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α-amino acids used were obtained from Serva
Electrophoresis GmbH (Heidelberg, Germany) and
all additional metabolite standards, as well as
HEPES, PIPES, imidazole, methoxyamine, propid-
ium iodide solution, and N-methyl-N-(trimethyl-
silyl)trifluoroacetamide, were purchased from
Sigma (St. Louis, MO, USA). Perchloric acid,
methyl chloroformate (MCF), sodium bicarbonate
and sodium sulphate anhydrous were obtained from
Merck (Darmstadt, Germany). EDTA was obtained
from Fluka Chemie (Buchs, Switzerland). Pyridine,
potassium hydroxide and sodium hydroxide were
purchased from J.T. Baker (Deventer, Holland). All
used chemicals were analytical grade.
Analytical procedures
The amino and non-amino organic acids and the
nucleotides were determined simultaneously by
GC–MS after MCF derivatization, according to
the method described by Villas-Boˆas et al. (2005).
Sugars, sugar phosphates, sugar alcohols and pep-
tides were determined simultaneously by GC–MS
after methoxymation and silylation derivatization,
following the protocol described by Roessner et al.
(2000). The determination of extracellular sugar
phosphates for the evaluation of leakage dur-
ing quenching was performed using solid-phase
extraction and high-pressure ion-exchange chro-
matography with pulsed amperometric detection
(HPIC–PAD), according to Smits et al. (1998).
All GC–MS analyses were performed with a
Hewlett-Packard system HP 6890 gas chromato-
graph coupled to a HP 5973 quadrupole mass
selective detector, with electron ionization (EI)
source operated at 70 eV. The capillary column
used for all analysis was a J&W DB1701 (Fol-
som, CA, USA; 30 m × 250 µm i.d., 0.15 µm film
thickness). The MS was always operated in scan
mode (start after 5 min, mass range 38–550 m/z
at 2.88 scans/s). Two different inlet inserts were
used, depending on the derivatives to be anal-
ysed: Siltek gooseneck splitless deactivated liner
(Restek, USA), 4.0 mm i.d., was used for anal-
ysis of MCF derivatives, and split straight liner
with glasswool (Agilent Technologies, USA) for
the TMS-derivatives. HPIC–PAD analysis was per-
formed with a Dionex BioLC (Dionex, Sunnyvale,
CA, USA) and the analytes were separated in a
CarboPac PA1 column (Dionex) and a Dionex PA1
guard column at 30 ◦C, under conditions described
by Smits et al. (1998).
The GC–MS data was analysed by the Auto-
mated Mass Spectral Deconvolution and Identifi-
cation System (AMDIS; http://chemdata.nist.gov/
mass-spc/amdis/) software, using a home-built
library of MCF or TMS derivatives.
Membrane integrity assay
The membrane integrity of the yeast cells was
assayed using propidium iodide (PI) according to
the protocol described by Alfenore et al. (2003).
PI is membrane-impermeant and can only pene-
trate the yeast cells if the membrane is damaged.
PI binds to either DNA or RNA and forms a fluo-
rescent complex.
The yeast cell pellets, after quenching, were
resuspended in 1 ml saline solution (NaCl, 0.85 g/l)
and then mixed with 0.5 ml propidium iodide solu-
tion (concentration 0.5 mg/ml; commercial solu-
tion, Sigma). After incubation for 10 min at 0 ◦C,
the samples were inspected using fluorescence
microscopy. The control samples consisted of yeast
cells centrifuged and resuspended in saline solution
without being in contact with methanol solution.
Quenching
Yeast cell cultures were quenched according to
the method described by de Koning and van
Dam (1992). Unless otherwise stated, the samples
were quenched in triplicate at OD600 = 6.0 (middle
exponential phase). Samples of culture (5 ml) were
quickly harvested with a 5 ml automate Gilson
pipette and released into 20 ml methanol–water
solution (60% v/v) at −40 ◦C, resulting in a final
methanol concentration of 50% (v/v) after quench-
ing. The samples were carefully released into the
centre of the methanol solution to avoid freezing
on the sides of the tubes. The biomass was sepa-
rated from the quenching solution by centrifugation
at 770 × g for 20 min at −20 ◦C.
For evaluation of the quenching procedure, we
quenched 5 and 10 ml samples released into
20 ml cold methanol solution at 60% (v/v) and
75% (v/v), respectively, in order to keep the
same final methanol concentration of 50% (v/v).
Both buffered (PIPES, 3 mM; EDTA, 3 mM; pH
7.0) and non-buffered cold methanol solutions
Copyright  2005 John Wiley & Sons, Ltd. Yeast 2005; 22: 1155–1169.
53
Sample preparation for global metabolite analysis 1159
were tested. The temperature inside the quench-
ing tubes during the quenching process was mon-
itored using a digital thermometer (HI 955 501,
Hanna Instruments, Italy). The biomass was sep-
arated from the quenching solution by centrifu-
gation at 770 × g for 20 min at −20 ◦C accord-
ing to the original protocol (de Koning and van
Dam, 1992). A faster biomass separation from the
quenching medium was also tested by centrifuga-
tion at 1540 × g for 5 min at −20 ◦C.
Extraction of intracellular metabolites
After quenching 5 ml yeast culture at exponential
phase (OD600 = 6.0) using 60% (v/v) non-buffered
cold methanol solution which, resulted in approxi-
mately 6 mg biomass, six methods for extraction of
intracellular metabolites were evaluated by taking
into account the number of compounds extracted,
recovery of spiked standards and reproducibility.
Figure 1 summarizes the methods evaluated and
their respective protocols are described as follows:
• Chloroform:methanol:buffer (CMB) extraction
(de Koning and van Dam, 1992). After quench-
ing, the biomass was resuspended in 5.0 ml cold
chloroform (−40 ◦C), followed by 2.5 ml cold
methanol (−40 ◦C). Then 2.0 ml ice-cold buffer
(PIPES, 3 mM; EDTA, 3 mM; pH 7.2) was added
to the mixture under manual shaking. The sus-
pension was agitated vigorously at 300 r.p.m. on
a platform shaker for 45 min at −20 ◦C. Sepa-
ration of the chloroform and the aqueous phase
was induced by centrifugation (770 × g , 20 min,
−20 ◦C). The upper aqueous phase, containing
the polar metabolites, was collected without dis-
turbing the pellet of the cell debris on top of
the lower chloroform phase. A second extrac-
tion was initiated by adding 2.0 ml methanol
(−40 ◦C) and 2.0 ml ice-cold buffer to the chlo-
roform phase, followed by manual shaking for
30 s using a vortex mixer. After centrifugation
(770 × g , 20 min, −20 ◦C) the upper aqueous
phase was collected and pooled with the previ-
ous extract and the solvents were removed by
lyophilization.
• Boiling ethanol (BE) extraction (Gonzalez et al.,
1997). Boiling buffered ethanol solution (5 ml
75% v/v HEPES, 0.25 M, pH 7.5) was added to
the cell pellet after quenching. The mixture was
incubated for 3 min at 80 ◦C and immediately
cooled in an ice-bath for 3 min. The cell residues
were separated from the extract by centrifugation
at 770 × g for 20 min at 4 ◦C. The supernatant
was lyophilized.
• Perchloric acid (PCA) extraction (Hajjaj et al.,
1998). After quenching, the biomass was resus-
pended in 6.4 ml ice-cold 10% (v/v) perchloric
acid and 0.6 ml imidazole (1.0 M). The extrac-
tion was performed by three freeze–thaw cycles
with vigorous shaking at 300 r.p.m. for 10 min
between each cycle. After centrifugation for
5 min at 770 × g and 0 ◦C, the supernatant was
neutralized with KOH (10 M) and the KClO4
precipitate was removed by centrifugation. The
supernatant was lyophilized.
• Potassium hydroxide (KOH) extraction (Hajjaj
et al., 1998). After quenching the biomass was
resuspended in 3.0 ml KOH (0.25 M) and the
mixture was incubated at room temperature for
15 min. The cell residues were separated by
centrifugation at 770 × g for 8 min (4 ◦C) and
the supernatant of the samples to be silylated
was neutralized with 10% (v/v) HClO4 prior to
lyophilization.
• Methanol:water (MW) extraction (Maharjan and
Ferenci, 2003). The biomass was resuspended
in 2.5 ml 50% (v/v) cold methanol solution
(−40 ◦C) after quenching and the mixture was
frozen in liquid nitrogen. The frozen suspension
was then thawed in an ice-bath and centrifuged
at 770 × g for 20 min at −20 ◦C. The super-
natant was collected and an additional 2.5 ml
of cold methanol solution 50% (v/v) (−40 ◦C)
was added to the pellet and shaken manually for
30 s using a vortex mixer. The mixture was cen-
trifuged at 770 × g for 20 min at −20 ◦C and
both supernatants were pooled and lyophilized.
• Pure methanol (PM) extraction. This method was
a slight modification of the previous method
described by Maharjan and Ferenci (2003).
The same procedure was applied, but the cold
methanol solution 50% (v/v) was replaced by
pure cold methanol (−40 ◦C).
Metabolite standards spiked in the samples
Representative compounds from different polar
metabolite classes were selected to be spiked into
the samples at the beginning of the different
extraction procedures. The following metabolites
(and their respective classes) were used: valine
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(neutral amino acid); glutamate (acidic amino
acid); lysine (basic amino acid); phenylalanine and
tryptophan (aromatic amino acids); pyruvate and
lactate (monocarboxylic acids); fumarate, succi-
nate (dicarboxylic acids); citrate and isocitrate (tri-
carboxylic acids); 2-oxoglutarate and 2-oxoadipate
(α-keto acids); myristate (fatty acid); NADH and
NADP (nucleotides); glutathione (peptide); tre-
halose and xylose (sugars); glucose 6-phosphate,
fructose 6-phosphate, mannose 6-phosphate, and
ribose 5-phosphate (sugar phosphates); glycerol,
mannitol, arabitol, and xylitol (sugar alcohols).
Two metabolite mixture solutions were prepared:
(a) 100 µl stock solutions (1 M) of each amino
and non-amino organic acids and nucleotides were
mixed and diluted to a final concentration of
10 µM/ml; (b) 400 µl each stock solution (0.5 M) of
sugars, sugar derivatives and peptide were mixed
and diluted to prepare a metabolite mixture pre-
senting a final concentration of 20 µM/ml. Before
extraction triplicate yeast biomass samples were
spiked with 100 µl of metabolite mixture (a) or (b).
Sample concentration
The sample extracts were concentrated by lyophili-
zation at low temperature (−56 ◦C) using a Christ
Alpha 1–4 freeze-dryer (Osterode, Germany). An
additional 10 ml MilliQ water was added to those
extracts containing organic solvents in order to
keep the samples frozen during the lyophilization
process (H2O content >75% (v/v)). The dried
samples were stored for 7 days at −20 ◦C prior to
the GC–MS analysis.
Evaluation of lyophilization and solvent
evaporation
Three variables during lyophilization process were
investigated: (1) deactivation of the lyophilization
glass flask by silylation; (2) breakage of the vac-
uum after the process using an inert gas (N2) or air;
and (3) storage of the dried samples before anal-
ysis under reducing and dry atmosphere (N2) at
−20 ◦C or in ordinary freezer at −20 ◦C. A factorial
optimization experiment was designed, as shown in
Figure 2. All experiments were performed in trip-
licate and the test samples were prepared adding
either 100 µl metabolite mixture (a) or (b) (see
metabolite standards) to 10 ml MilliQ water.
Solvent evaporation was performed under vac-
uum using a Thermo Savant SC210A SpeedVac
Variables
Flask deactivation
Vacuum breakage
Non-silanized Silanized
Nitrogen
−20°C, dry and reducing
atmosphere
Air
−20°C, freezerStorage
I −
−
−
+
+
+
−
−
+
+
+
−
−
+
+
+
−
−
II
III
IV
V
VI
Experiments Flask
deactivation
Vacuum
breakage
Storage
+−
Figure 2. Factorial optimization of the lyophilization
process, using a reduced 23-factorial design with six
instead of eight different experiments. Each experiment
was performed in triplicate
Plus without heating for approximately 3.5 h. The
test samples were prepared by adding 100 µl
metabolite mixture (a) or (b) (see metabolite stan-
dards) to 3 ml pure methanol.
Calculations
All calculations are performed using the amount
estimated by AMDIS, which is equivalent to the
peak area obtained by integration of the peak in
the chromatogram.
Leakage of intracellular metabolites
The concentration of intracellular metabolites was
estimated based on data previously reported by
Villas-Boas et al. (2005) and the metabolite con-
centrations found in the quenching solution corre-
sponding to similar quenching conditions used by
Villas-Boas et al. (2005):
cˆintra = xquenching + xintraVsample − cextra (1)
where cˆintra is the estimated concentration of intra-
cellular metabolites, xquenching is the measured total
amount of metabolites in the quenching solution,
xintra is the determined amount of intracellular
metabolites after quenching as reported by Villas-
Boas et al. (2005), cextra is the concentration of
extracellular metabolites detected in the culture fil-
trate, and Vsample is the volume of the sample.
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Therefore, the relative leakage of intracellular
metabolites was calculated for each quenching
method tested according to equation (2):
Leakage = xquenching/Vsample
cˆintra
· 100% (2)
Recovery of spiked metabolites after extraction
and sample concentration
The recovery was calculated based on the total
signal of the GC peaks. Values obtained from the
extracted/concentrated samples were divided by the
values obtained in the control samples according to
equation (3):
Recovery = xextract
xcontrol
· 100% (3)
where xextract is the total signal of the metabolite
detected in the sample extract, and xcontrol is the
total signal of the metabolite detected in the control
sample (standard).
The control sample was 100 µl metabolite mix-
ture (a) or (b) (see metabolite standards), directly
lyophilized and analysed by GC–MS after proper
derivatization. When the recovery results were
higher than 100% (spiked + cell metabolites), the
recovery was presented as >100%, which apply
only for the evaluation of the extraction pro-
cedures. Recoveries above 100% were typically
observed when high metabolite concentrations
were extracted from the biomass.
Results
Quenching
Fast transfer of 5 ml fermentation broth at 30 ◦C
into 20 ml 60% (v/v) methanol solution at −40 ◦C
resulted in a cell suspension at −20 ◦C, returning
to −40 ◦C within 3 min. Fast sampling of 10 ml
fermentation broth at 30 ◦C into 20 ml 75% (v/v)
methanol solution at −40 ◦C resulted in a cell
suspension at −10 ◦C, re-establishing the original
temperature (−40 ◦C) in 5 min.
The membrane integrity assay showed that
the yeast cell membrane is damaged by con-
tact with both buffered and non-buffered cold
methanol solution at either 60% (v/v) or 75%
(v/v) (Figure 3). The metabolite levels in the super-
natant of quenched samples confirmed that the
Table 1. Relative metabolite leakage levels after different
quenching experiments using cold methanol solution
Experiments
Metabolites I II III IV V
Lactate 13 0 8 3 78
Fumarate 0 0 0 0 0
Malate 0 0 0 0 0
Succinate 0 0 0 0 0
Citramalate 0 0 92 0 ∼100
PEP1 ∼100 ∼100 ∼100 ∼100 0
cis-Aconitate1 ∼100 ∼100 ∼100 ∼100 0
Citrate 34 86 ∼100 51 0
Myristate 0 0 0 0 ∼100
Alanine 0 0 40 37 0
Glycine 8 10 16 14 12
Valine 76 56 86 58 8
Leucine 78 57 ∼100 59 32
Isoleucine 83 60 ∼100 61 6
Proline ∼100 82 ∼100 83 8
Threonine 21 47 49 44 0
Aspartate 71 69 77 52 0
Phenylalanine 0 0 0 0 0
α-Ketoglutarate 0 0 0 0 0
Butyrate 70 77 ∼100 80 0
Glyoxylate 0 0 40 37 0
Asparagine 14 44 73 0 0
Glutamate ∼100 71 ∼100 62 0
Methionine 0 81 0 0 0
Serine 0 79 0 0 0
Histidine 0 0 0 16 0
Ornithine 0 5 9 7 0
Lysine 6 18 26 24 0
Tyrosine 0 21 82 58 0
Values expressed in percentage of the total intracellular level. The
total intracellular level is calculated from intracellular concentration
(Villas-Boˆas et al., 2005) plus leaked levels (for details, see Materials
and methods). Experiments: I, 5 ml sample to 20 ml 60% (v/v) cold
methanol solution; II, 10 ml sample to 20 ml 75% (v/v) cold methanol
solution; III, 5 ml sample to 20 ml 60% (v/v) buffered cold methanol
solution; IV, 10 ml sample to 20 ml 75% (v/v) buffered cold methanol
solution; V, 5 ml sample to 20 ml 60% (v/v) cold methanol solution
and biomass separation under fast centrifugation (5 min at 1540 × g).
1 Metabolites not detected intracellularly.
methanol solution caused damage to the yeast cell
membrane (Table 1). Several organic and amino
acids were practically extracted from the cells dur-
ing the quenching process. On the other hand, sugar
phosphates did not appear to leak from the intra-
cellular medium because their levels were roughly
the same as those found in the culture media (data
not shown).
Increasing the speed and decreasing the time
of centrifugation to separate the yeast cells after
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A
B
C
Figure 3. Yeast cells assayed with propidium iodide to test the membrane integrity during quenching with cold methanol
solution at −40 ◦C. (A) Control cells centrifuged and resuspended in saline solution. (B) Cells quenched with 60% (v/v)
methanol solution at −40 ◦C. (C) Cells quenched with 60% (v/v) buffered methanol solution at −40 ◦C
quenching resulted in a considerably reduced
number of metabolites that leaked from the cells
(Table 1), showing that the longer the time the cells
stay in contact with the quenching solution, the
higher is the leakage of intracellular metabolites,
which is especially the case for amino acids. How-
ever, a few metabolites presented higher leakage
when compared to the original protocol (de Kon-
ing and van Dam, 1992), e.g. lactate, citramalate
and myristate were detected at a higher level in the
supernatant of samples centrifuged at higher speed
(Table 1).
Intracellular metabolite extraction
None of the extraction methods tested ensured a
100% recovery of all classes of metabolites spiked
into the samples. Each method favoured some
classes of compounds and even some discrimina-
tion within the same class was observed. Table 2
presents the global recovery for the different classes
of metabolites: that is the average value of the
recovery of different representatives for each class
(some classes have only one representative).
In particular, the acidic amino acid glutamate
showed 100% recovery in all methods tested.
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Table 2. Global recovery of the different metabolite classes after different extraction method (n = 3)
Metabolite class CMB (%) BE (%) PCA (%) KOH (%) MW (%) PM (%)
Amino acid (neutral) >100 87 9 96 58 96
Amino acid (basic) 100 36 0 0 36 >100
Amino acid (acidic) >100 >100 >100 >100 >100 >100
Amino acid (aromatic) 100 49 2 >100 75 85
Organic acid (1-COOH) 75 90 2 13 >100 98
Organic acid (2-COOH) 77 97 6 72 98 94
Organic acid (3-COOH) 85 66 0 3 60 72
Organic acid (α-keto) 53 58 1 3 49 82
Fatty acid 0 43 5 64 50 71
Nucleotide 54 3 8 22 62 83
Peptide 57 31 49 41 28 44
Sugar 56 2 54 21 27 30
Sugar alcohol 69 50 68 80 69 78
Sugar phosphate 27 0 0 0 0 0
Extraction method: CMB, chloroform : methanol : buffer; BE, boiling buffered ethanol; PCA, perchloric acid; KOH, potassium hydroxide; MW,
cold methanol solution 50% (v/v); PM, pure cold methanol.
Table 3. General classification of the different extraction methods based on the recovery of spiked metabolite standards
(n = 3)
Classes of metabolites
Method
Amino
acids
Organic
acids
Fatty
acids Nucleotides Peptides Sugars
Sugar
alcohols
Sugar
phosphates
CMB ∗∗∗∗∗ ∗∗∗∗ nr ∗∗∗ ∗∗∗ ∗∗∗ ∗∗∗∗ ∗∗
BE ∗∗∗∗ ∗∗∗∗ ∗∗∗ ∗ ∗∗ ∗ ∗∗∗ nr
PCA ∗∗ ∗ ∗ ∗ ∗∗∗ ∗∗∗ ∗∗∗∗ nr
KOH ∗∗∗∗ ∗∗ ∗∗∗∗ ∗∗ ∗∗∗ ∗∗ ∗∗∗∗ nr
MW ∗∗∗∗ ∗∗∗∗ ∗∗∗ ∗∗∗∗ ∗∗ ∗∗ ∗∗∗∗ nr
PM ∗∗∗∗∗ ∗∗∗∗∗ ∗∗∗∗ ∗∗∗∗∗ ∗∗∗ ∗∗ ∗∗∗∗ nr
Extraction method: CMB, chloroform : methanol : buffer; BE, boiling buffered ethanol; PCA, perchloric acid; KOH, potassium hydroxide; MW,
cold methanol solution 50% (v/v); PM, pure cold methanol.
∗∗∗∗∗ >80%; ∗∗∗∗ >60%; ∗∗∗ >40%; ∗∗ >20%; ∗ >0%; nr, not recovered.
However, the high recovery of glutamate can be
explained by the high natural intracellular concen-
tration of this metabolite in S. cerevisiae (Villas-
Boˆas et al., 2005). All methods recovered more
than 100% glutamate, which makes it difficult
to define how much was lost. In contrast, the
sugar phosphates were recovered only by the CMB
method. NADH and NADP showed very dis-
tinct recoveries, resulting in bigger standard devia-
tions, since NADP was much better recovered than
NADH (data not shown). The recovery of the fatty
acid, peptide, sugars and sugar phosphates did not
reach 80% in any extraction method tested.
Table 3 rates the different methods according to
their capability in recovering the spiked classes of
metabolites. The CMB method presented excellent
recoveries of amino acids, organic acids and sugar
alcohols, and was the only method able to recover
part of the sugar phosphates spiked into the samples
(Table 2). However, the nucleotides were poorly
recovered and the fatty acid was not detected at all.
Extraction with BE resulted in reasonable recov-
eries of amino and non-amino organic acids includ-
ing the fatty acid (Table 3). This method espe-
cially recovered the mono- and dicarboxylic acids
better. Nonetheless, sugars, sugar phosphates and
nucleotides were poorly recovered and the pep-
tide, tricarboxylic acids and basic and aromatic
amino acids showed comparatively poorer recov-
eries (Table 2).
Acidic extraction with PCA presented the worst
recoveries in general and the extracts after lyophili-
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zation contained a large amount of salt (KClO4),
making it difficult to redissolve for derivatization.
Only sugars, sugar alcohols and the peptide pre-
sented relatively good recoveries. All the other
metabolite classes presented recoveries lower than
10% (except glutamate). Similarly, alkaline extrac-
tion using KOH also resulted in a large amount
of salt after the sample concentration step, giving
the same analytical problems. However, the latter
presented good recoveries of amino acids (except
basic amino acid), fatty acid and sugar alcohols
(Table 2). Nucleotides, sugars, sugar phosphates
and most of the organic acids were poorly recov-
ered by extraction with KOH.
Although not presenting excellent recoveries of
neutral and basic amino acids, sugars and sugar
phosphates, the MW extraction recovered most
of metabolite classes reasonably well. Particularly
the nucleotides were significantly better recov-
ered by this method. However, by changing the
methanol concentration from 50% (v/v) to pure
cold methanol (PM) it was possible to get outstand-
ing metabolite recoveries for most of the metabolite
classes tested (Table 3). The modified method pre-
sented the best recovery results for nucleotides and
α-keto acids. Only sugars and sugar phosphates
showed relative poor recoveries (Table 2). Further-
more, the pure methanol method achieved the best
reproducibility compared to the other methods.
Figure 4 shows the global extraction results
based on the number of peaks detected and
identified by GC–MS after MCF derivatization.
0
50
100
150
(n)
200
250
CMB BE PCA KOH MW PM
Detected peaks Identified peaks
Figure 4. Total number of MCF derivatives detected and
identified by GC–MS after different extraction procedures
(n = 3). CMB, chloroform : methanol : buffer; BE, boiling
buffered ethanol; PCA, perchloric acid; KOH, potassium
hydroxide; MW, cold methanol solution 50% (v/v); PM,
pure cold methanol
Although not every GC peak corresponds to a sin-
gle metabolite, because one metabolite can yield
more than one product after the derivatization reac-
tion, the number of detected peaks and the number
of identified metabolites is undoubtedly a strong
indication of the extraction efficiency. Again PM
extraction yielded the highest number of GC peaks
(>150) as well as the highest number of identified
peaks. Besides the highest number of metabolite
extracted, this method presented an excellent con-
sistency in the number of compounds extracted
(Figure 4). CMB, BE and MW extractions yielded
a quite similar number of GC peaks (fewer than
100) and identified compounds. However, among
them, CMB gave the best reproducibility. Extrac-
tions at extreme pH, alkaline and particularly acidic
extractions presented the poorest efficiency with
respect to extraction of metabolites. Extraction with
PCA resulted in the lowest number of GC peaks
and identified compounds as well as this method
had the lowest reproducibility (Figure 4).
Sample concentration
The lyophilization process resulted in a very
diverse recovery pattern depending on the class of
metabolites, and similarly to the extraction results,
discrimination was observed even within the same
metabolite class. Table 4 presents the overall recov-
ery of the different metabolite classes after the
lyophilization process. Basically, all organic acids,
nucleotides, sugars and the peptide presented
recovery higher than 80% under one or more
lyophilization condition tested. The fatty acid was
poorly recovered in all conditions and the basic
amino acid lysine was practically not recovered at
all. The recovery of sugar alcohols and sugar phos-
phates was <75%.
The experiment was designed as a reduced 23-
factor experiment and was evaluated by analy-
sis of variance (ANOVA). The deactivation of
the lyophilization flasks (50 ml Erlenmeyer) by
silanization was the only variable that slightly pos-
itively affected the recovery of metabolites, but
the only affected classes were the aromatic amino
acids and nucleotides. Keeping the lyophilized
samples in a dry and reducing environment slightly
improved the recovery of sugars and, interestingly,
the breakage of vacuum with nitrogen seems to
affect negatively the recovery of the fatty acid,
sugar alcohols and sugar phosphates. Overall, the
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Table 4. Global recovery of the different metabolite classes
after lyophilization under different conditions (n = 3)
Lyophilization conditions
Class of metabolites I II III IV V VI
Amino acid (neutral) 95 92 92 99 98 99
Amino acid (basic) 0 0 0 3 5 0
Amino acid (acidic) 100 83 100 100 100 100
Amino acid (aromatic) 50 41 52 59 54 44
Organic acid (1-COOH) 100 94 96 100 100 96
Organic acid (2-COOH) 100 96 91 100 100 96
Organic acid (3-COOH) 100 92 100 91 100 98
Organic acid (α-keto) 90 76 63 86 81 85
Fatty acid 42 24 9 32 22 47
Nucleotide 48 38 59 70 84 71
Peptide 100 87 87 66 75 91
Sugar 66 84 90 86 80 70
Sugar alcohol 73 68 67 49 61 71
Sugar phosphate 74 68 46 46 52 71
Variables: FD, flask deactivated by silanization; FND, flask not
deactivated; VO2, vacuum broken with air; VN2, vacuum broken
with nitrogen; SF, samples stored after being dried in freezer at
−20 ◦C; SDN2, samples stored after being dried in dry and reducing
atmosphere at −20 ◦C.
Conditions: I, FND/VO2/SF; II, FND/VO2/SDN2; III, FND/VN2/SDN2;
IV, FD/VN2/SDN2; V, FD/VN2/SF; VI, FD/VO2/SF.
three variables investigated did not significantly
change the recovery of the different metabolite
classes after lyophilization.
On the other hand, concentration of samples
by solvent evaporation under vacuum presented
an excellent recovery for all amino acids, organic
acids, nucleotides, sugars and sugar alcohols
(Table 5). About 100% of amino acids, nucleotides
and organic acids (excluding the fatty acid) were
recovered after solvent evaporation. Only sugar
phosphates and glutathione (peptide) presented
a comparatively lower recovery, 67% and 56%,
respectively. However, this procedure is only suit-
able for extraction methods based on organic sol-
vents if there should be a fast sample concentration.
Aqueous extracts would take a considerably longer
time for concentration and use of heating would be
required.
Discussion
The results from quenching yeast cultures with
cold methanol solution were surprising. This is the
most frequently employed method for quenching
microbial cells and several previous works have
Table 5. Global recovery of different metabolites after
solvent evaporation under reduced pressure at room
temperature (n = 3) RSD, relative standard deviation
Metabolites Recovery (%) RSD (n = 3)
Valine 100 3.5
Lysine 100 10.7
Glutamate 100 8.8
Phenylalanine 100 6.8
Tryptophane 100 8.7
Pyruvate 100 10.0
Lactate 100 6.0
Fumarate 100 9.3
Succinate 100 8.9
Citrate 100 8.7
Isocitrate 100 10.0
2-Oxoglutarate 100 13.2
2-Oxoadipate 100 11.7
Pimelate 100 11.9
Myristate 83 4.3
NADP 100 10.5
NADH 100 11.6
Glutathione 56 11.0
Xylose 85 10.0
Trehalose 100 1.0
Glycerol 92 10.0
Xylitol 85 3.0
Arabitol 85 3.0
Mannitol 62 8.0
Ribose 5-phosphate 42 4.0
Glucose 6-phosphate 100 8.0
Fructose 6-phosphate 84 10.0
Mannose 6-phosphate 41 4.0
reported the absence of significant intracellular
metabolite leakage using this method (de Koning
and van Dam, 1992; Gonzalez et al.,1997; Hans
et al., 2001). However, these results explain the
high variability of microbial metabolome data as
well as the discrepancies often found between
laboratories, usually attributed to differences in
strain backgrounds and/or bad reproducibility of
different cultivations.
Although Hans et al. (2001) did not detect sig-
nificant leakage of amino acids during quenching
using cold methanol solution, our results show
that several amino acids leak significantly from
the yeast cells after contact with cold methanol
solution. However, these authors applied faster
biomass separation from the quenching solution,
using higher centrifugation speed for a shorter time
(5 min), and they buffered their quenching solu-
tion at pH 7.5. Therefore, their report is actually
in agreement with our results, because we only
observed a minor leakage of a few amino acids
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(mainly leucine and glycine) under very similar
conditions (Table 1, experiment V).
On the other hand, a significant leakage of
organic acids from the yeast cells, mainly phos-
phoenolpyruvate and cis-aconitate, was observed
following the original protocol proposed by de
Koning and van Dam (1992). However, we did not
detect leakage of pyruvate, which is in agreement
with the original results reported by de Koning
and van Dam (1992). Similarly, we also confirmed
the results reported by Gonzales et al. (1997),
where detectable leakage of sugar phosphates and
nucleotides were not observed through quenching
yeast cells in cold methanol solution.
Yeast cells, like bacterial cells (Jensen et al.,
1999; Letisse and Lindley, 2000; Wittmann et al.,
2004), are therefore concluded to be sensitive to
cold methanol solution either buffered or non-
buffered (Figure 3). Even varying the concentration
of cold methanol solution from 25% to 75% did
not prevent cell membrane damage as assayed with
propidium iodide (data not shown). In addition, we
did not observe sample freezing in any quenching
condition tested, which could be pointed out as a
reason to provoke membrane damage. However, by
decreasing the time in which the yeast cells were
exposed to cold methanol solution, the leakage of
intracellular metabolites was generally minimized.
Furthermore, the possibility of quenching larger
sample volumes into a smaller volume of cold
quenching solution would be beneficial for many
laboratories in order to achieve easier automation,
as well as obtaining a higher final biomass con-
tent per sample. The dilution of yeast fermentation
broths very often imposes severe limitations on
the detection of intracellular metabolites. Doubling
the volume of sampling did not result in a drastic
increase of the final mixture temperature (−10 ◦C),
which was reestablished to −40 ◦C within 5 min;
however, it is recommended to keep the temper-
ature below −20 ◦C until extraction (Lange et al.,
2001).
The leakage observed after quenching yeast cells
with cold methanol solution does not exclude
the use of this method in several approaches of
metabolome analysis. However, precautions must
be taken in order to minimize losses of intracellular
metabolites. The longer the cells are in contact with
the quenching solution, the higher the leakage will
be; thus, the common practice of washing the cell
pellet with cold methanol solution to eliminate the
interference of extracellular metabolites should be
reconsidered and probably avoided. Alternatively,
Wittmann et al. (2004) proposed a protocol for
fast separation of bacterial cells from extracellular
media by fast filtration under vacuum and wash-
ing the biomass with four volumes of cold saline
solution at room temperature (the whole filtration
step including the washing was finished in less than
45 s). This method permitted authentic quantifica-
tion of intracellular amino acid pools, which could
probably be adapted to yeast cells. However, this
method seems not to be suitable for precise analysis
of metabolites with rapid turnover, e.g. phosphory-
lated intermediates.
Another important issue in sample preparation
for metabolome analysis is the procedure for
an efficient extraction of intracellular metabolites.
Most of the extraction protocols currently being
applied for extraction of intracellular metabolites
of yeasts are protocols originally developed for
the analysis of targeted compounds, and it is quite
clear that they do not suit to the needs of many
metabolome approaches where a global metabolite
profile is desired.
By examining the different extraction procedures
it has become evident that there is a strong influ-
ence of the extraction method on the metabolite
profile of yeast cells. Similar conclusions were also
achieved for filamentous fungi (Hajjaj et al., 1998)
and bacterial cells (Maharjan and Ferenci, 2003).
The recent methodologies developed to acquire
accurate information on microbial metabolite levels
(Buchholz et al., 2002; Soga et al., 2002; van Dam
et al., 2002; Mashego et al., 2004; Villas-Boˆas
et al., 2005; and others) urgently need an extrac-
tion protocol that is able to trap a higher diver-
sity of intracellular metabolites of yeasts. However,
the yeast metabolome comprises a variety of com-
pounds with a wide range of physical and chemical
properties that make this task virtually impossible.
Within this context, and based on the results pre-
sented here, we can draw a hierarchical scale for the
six methods evaluated here, concerning their dis-
criminative power. Starting from the less discrim-
inative to the most discriminative, PM < MW <
CMB < BE < KOH < PCA (Table 3). It was evi-
dent that acidic and alkaline extractions do not
suit the requirements for a global metabolome
analysis. These methods could be very efficient
in targeted analysis of metabolites, e.g. amines
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(Bouchereau et al., 2000), and the data acquisi-
tion method should be carefully chosen in order
to eliminate the interferences of high salt con-
centrations. According to Maharjan and Ferenci
(2003), destruction of compounds such as pyru-
vate, nucleotides and phosphorylated sugars under
extreme acidic or alkaline pH is well documented.
In addition, the neutralization of the extracts may
increase the losses of metabolites by absorbing to
the KClO4 precipitate.
On the other hand, the solubility of the metabo-
lites in the extraction solution is related to their
polarity. Taking the principle that ‘like dissolves
like’, more polar extraction media will dissolve
more polar compounds and vice versa, explaining
mainly the losses observed here. For instance, the
poor recovery of fatty acid during CMB extrac-
tion could have been resulted from it being dis-
solved in the chloroform phase, which was not
analysed. Similarly, sugars, and sugar phosphates
were badly recovered in most of the methods tested
probably due to the lack of polarity to extract
them efficiently. When the polarity was high, such
as in PCA and KOH methods, these compounds
were probably not stable at the extreme pH condi-
tions applied. Sugar phosphates presented the worst
recovery results and this can be attributed mainly
to their instability. These metabolites are extremely
labile, which makes their detection by GC–MS dif-
ficult. Therefore, the recovery results concerning to
this particular metabolite class could benefit from
using a more targeted sample work-up and a more
appropriate analytical method than GC–MS (see
Concluding remarks).
Loss of several metabolites were also observed
during BE extraction; most likely because many
metabolites are heat-labile. The sugars and the
nucleotides in particular presented the worst recov-
eries, but even several amino and organic acids
presented bad recoveries. Maharjan and Ferenci
(2003) obtained similar results using BE to extract
intracellular metabolites of bacteria. We excluded
the evaporation step as proposed in the original
BE protocol. Instead of evaporating the buffered
ethanol solution after the extraction and resuspend-
ing the cell debris in water and then lyophilizing the
aqueous extract after centrifugation, we lyophilized
the buffered ethanol solution directly after centrifu-
gation. It is possible that the spiked metabolites
would have had better solubility in water rather
than in buffered ethanol solution, resulting in better
recovery values. Nonetheless, we argue that inclu-
sion of the evaporation step would not have sig-
nificantly changed the results presented here, since
we got excellent recoveries using pure methanol
(PM protocol) that has solubility properties similar
to ethanol.
On the other hand, the extraction method pro-
posed by Maharjan and Ferenci (2003) for intra-
cellular metabolite extraction of bacteria pre-
sented distinct advantages over the other methods
and showed to be well applicable to yeast cells
(Tables 2 and 3). The modification of this method
proposed in this present work overcame most of our
expectations. Extraction using pure cold methanol
presented the lowest discrimination, coupled to a
quite simple sample work-up and excellent recov-
ery and reproducibility. In addition, this method
makes use of a single organic solvent that is not
as toxic as chloroform and can be easily removed
from the sample by solvent evaporation. Despite
its limitations in the extraction and recovery of
sugar and sugar phosphates, this method has excel-
lent potential to be employed routinely in high-
throughput metabolome analysis of yeasts; further-
more, it presents a great potential for automation.
Nonetheless, it is evident that the lyophilization
is partly responsible for the poor recovery of many
metabolite classes when comparing the different
extraction procedures. Most metabolite classes pre-
sented losses during lyophilization. Therefore, the
results from extractions and lyophilization could
be taken into account in order to get a more pre-
cise view regarding to the efficiency of the differ-
ent extraction methods. This would not change the
conclusions of this work, since the relative perfor-
mance of the method would remain unchanged.
However, the losses during lyophilization are
quite significant, as this sample concentration tech-
nique was supposed to be a gentle methodology
to concentrate aqueous samples. The losses of the
different metabolites could be related to discrimina-
tion during resuspension. The different metabolites
present different solubilities in the reduced volume
of resuspension solution, which is 200 µl 1% (w/v)
NaOH for MCF derivatization and 200 µl deion-
ized water for TMS derivatization, followed by a
second freeze-drying to eliminate the water. There-
fore, discrimination during dissolving these solutes
in a very small volume of solvent is likely to hap-
pen. In addition, considering that most extraction
procedures end up with approximately 5–10 ml
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extracts, we were forced to use relatively large
flasks for lyophilization. Thus, to dissolve the
remaining salts after the concentration process into
the 200 µl of solvent was definitely a challenge,
contributing for the losses observed. However, the
resuspension was in general reproducible. Increas-
ing the solvent volume for resuspension to cover
a larger surface area in the flask could improve
the recovery, but this would also require a second
concentration step.
Organic solvent evaporation showed to be a
viable method for concentration of samples con-
taining primary metabolites. The excellent recov-
ery achieved by this technique with reliable repro-
ducibility (Table 5) indicates that this methodology
is the best alternative for sample concentration in
metabolome analysis. However, this technique is
dependent on the type of extraction procedure used,
since this method is not suitable for aqueous sam-
ple extracts unless acetone is added to the mixture
to accelerate the evaporation process. Still, sol-
vent evaporation poses several advantages over the
lyophilization process, since it is faster and seems
less aggressive and less discriminative. Consider-
ing that we have obtained the best extraction results
using cold pure methanol as the extractive agent,
solvent evaporation is undoubtedly the method of
choice to concentrate the extracted samples. By
combining the PM extraction procedure with sam-
ple concentration by solvent evaporation, it should
be possible to improve the throughput of sample
preparation in metabolome analysis of yeast.
Concluding remarks
This work aimed to evaluate the relative over-
all performance of the different commonly used
sample preparation methods in the metabolomic
field, by fixing the analytical method (GC–MS)
and the biological sample (yeast cells in expo-
nential phase during aerobic growth on glucose).
For instance, one can argue that GC–MS was not
the most adequate method for the analysis of the
different classes of metabolites considered in this
study. However, our aim was not to analyse the
different metabolites accurately, but analyse them
precisely in a pool, under the influence of many
other metabolites, to become as close as possi-
ble to the reality of metabolome analysis. The
results should asses the relative performance of
several sample preparation steps. Furthermore, it
was clear from the different recoveries obtained
within the same metabolite class that the cho-
sen representative metabolites do not reflect pre-
cisely the real metabolome complexity; rather, it
gave us an insight into the complex microscopic
world of small molecules that comprise the whole
metabolome. Hence, the greater the accuracy of the
analysis of these molecules, the closer we will be to
puzzling out the in vivo cell function at the molec-
ular level.
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Chapter 6
Metabolic footprinting of
Saccharomyces cerevisiae
grown in microtiter plates
6.1 Introduction
Shaken cultures are widely used for microbial cultivation (Buchs, 2001). The
design and setup is simple and this makes it easy to handle multiple cultures at
a time. With the trend of increased throughput for screening multiple strains
there is a considerable interest in miniaturization of the fermentation processes
too (Duetz, 2007). The reduction of cultivation volume eases the handling, and
the use of microtiter plates (MTPs) enables handling of several cultivations in
parallel (Duetz et al., 2000). This increases the throughput of experiments and
allows conduction of many replicates within experiments. This is beneficial in
comparative studies as an increased number of replicates substantially improve
the statistics and hereby better allow unraveling differences between strains. Also
the inter-sample variance within a MTP can be reduced compared to running
separate shake flasks (Borner et al., 2007), and this will further strengthen the
data analysis.
Duetz et al. (2000) performed a detailed evaluation of the performance of
MTPs, by investigating these with respect to mass transfer using a biological and
chemical method to quantify the maximum oxygen transfer rate. The MTP setup
was suggested for handling of culture collections and genome libraries. The group
of Sauer also has numerous examples of using a 96-well MTP setup to culture
different microorganisms (Blank et al., 2005a,b; Fischer et al., 2004; Fischer and
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Sauer, 2005; Sonderegger et al., 2005). In their studies the cultures are primarily
used for metabolic flux analysis using 13C-labeled glucose. This has enabled in
vivo flux estimation of up to 137 mutants in one study (Fischer and Sauer, 2005)
and thereby presenting a technique for phenotyping a large number of strains,
which is complementing high-throughput approaches like microarrays and pro-
teome analysis (Sauer, 2004). For metabolite profiling Allen et al. (2003) used
a commercial 100-well MTP for growing yeast prior to metabolic footprinting.
In this study the optical density was automatically measured to ensure that the
cultures had reached the stationary phase at the time of sampling. Another ex-
ample of metabolite profiling involved direct integration with GC-MS and here
the cells were cultured, extracted and derivatized directly in the MTP (Borner
et al., 2007).
The purpose of this study was to evaluate the feasibility of cultivation in
MTPs rather than traditional Erlenmeyer shake flasks beyond the default carbon
source glucose. We investigated the growth of Saccharomyces cerevisiae in MTP
cultures with glucose, galactose or ethanol as the sole carbon source. Glucose
is the most common carbon source for growing S. cerevisiae and the only one
used in previous studies based on cultivation in MTPs. Galactose is a another
fermentative sugar, which is less repressive compared to glucose and might be
used for induction of genes expressed under the GAL promoters. Both glucose
and galactose are fermentable sugars, thus oxygen is not required for growth.
Ethanol is an example of a more reduced substrate that requires oxygen to be
metabolized. In order to evaluate the cultures metabolic footprinting was used to
analyze the effect of different carbon sources.
6.2 Materials and methods
6.2.1 Strain
The Saccharomyces cerevisiae strain BY4741 (MATa his3∆1 leu2∆0 met15∆0
ura3∆0) obtained from the European Saccharomyces cerevisiae archive for func-
tional analysis (EUROSCARF, Frankfurt, Germany) was used in the study (Brach-
mann et al., 1998).
6.2.2 Medium
The strain was cultivated in a minimal synthetic medium supplemented with a
metabolite cocktail according to Allen et al. (2003). The metabolite cocktail con-
tained a selection of amino acids, organic acids and organic bases. The medium
was based on yeast nitrogen base (YNB) without amino acids (BD Difco, Franklin
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Lakes, NJ, USA) and the metabolite cocktail was composed of L-arginine, L-
aspartate, L-glutamate, L-histidine, L-leucine, L-lysine, L-methionine, L-serine,
L-threonine, L-tryptophan, L-valine, citrate, fumarate, malate, pyruvate, succi-
nate, cytosine and uracil. All compounds from the metabolite cocktail had a
concentration of 1 mM in the final medium. Cultivations were performed with
either glucose, 20 g L−1; galactose, 20 g L−1; or ethanol, 5 g L−1; as carbon
source.
6.2.3 Pre-culture
Pre-cultures were prepared by inoculating a colony in 5 mL synthetic minimal
medium with metabolite cocktail and glucose as carbon source. The pre-cultures
were grown for 12 hours in an incubator at 30◦C and 150 rpm.
6.2.4 Shake flask cultivation
Shake flask cultivations were performed in 500-mL baﬄed flasks with 50 mL
medium. The medium was inoculated with the pre-cultures to OD600 = 0.01
and incubated at 30◦C and different shaking speeds.
6.2.5 Microtiter plate cultivations
Cultivations were carried out in MTPs as demonstrated by Duetz et al. (2000).
A 96-well plate with squared 2-mL wells (Whatman, Middlesex, UK) was covered
with a 4-mm thick plate of spongy silicone. The spongy silicone plate was per-
forated with 96 1.5-mm holes located exactly above the center of each well. The
spongy silicone plate was covered with 2-mm cotton wool and finally covered by
a rigid lid of 6-mm aluminium. The aluminium lid had 96 6-mm holes exactly
positioned above each of the wells. The aluminium plate was tightened by two
screws. For MTP cultures, a culture with OD600 = 0.01 was prepared from the
pre-culture into fresh medium. Aliquots of 500 µL of this culture were added to
the respective wells in the MTP. The cultures were incubated at 30◦C on a rotary
shaker (Ku¨hner AG, Schweiz) at 400 rpm with a shaking diameter of 25 mm.
6.2.6 Growth rate determination
For the cultivations the specific growth rates were estimated by measuring optical
density (OD) at 600 nm on a Hitachi U-1100 spectrophotometer (San Jose, CA).
The OD600 was assumed to be proportional with cell dry weight for OD600 values
below 0.3. Thus the samples were diluted if necessary to stay below an OD600 of
0.3.
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6.2.7 Analysis of extracellular metabolites
The samples were centrifuged (6400 rpm, 15 min) to remove biomass and stored
at −20◦C. Before analysis 150 µL of each sample were mixed with 150 µL of
methanol. Metabolic footprints were obtained by direct infusion mass spectrome-
try (MS). A Micromass Q-Tof (Manchester, UK) mass spectrometer was equipped
with a NanoMate device from Advion Biosciences (Ithaca, NY) for analysis by
nano-electrospray ionization MS. The source block temperature was held at 60◦C.
High-resolution continuum data was acquired in negative mode in the mass range
of 40-500 Da for 2 min with a scan time of 1.0 s and interscan of 0.1 s. The cap-
illary voltage was set to +1.43 kV and 0.09 psi head pressure. The cone voltage
was 20 V.
6.2.8 Data analysis
The mass spectra were converted by in-house written software and normalized by
the total sum of ion intensities. The spectra were aligned in bins of 0.1 Da widths
between 40 and 500 Da. The data was organized into at matrix with each row
representing a sample and the columns containing the variables corresponding
to the binned masses from the mass spectrum. All variables (columns in the
data matrix) only containing zeros were removed from the data. Before principal
component analysis (PCA) the individual variables were centered and scaled to
unit variance. Analysis of variance (ANOVA) was used to select medium specific
variables. The data analysis was executed in MATLAB (MathWorks, Natick,
MA, USA).
6.3 Results
Initially, the yeast was cultivated in shake flasks to get a reference of specific
growth rates for comparison with the MTP cultures. The results from the shake
flask experiment are summarized in Table 6.1. Three different shaking speeds
were used for the cultures and it turned out to have a significant (α = 0.05)
influence on the measured specific growth rate on glucose. The specific growth
rate varied from 0.357–0.420 h−1 for glucose and increased with increasing shaking
speed. Specific growth rates of 0.306 h−1 and 0.150 h−1 were measured in shake
flasks with respectively galactose and ethanol as carbon source. The influence of
shaking effect was not tested for these two substrates.
To characterize the growth of S. cerevisiae in MTPs and to investigate the
variation between wells the BY4741 strain was cultivated on glucose, galactose
or ethanol in MTPs. OD measurements were performed to determine the spe-
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Table 6.1 Specific growth rates obtained from shake flask cultiva-
tion (n = 3) of Saccharomyces cerevisiae BY4741 on different carbon
sources at different shaking speeds
Carbon source Shaking speed Specific growth rate
[rpm] [h−1]
Glucose 150 0.420 ± 0.007
133 0.401 ± 0.003
113 0.357 ± 0.006
Ethanol 113 0.150 ± 0.005
Galactose 113 0.306 ± 0.004
Table 6.2 Specific growth rates observed during micro-cultivation of
Saccharomyces cerevisiae BY4741 on glucose, galactose and ethanol
Carbon source Specific growth rate Correlation coefficient
[h−1]
Glucose 0.438 0.9987
Galactose 0.307 0.9961
Ethanol 0.145 0.9985
cific growth rate. At each time point OD was measured in two or three different
wells. The whole content of a well was used for measuring OD, thus sequential
measurements were never made from the same well. The results are presented in
Figure 6.1, and Table 6.2 summarizes the growth characteristics. S. cerevisiae
grew exponentially until the stationary phase on both glucose and galactose.
However, during the cultivation of ethanol a sudden slow-down in growth rate
was observed from exponential to approximately linear growth. Specific growth
rates of 0.438 h−1, 0.307 h−1 and 0.145 h−1 were observed in the exponential
growth phase on glucose, galactose and ethanol, respectively.
Samples for metabolic footprinting were taken from the MTP cultures. Due
to different specific growth rates the samples were taken after 24 hours for glucose
and galactose cultures and after 64 hours for the ethanol culture to ensure that
the stationary growth phase was reached. A principal component analysis (PCA)
was performed for dimension reduction. The analysis was capable of capturing
64% of the total data variance within the first and second principal component.
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Figure 6.1 Growth of S. cerevisiae in microtiter plates on either A: glucose, B: galactose,
or C: ethanol
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Figure 6.2 Principal component analysis (PCA) of metabolic footprints of S. cerevisiae
BY4741 grown on glucose, galactose and ethanol. The PCA was based on binned and
normalized mass spectra.
The samples were clearly clustering according to carbon source as seen in the
score plot in Figure 6.2. The clusters of ethanol and galactose were well-defined,
whereas the glucose samples were positioned further apart from each other and
giving a more disperse cluster.
Statistical analysis of variance (ANOVA) was used to extract variables that
were specific for the individual carbon sources. From ANOVA ions of 179.1 Da
and 277.1 Da were found to be significantly higher for all samples taken from the
cultures grown on galactose. This was most likely the deprotonated molecular ion
[M − H]− and a hydrogen sulphate adduct [M + HSO4]− of galactose indicating
that the galactose was not fully depleted at the time of sampling. Another few
ions were found to be specific for the different carbon sources, e.g. ion 147.0 and
189.0 for glucose, ion 175.4 and 177.1 for galactose, and ion 149.1 for ethanol.
6.4 Discussion
The specific growth rates observed in MTPs (Table 6.2) were very similar to those
obtained in shake flasks (Table 6.1), but the specific growth rate on glucose for
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the MTP culture was slightly higher than what was observed for shake flask cul-
tivations. Taking into account the variation caused by shaking speed the results
match very well. The observation of correlation between shaking speed and spe-
cific growth rate could be a coincidence, since different shakers were used and the
temperature might not have been exactly the same.
The slow-down in growth rate on ethanol (Figure 6.1C) is most likely caused by
oxygen limitation, which is set by the oxygen transfer rate. The maximum oxygen
transfer rate is determined by the well geometry, shaking speed, shaking diameter,
and culture volume as these factors affect the mixing and surface-volume ratio
(Duetz et al., 2000; Duetz and Witholt, 2001, 2004; Duetz, 2007; Kensy et al.,
2005). In these experiments the shaking diameter was 25 mm and increasing it
to 50 mm would increase the maximum oxygen transfer rate by approximately
three times (Duetz and Witholt, 2001, 2004), which would extend the exponential
growth phase on ethanol and the stationary phase would be reached faster.
Looking into the metabolic footprinting obtained by negative direct infu-
sion mass spectrometry, the individual samples clustered according to the car-
bon source. The differences in the culture media were only the carbon source.
Substituting glucose with galactose has practically no impact on the direct infu-
sion mass spectrum of the medium, since glucose and galactose have the same
molecular composition and MS ionization. In the ethanol medium, the C6H12O6
associated ions from glucose or galactose (e.g. [M − H]− and [M + HSO4]−) are
absent in the mass spectrum and no particular ionization of ethanol is expected.
Secondly, ethanol is known to be a product from respiro-fermentative growth of
S. cerevisiae on glucose and galactose. Despite these minor medium differences
footprinting of BY4741 proves to be specific in terms of physiology and differences
in metabolism.
In order to explore genotypes, it is important to challenge the metabolic net-
work by varying the primary carbon source for the experiments and this way
finding fitness of growth (phenotype). Growing S. cerevisiae on different carbon
sources is possible in MTPs as shown in this study, and the application of MTPs
in connection with metabolic footprinting is an option as earlier demonstrated by
Allen et al. (2003). Although Allen et al. (2003) argued that high cell densities
was sufficient to inhibit growth on ethanol after the cultures had entered the sta-
tionary phase, taking the results of this study into account we have shown that
S. cerevisiae grows well on ethanol in MTPs. As ethanol is a product of respiro-
fermentative batch growth of S. cerevisiae on glucose, a significant amount of
ethanol will be present in the medium after glucose in depleted; and therefore
changes in the metabolic footprint will occur as ethanol is metabolized, but this
is of cause dependent on the oxygen transfer rate.
The standardized format of MTPs calls for automation, which will allow high-
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throughput screening. Even if a robot is not available, several tools can increase
throughput like multi-channel pipettes, MTP spectrophotometers, special cen-
trifuge holders etc. One concern of cultivation in MTPs is the difficulty of han-
dling the individual wells in the plate independently. When different strains are
inoculated in the different wells of a MTP, all wells should not be harvested at
the same time due to differences in lag time and growth rates.
6.5 Conclusion
The scale-down from shake flask (50 mL) to MTP (500 µL) was successful. The
cultivation in shaken MTPs mimics the growth in shake flasks very well for S.
cerevisiae on different carbon sources. Cultivation in MTP has a major potential
for handling several cultures in parallel, but for metabolic footprinting this will
ideally require automation to monitor growth and allow independent sampling.
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Abstract Mass spectrometry (MS) has been a major
driver for metabolomics, and gas chromatography (GC)-
MS has been one of the primary techniques used for
microbial metabolomics. The use of liquid chromatography
(LC)-MS has however been limited, but electrospray ion-
ization (ESI) is very well suited for ionization of microbial
metabolites without any previous derivatization needed. To
address the capabilities of ESI-MS in detecting the me-
tabolome of Saccharomyces cerevisiae, the in silico
metabolome of this organism was used as a template to
present a theoretical metabolome. This showed that in
combination with the specificity of MS up to 84% of the
metabolites can be identified in a high mass accuracy ESI-
spectrum. A total of 66 metabolites were systematically
analyzed by positive and negative ESI-MS/MS with the
aim of initiating a spectral library for ESI of microbial
metabolites. This systematic analysis gave insight into the
ionization and fragmentation characteristics of the different
metabolites. With this insight, a small study of metabolic
footprinting with ESI-MS demonstrated that biological
information can be extracted from footprinting spectra.
Statistical analysis of the footprinting data revealed dis-
criminating ions, which could be assigned using the in
silico metabolome. By this approach metabolic footprinting
can advance from a classification method that is used to
derive biological information based on guilt-by-associa-
tion, to a tool for extraction of metabolic differences, which
can guide new targeted biological experiments.
Keywords Mass spectrometry  Metabolic footprinting 
Saccharomyces cerevisiae  Mass spectral library 
Metabolic marker
1 Introduction
Mass spectrometry (MS) has been one of the primary
technologies contributing to the continuing advancement of
metabolite analysis (Dunn 2008). MS has been refined in
the last 20 years and this has enabled today’s development
of metabolomics, which is aiming at measuring the com-
plete pool of metabolites associated with a cell or an
organism. First of all extensive analytical methods are
needed, but for metabolomics to succeed in pursuing the
goal of global metabolite profiling, efficient data interpre-
tation is required. As many of the analytical strategies for
metabolite profiling are based on MS, it is advantageous to
compile mass spectra into libraries to facilitate an efficient
interpretation of data. The spectral libraries enable efficient
identification (dereplication) of compounds, which will
speed-up the data digestion and information extraction
from metabolite profiles.
There has been a long tradition within GC-MS for
construction of mass spectral libraries. While numerous
libraries are available with electron impact (EI) spectra
(Halket et al. 2005; Schauer et al. 2005) there is a low
coverage of spectra for primary metabolites in these
libraries. Recently specific emphasis has been put on
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construction of biologically relevant libraries that contain
metabolite derived spectra, and in this context both sample
preparation and derivatization procedures have been
addressed. This has placed GC-MS as the preferred ana-
lytical techniques for comprehensive and quantitative
metabolite profiling for metabolomics (Dunn 2008; Villas-
Boas et al. 2005). EI is the primary mode of ionization used
for GC-MS and the ionization yields molecular fragments
that are specific for the respective compound and represent
a fingerprint of the molecule that is well suited for identi-
fication (McLafferty and Turecek 1993). Furthermore, the
ionization is standardized and very reproducible and this
has eased the data collection for libraries that can be
applied across instruments and laboratories for decades.
Until now the application of LC-MS for profiling of
primary metabolites has been limited. One of the major
reasons probably being that no standard reversed phase
liquid chromatography method performs very well for a
wide range of primary metabolites as these typically are
highly polar. Alternatives to standard reversed phase liquid
chromatography exist and chromatographic methods like
HILIC (hydrophilic interaction chromatography; Nguyen
and Schug 2008) or ion-pair chromatography (Coulier et al.
2006) make it possible to separate polar metabolites by LC.
The polar properties of primary metabolites make them
suited for analysis by electrospray ionization (ESI)-MS. By
collecting data for libraries containing ESI spectra, this can
ease the interpretation of ESI data from LC-MS or MS
fingerprinting. The ESI process is initiated in the liquid
phase at atmospheric pressure, and therefore the ESI is
affected by the liquid matrix (Matuszewski et al. 2003;
Taylor 2005). This gives rise to spectral variation for dif-
ferent sample matrices and makes ESI less robust in terms
of spectral reproducibility, because adduct intensities are
dependent on e.g., ion strengths (i.e., charge concentration
in the liquid phase), ion species, co-elution and design of
ion source. This means that sample matrices resulting from
sample handling and buffers are reflected in the mass
spectrum (Castrillo et al. 2003; Taylor 2005).
ESI will in many cases complement the compound range
compared to EI that requires derivatization (van der Werf
et al. 2007), and this makes the ESI technique of interest
for metabolome analysis as a complementary technique.
ESI is a soft ionization technique that only mediates lim-
ited molecular fragmentation dependent on instrument
operation. Thus, the mass spectrum will primarily contain
molecular adduct ions and only provide limited structural
information. Fragmentation of ions can be used to gain
structural information, and this may be obtained by colli-
sion-induced dissociation (CID) either in the ion source
region or by tandem MS in a collision cell. Ion source CID
is in some cases instrument dependent and resulting mass
spectra will also be solvent matrix dependent although
standardization can partly reduce this (Bristow et al. 2002).
In tandem MS, the ion is pre-selected and fragmented and
therefore tandem mass spectra are more specific, and the
reproducibility is in general better compared to ion source
region fragmentation (Bristow et al. 2004; Gergov et al.
2004; Josephs and Sanders 2004). In addition the sensi-
tivity can be increase by tandem MS since the signal-to-
noise ratio (S/N) can be improved dependent on the mass
spectrometry technology. The tandem mass spectra can
then be used for compound identification by spectral
comparison, similarly to identification of EI spectra from
GC-MS. The mechanism for fragmentation by CID is
caused by collision. The gas phase ions are accelerated and
collide with inert gas molecules like nitrogen (N2) or argon
(Ar). The exchange of energy at the time of collision
transfers to rotational and translational energy, which
causes the fragmentation by bond breakage. The energy
required for CID varies dependent on the ion stability,
which then make the fragmentation pattern dependent on
the fragmentation energy and the partial pressure of the
collision gas. The transferability of ESI libraries between
instruments is not as good as seen for EI libraries for GC-
MS, but Bristow et al. (2004) have successfully created a
tandem MS library and evaluated the performance for five
different MS instruments.
Applications of ESI tandem MS without a prior sepa-
ration step (e.g., chromatography or electrophoresis) can be
used for direct identification (Boernsen et al. 2005) and
even quantification (Nagy et al. 2003) of metabolites in
blood samples. Direct infusion ESI-MS has also been used
for metabolic footprinting, which is a fingerprinting tech-
nique (Fiehn 2002) using the extracellular medium from
submerged microbial cultures (Allen et al. 2003; Howell
et al. 2006; Kell et al. 2005; Pope et al. 2007). A finger-
printing technique primarily aims at classifying different
species and/or samples and can be carried out by MS or
various types of spectroscopy e.g., NMR, IR, NIR or
fluorescence. The use of ESI-MS provides a fingerprint of
the samples, which contains structural information about
the metabolites differentiating the samples. The ions in the
mass spectrum are directly related to the metabolites in the
sample and by identification of ions in the mass spectrum it
is possible to extract information about physiological dif-
ferences rather than just spectral differences assigned by
guilt-by-association (Allen et al. 2003). Thus, annotation of
the different spectra in ESI-MS will substantially improve
the use of this technique for obtaining high-throughput
metabolome data that can be used in systems biology.
In an attempt to annotate spectral data from ESI-MS we
first approximated the metabolome of S. cerevisiae based
on the in silico metabolic network of this organism (Forster
et al. 2003). Hereby we identified the theoretical metabo-
lome that can be measured by MS. We then started to
J. Højer-Pedersen et al.
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construct a spectral library containing mass spectra of
microbial primary metabolites. This spectral library was
initiated with the intension of making it available for the
metabolomics community, and hereby allow for a wider
use of ESI-MS for metabolome analysis of yeast. The
library holds information about the metabolite derived ions
observed in positive and negative ESI and the tandem mass
spectra resulting from fragmentation of the [M ? H]? and
[M - H]- ions in positive and negative mode, respec-
tively. To validate our approach we performed ESI-MS
analysis of the metabolic footprint of different yeast
mutants and then used statistics to identify discriminant
ions. Some of these ions were then identified using our
library and the in silico metabolome, and hereby the library
was used to directly gain insight into the physiological and
metabolic differences of the mutants evaluated.
2 Materials and methods
2.1 In silico metabolites
The in silico metabolic model of Saccharomyces cerevisi-
ae, which was compiled by Forster et al. (2003), was used
as a template for generating the theoretical metabolome of
S. cerevisiae. Furthermore the LIGAND database, which is
part of the KEGG database (http://www.kegg.com), was
downloaded (March 2006). This contains molecular infor-
mation about the different metabolites. The intersection
between the metabolic model and the LIGAND database
was used to obtain a list of defined metabolites for
S. cerevisiae.
3 Mass spectral library
3.1 Chemicals
Metabolites were all analytical grade and the providers
were either Sigma-Aldrich (St. Louis, MO, USA) or Serva
(Heidelberg, Germany). Methanol and formic acid used for
mass spectrometry were obtained from Sigma-Aldrich
(St. Louis, MO, USA). MilliQ-purified water was used for
aqueous solutions.
3.2 Metabolite standards
A total of 66 metabolites were prepared in 10 mM aqueous
solution and stored at -20C until analysis. The selected
metabolites are listed in Supplementary Material (Table
S1) and are primarily from the central carbon metabolism
covering a selection of amino acids, organic acids, nucle-
otides, and glycolytic intermediates.
3.3 MS analysis
All standards were analyzed by nano-ESI-MS using a chip-
based Nanomate (Advion BioSciences, Ithaca, NY, USA)
robot coupled to a hybrid orthogonal acceleration Q-tof I
mass spectrometer with 3.6 GHz TDC detector (Micro-
mass, Manchester, UK).
The Q-tof was tuned to a resolution around 7,000 at full-
width half maximum (FWHM) for leucine enkephalin
(C28H37N5O7; [M ? H]
? = 556.2771 Da and [M - H]-
= 554.2615 Da). In positive mode the mass scale was
calibrated using an acidified poly(ethylene glycol) (PEG)
solution containing ammonium formate and a fifth-order
polynomial mass calibration fit was applied. The calibra-
tion in negative mode was obtained by infusion of a PEG
bis(carboxymethyl) ether solution, and again a fifth-order
polynomial mass calibration fit.
The source block temperature was held at 60C. High-
resolution continuum data was acquired in the mass range
of 50–900 Da with a scan time of 1.0 s and interscan of
0.1 s. For positive ESI-MS, the capillary voltage was set to
-1.55 kV and 0.35 psi head pressure, and in negative
mode the nanospray parameters were set to ?1.67 kV and
0.40 psi. Continuum mass spectra were acquired for 1 min
at sequentially three different cone voltages of 10 V, 25 V
and 40 V. This was done to induce in-source fragmentation
and address the ion stability.
Apart from the fragmentation observed by in-source
fragmentation caused by elevated cone voltage, the frag-
mentation patterns were studied by tandem MS. The first
quadrupole was set to allow passage of the [M ? H]? and
[M - H]- ions in positive and negative mode, respec-
tively. Nitrogen was used as collision gas in the collision
cell at 1.0 9 10-5 mbar and collision energy of 16 eV,
20 eV and 24 eV were applied with cone voltage of 10 V,
25 V and 40 V, respectively.
All standards were diluted to 50 lM with 75% aqueous
methanol, and for the analysis in positive ESI-MS the
aqueous methanol solution contained 25 mM formic acid
as modifier to improve ionization.
The high-resolution continuum data was analyzed by
MassLynx 4.0 (Waters, Milford, MA, USA).
4 Metabolic footprinting
4.1 Strain
The S. cerevisiae strain BY4741 (MATa his3D1 leu2D0
met15D0 ura3D0), BY4741 hxk2D, and BY4741 pck1D
obtained from the European S. cerevisiae archive for
functional analysis (EUROSCARF, Frankfurt, Germany)
was used in the study (Brachmann et al. 1998). The strains
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were auxotrophic and needed histidine, leucine, methionine
and uracil, which were available in the medium.
4.2 Medium
The strains were cultivated in a minimal synthetic medium
supplemented with a metabolite cocktail according to Allen
et al. (2003). The metabolite cocktail contained a selection
of amino acids, organic acids and organic bases. The
medium was based on yeast nitrogen base (YNB) without
amino acids (BD Difco, Franklin Lakes, NJ, USA) and the
metabolite cocktail was composed of L-arginine, L-aspar-
tate, L-glutamate, L-histidine, L-leucine, L-lysine,
L-methionine, L-serine, L-threonine, L-tryptophan, L-valine,
citrate, fumarate, malate, pyruvate, succinate, cytosine and
uracil. All compounds from the metabolite cocktail had a
concentration of 1 mM in the final medium. Cultivations
were performed with glucose, 20 g l-1, as carbon source.
4.3 Pre-culture
Pre-cultures were prepared by inoculating a colony in 5 ml
synthetic minimal medium with metabolite cocktail and
glucose as carbon source. The pre-cultures were grown for
12 hours in an incubator at 30C and 150 rpm.
4.4 Shake flask cultivation
Shake flask cultivations were performed in 500-ml baffled
flasks with 50 ml medium. The medium was inoculated
with the pre-cultures to OD600 0.01 and incubated for 24 h
at 30C and 150 rpm.
4.5 Mass spectrometry analysis
The samples taken from the shake flasks were filtered
immediately after sampling to obtain the metabolic foot-
print. Prior to analysis the samples were diluted 10 times
by methanol. Samples of 1 ll were injected via a FAMOS
autosampler (LC packings, The Netherlands) into a carrier
flow of methanol at 15 ll min-1 from a microflow binary
pump (Agilent Technologies, Santa Clara, CA, USA).
Before reaching the mass spectrometer additionally
5 ll min-1 of 2.0% (v/v) aqueous formic acid was added
through a T-piece using a syringe pump. The total flow of
20 ll min-1 was injected into a Micromass Q-tof I mass
spectrometer with 3.6 GHz TDC detector (Manchester,
UK) equipped with a Z-spray ion sources.
The Q-tof was tuned in positive mode as described
above for the mass spectral library. For analysis, the
desolvation and nebulizer gas flow was 320 l h-1 and
20 l h-1, respectively. The source block temperature was
set to 80C and the desolvation temperature was 100C.
The capillary voltage was 3,200 V and the cone voltage
was 17 V. Scans were collected from m/z 40 to 500 with a
scan time of 2.0 s and 0.1 s interscans delay.
4.6 Data analysis
The mass spectra were converted by in-house written
software and normalized by the total sum of ion intensities.
The spectra were aligned in bins of 0.1-Da width between
40 and 500 Da. The data was organized into at matrix with
each row representing a sample and the columns containing
the variables corresponding to the binned masses from the
mass spectrum. All variables (columns in the data matrix)
only containing zeros were removed from the data. Prin-
cipal component analysis (PCA) was used to visualize the
data (Jolliffe 2002). Before PCA the individual variables
were centered and scaled to unit variance. Analysis of
variance (ANOVA) was used to select group specific
variables. The data analysis was executed in MATLAB
(MathWorks, Natick, MA, USA).
5 Results and discussion
5.1 In silico yeast metabolites
The metabolic network of the yeast S. cerevisiae has been
extensively studied in the last decade using various flux
models of different complexity. Based on the genome
sequence, Forster et al. (2003) compiled a genome-scale
metabolic model of S. cerevisiae, which contained
approximately 1,200 metabolic reactions involving around
550 metabolites. The metabolites contained in the model
were used to identify the theoretical metabolome of
S. cerevisiae. In order to obtain chemical structures and
molecular masses the LIGAND part of the KEGG database
(http://www.kegg.com), which contains 13,785 metabolite
entries (March 2006), was used. By extracting the inter-
section of the around 550 in silico metabolites from the
metabolic model and of the compound list from KEGG, it
was possible to compile a list of 438 unique metabolites
with known (and exact) molecular formula, from which the
accurate (monoisotopic) mass could be calculated (Sup-
plementary Material, Table S2). Here it should be noted
that the genome scale model of S. cerevisiae does not cover
detailed metabolic pathways for lipids, and basically no
lipids are therefore included in the metabolite list.
Of the 438 metabolites 366 (84%) molecular formulas
are unique in terms of elemental composition and ideally
possible to distinguish by MS simply based on the accurate
mass. Deriving the nominal mass of these unique formulas
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gives rise to 268 (61%) distinct nominal masses. And
therefore high resolution mass spectrometers will be
superior; since they can distinguish many more metabolites
compared to low resolution instruments with unit mass
resolution. Although some metabolites may have the exact
same elemental composition and thereby mass, in some
cases tandem MS can be used to distinguish these due to
differences in fragmentation of these molecules. For
complex mixtures analyzed by direction infusion tandem
MS, a mixture of ions may enter the collision cell and
result in mixed tandem MS spectra, since the selection of
precursor ions in the first quadrupole is at nominal mass.
The mixed tandem MS spectra will composite of a mixture
of fragmented ions dependent on the abundance on the
individual precursor ions. Hence, the ability to distinguish
metabolites with the same nominal mass will require sep-
aration before tandem MS detection.
The mass distribution of metabolites is illustrated in
the histogram in Fig. 1. Here it is observed that there is a
high density of metabolites having a molecular mass
between 100 and 300 Da in accordance with the metab-
olite mass distribution presented by Kell et al. (2005).
Further the atomic composition for the metabolites was
analyzed and reported in Table 1. Carbon, hydrogen and
oxygen are present in almost all metabolites. Nitrogen is
present in about 2/3 of the metabolites and phosphor is
found in 39%. Sulphur is contained in 10% of the
metabolites. Especially, the isotope pattern of sulphur
might be helpful for identification of this part of the
metabolome with MS. Iron is rarely found, but the iso-
tope pattern will be characteristic for these metabolites.
6 ESI-MS/MS library
In order to establish an initial library, 66 metabolites from
the core of the central metabolism were selected. Of the
metabolites in the library, 27 were associated with amino
acid metabolism, 11 were related to the TCA and the
glyoxylate cycle, 5 related to glycolysis, 4 involved in fatty
acid metabolism, 1 from the pentose phosphate pathway, 2
related to redox metabolism, 4 related to galactose and
starch metabolism, and 5 were nucleotides.
The diluted metabolite standards were analyzed one by
one. The sensitivity of detection of the individual metab-
olites varied dependent on ionization polarity and cone
voltage. The analysis of the metabolite standards revealed
that positive and negative electrospray complement each
other very well. They favor different metabolites, but in
combination they can ease the identification. There are no
rules without exceptions, but as expected, amino acids and
generally metabolites containing amino groups are detected
better by positive ESI, whereas organic acids and phos-
phorylated compounds were commonly better detected
by negative ESI when quantifying the [M ? H]? and
[M - H]- detection.
6.1 Positive mode
It was observed that the compounds––apart from formation
of different adduct ions (Table 2)––can ion-exchange
acidic protons with positive metal ions and especially Na?.
This was observed for metabolites having one or several
carboxylic acid groups, but also phosphorylated metabo-
lites showed extensive ion-exchange. In some cases two or
three protons were exchanged by sodium. Therefore, the
observation of ion-exchange patterns is helpful in terms of
ion identification and can indicate the number of acidic
protons in the compound.
In this experiment the cone voltage was set to sequen-
tially be 10 V, 25 V and 40 V during MS analysis of the
individual metabolites. The optimal cone voltage was pri-
marily found to correlate with the molecular mass, so that
the higher the mass the higher the cone voltage. Up to m/z
Fig. 1 Histogram showing the distribution of molecular masses for
metabolites present in the in silico metabolome of yeast
Table 1 Frequency of atoms in metabolites
Atom In # of metabolites Percentage
C 430 98
H 436 99
N 283 65
O 426 97
S 46 11
P 172 39
Fe 3 1
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around 300 Da/e, a cone voltage of 25 V was found to give
the best detection, and above m/z 300 Da/e 40 V was
preferred. None of the metabolites were well detected at
10 V.
Amino acids were best detected in positive mode,
probably due to the amino group. The typical base peak ion
was [M ? H]?. During tandem MS loss of formic acid
(CHOOH) was observed and when an additional amino
group, apart from the a-amino group, was present in the
molecule, then one amino group was typically lost as
ammonia (Rogalewicz et al. 2000).
An extensive formation of sodium adducts appeared for
carboxylic acids. In Fig. 2a the positive mass spectrum for
citramalic acid is presented. Both the [M ? H]? and the
[M ? Na]? ion were found in the spectrum and here the
sodium adduct was the larger of those, but the ratio
between the ions varies dependent of the sodium concen-
tration in the solution used for ESI-MS analysis. Further
inspection of the spectrum in Fig. 2a shows a dimer sodium
adduct ([2 M ? Na]?) at mass 319.10 Da/e. Apart from
molecular adduct ions one clear fragment from in-source
CID at mass 103.05 Da/e was seen. This ion corresponds to
the loss of formic acid from the protonated molecular ion.
The fragmentation was confirmed by tandem MS, where
loss of formic acid gave the predominant ion (Table S3).
Additionally, loss of water and a combined loss of water
and formic acid was observed by tandem MS. The loss of
water (H2O) and formic acid (CHOOH) were the main
neutral losses found by tandem MS of carboxylic acids.
For nucleotides containing one or multiple phosphates
several ion adducts were observed (Fig. 3). The multiple
adducts arose from ion exchange of acidic protons with
primarily sodium. From the chemical structure, GTP
(guanosine triphosphate) seemingly contains four acidic
protons associated with the triphosphate; but from the
mass spectrum in Fig. 3 an ion corresponding to
[M - 5H ? 6Na]? was present. The fifth proton might
have been recruited from the guanine part of GTP, where a
resonance form of the purine derived rings might have
bounded a sodium ion instead of a proton. The mass spectrum
Table 2 Frequently observed
ions for the metabolites in the
spectral library
a Adduct ions have
characteristic isotope pattern
according to the adduct
molecule
Positive ESI Negative ESI
Ion composition Mass change Ion composition Mass change
Adducts [M ? H]? 1 [M ? Cl]- ?35a
[M ? Na]? 23
[M - H ? 2Na]? 45
[M - 2H ? 3Na]? 67
Fragments [M - NH3 ? H]
? -16 [M - H]- -1
[M - H2O ? H]
? -17 [M - NH3 - H]
- -18
[M - CHONH2 ? H]
? -44 [M - H2O - H]
- -19
[M - CHOOH ? H]? -45 [M - CO2 - H]
- -45
[M - H3PO4 - H]
- -99
Multimers [2 M ? H]? ?M ? 1 [2 M - H]- ?M - 1
[2 M ? Na]? ?M ? 23
Fig. 2 ESI-MS of citramalic
acid (M = 148.0372 Da). In
positive mode (a) both the
protonated and sodiated
molecular ion is observed.
Negative ESI-MS (b) is found
to mainly produce the
deprotonated molecular ion
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for ATP (data not shown) did not contain an
[M - 5H ? 6Na]? ion, but up to [M - 4H ? 5Na]?
matching the four acidic protons from the triphosphate. The
high degree of sodium-adduct formation in both cases
probably originated from the metabolite standard solutions,
which were based on the sodium salt of the compounds. In
biological samples the sodium concentration would pre-
sumably be lower and therefore the adducts with high
exchange of sodium would be less frequent, but trace amount
of sodium will almost always cause sodium adduct formation
in positive ESI.
The cone voltage determined the acceleration of the ions
in the ion-source and thereby the fragmentation by in-source
CID. The in-source CID should be minimized for tandem
MS, since the CID preferably should occur in the collision
cell after ‘‘isolation’’ of the precursor ion. In the current
experimental setup for MS analysis, the cone voltage was
confounded with the collision energy. This means that for
low cone voltage (10 V) low collision energy (16 eV) was
used and vice versa. This was based on the assumption that
the more stable the ion, the higher the cone voltage and thus
the higher the collision energy. Standard conditions for
tandem MS could not be derived from the data. The frag-
mentation energy needed to fragment the precursor ion was
metabolite dependent. Rather a setup with ramping frag-
mentation energy is suggested to obtain the tandem mass
spectrum. An example of fragmentation is shown in Fig. 4a,
where [M ? H]? of glutamine is fragmented at 20 eV. A
very clean mass spectrum with practically no noise was
obtained. The fragments corresponded to loss of ammonia
and formic acid plus a combination of both. All fragmen-
tation resulted from positive mode are summarized in
Supplementary Material, Table S3. The CID revealed no gas
phase reactions with radical ions in comparison with frag-
mentation from EI ionization. This made the spectra
simpler, but also less specific. However, specificity was
gained by accurate mass fragments.
6.2 Negative mode
It was difficult to get a stable nanospray in negative mode.
Loss or drop-out of signal/spray happened in many cases
and caused a reduced data quality for the negative ESI
results. Therefore, the library is sparse and not optimal in
negative mode.
In contrast to positive mode, no correlation between
molecular mass and cone voltage was found. Rather the
choice of cone voltage seemed to be compound specific.
Fig. 3 Positive ESI-MS of GTP
(guanosine triphosphate). The
major ions are assigned and
shows extensive adduct
formation with sodium. A
combined sodium and
potassium adduct is also present
Fig. 4 Tandem mass
spectrometry. a Fragmentation
of the [M ? H]? ion of
glutamine (M = 146.0691 Da)
giving three fragments which
are assigned according to their
loss of mass. b Fragmentation of
the [M - H]- ion of 6-
phosphogluconic acid
(M = 276.0246 Da). Note that
the H2PO4
- ion is a
characteristic fragment in
negative mode for phosphate-
containing compounds
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E.g., citric acid was very labile in negative ESI and the low
cone voltage of 10 V was optimal for the [M - H]- ion.
At higher cone voltage the de-protonated molecular ion
exhibited pronounced fragmentation. The lack of correla-
tion between molecular mass and cone voltage in negative
mode might be caused by the ionization mechanism, which
requires breakage of covalent bonds to produce [M - H]-
ions. The energy needed for bond breakage is compound
specific and not just related to the mass, e.g., it requires less
energy to ionize a carboxylic acid than a carbohydrate in
negative mode.
Compared to positive ESI, the mass spectra were gen-
erally simpler in negative ESI, since the molecules mainly
produced [M - H]- ions. This makes negative ESI suited
for determination of molecular mass preferably in combi-
nation with positive ESI. Figure 2b shows the negative ESI
spectrum of citramalic acid and a clear peak corresponding
to the de-protonated molecular ion is seen at 147.02 Da/e.
Tandem MS confirmed that the ion of 87.00 Da/e was a
fragment of citramalic acid, which corresponds to the loss
of acetic acid. Figure 4b shows an example of tandem MS
of 6-phosphogluconic acid fragmented at 24 eV. First of all
the fragment of 96.96 Da/e was a strong indication of a
phosphate containing compound. Secondly, the fragment of
177.04 Da/e corresponded to the loss of phosphoric acid
from the precursor ion. Except for these phosphate-related
fragments there was only limited structural information
available in the tandem MS spectrum. Loss of water from
the precursor ion was observed. A list of all CID results in
negative mode is summarized in Supplementary Material,
Table S4.
7 Metabolite identification
Combination of the knowledge of ionization (Table 2) and
the metabolite list corresponding to the theoretical metab-
olome (Table S2) serves as a good starting point for
identification of unknown metabolites in mass spectra.
Before starting to search the metabolite list, it is important
to consider which adducts and fragments can be expected.
To illustrate this, take e.g., a mass spectrum in positive
mode, in which an unknown ion of mass 203.06 Da/e is
found. First of all it relevant to confirm that it is a single
charged ion by looking at the neighboring isotope ions in
the mass spectrum. If the ions are separated by approxi-
mately 1.0 Da, the ion is single-charged. Secondly, a
number of adduct ions are common in positive mode
(Table 2). If the ion was an [M ? H]? ion the M would
have mass 202.05 and similarly 185.03 for [M ? NH4]
?,
180.07 for [M ? Na]?, 164.10 for [M ? K]?, and 158.09
for [M - H ? 2Na]?. Assuming a mass precision
of ± 0.1 Da, it is possible to suggest the metabolites for
ion 203.06 in Table 3 using Table S2 from Supplementary
Material. This reduces the possibilities to 9 different ele-
mental compositions, because fructose, galactose, glucose,
inositol, mannose and sorbose; and fucose and rhamnose
have the same elemental composition, respectively. The
final identification requires additional information. The
suggested metabolite/molecule can be further supported by
adding a priori knowledge. If a suggested metabolite
contains sulfur, then the isotope pattern for sulfur should be
reflected in the mass spectrum. Similarly, if the ion is a
potassium adduct the isotope pattern can reveal it.
8 An example of metabolic footprinting
The principal of footprinting for S. cerevisiae was pre-
sented by Allen et al. (2003) and is closely related to
fingerprinting especially in terms of the analytical
approach, in which high-throughput techniques are used.
Fingerprints are directed towards intracellular metabolites
and footprints aim at covering the extracellular metabo-
lites. A fingerprint is a snapshot of a metabolic state in
contrast to footprints that are resulting from integrated
changes over time as a function of substrate uptake and
secretion.
The footprints contain integrated information which
eventually might strengthen a characteristic response and
reveal a biomarker. The distinction between finger- and
footprinting is not stringent (in the literature) and probably
the term fingerprinting is the most frequently used to cover
the approach. For this study the sampling of extracellular
metabolites was used, since this is much simpler compared
Table 3 Tentative metabolites for ion 203.06 ± 0.1 Da
Ion M Tentative identification
[M ? H]? 202.05 ± 0.1 None
[M ? NH4]? 185.03 ± 0.1 3-phosphoserine
2-amino-3-carboxymuconate
semialdehyde
[M ? Na]? 180.07 ± 0.1 Fructose
Galactose
Glucose
Inositol
Mannose
Sorbose
Hydroxyphenylpyruvate
[M ? K]? 164.10 ± 0.1 Phenylpyruvate Fucose
Rhamnose
S-methyl-L-methionine
[M - H ? 2Na]? 158.09 ± 0.1 Dihydrooroate allantoin
2-isopropylmaleate
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to sampling for intracellular metabolites, and because the
extracellular metabolites are easily accessible and allow
high-throughput (Kell et al. 2005).
In the present example we employed direct infusion
ESI-MS for metabolite footprinting. The MS analysis is
used to study the metabolite profiles of a reference strain
and two single gene deletion mutants of S. cerevisiae
carrying deletions in genes encoding enzymes in the central
carbon metabolism.
The shake flask cultures were grown for 24 h and
samples were taken for MS analysis. Each strain were
cultured in triplicate (biological replicates) and three
samples were taken from each culture (analytical repli-
cates)––giving a total of 27 data points. Typical mass
spectra from the three different strains are shown in Fig. 5.
The spectra are very similar and not readily possible to
distinguish by the naked eye.
The data was aligned in order to make the data acces-
sible for multivariate analysis. Alignment was obtained by
overlaying a grid with 0.1 mass units to bin the data, which
yielded 159 non-zero variables (masses). By subjecting the
processed data to PCA, the score plot in Fig. 6 showed that
strain specific information was available in the data. The
first and second principal component (PC) explained 24%
and 13% of the data variation, respectively. There was high
similarity for the samples from the hxk2D strain, which
clearly clustered in the loading plot and the variability
between samples could not be distinguished from the
analytical replicates. Similar observations were found for
the reference strain BY4741. The same data consistency
was not observed for the pck1D strain although the ana-
lytical replicates are alike. Especially one of the biological
replicates of pck1D seemed to be rather different from the
two others. This might indicate the presence of an outlier,
but it was difficult to justify an omission of the sample
(pck1D3) when the remaining group was defined by only 6
data points from 2 biological replicates with 159 variables.
Therefore, the data analysis was done both with and
without the most extreme sample (pck1D3) of the pck1D
mutant. Repeating the PCA without pck1D3 gave the score
plot in Fig. 7. This PCA was capable of capturing 86% of
the overall variation by the two-first components, thus
representing the full data variation much better. Still the
data for the hxk2D strain formed a cluster and this mutant
was separated from the two others by the first PC. The
second PC explained 30% of the data variation and partly
accounted for the differences between BY4741 and pck1D,
but there seemed to be a striking similarity between the
pck1D1 sample and all the BY4741 samples.
Analysis of variance (ANOVA) was used to address the
differences between the S. cerevisiae strains. A histogram
of the P-values from the ANOVA is presented in Fig. 8 and
reveals that there was a considerable number of variables
for which P \ 0.05. To inspect the low P-values the
Fig. 5 Examples of metabolic footprints obtained by direct infusion
mass spectrometry. The mass spectra represent the BY4741, hxk2D
and pck1D strain, respectively
Fig. 6 Principal component analysis (PCA) of mass spectrometry
footprinting data. The score plot shows the first two principal
components (PCs) describing 37% of the data variation
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histogram to the right in Fig. 8 shows the distribution of
log10(P), and from this histogram it is seen that some of the
variables were highly significant. The most significant
variables were selected for investigation, since these might
represent physiological markers for the individual mutants.
A very conservative level was set and only variables with
P \ 10-5 were chosen, which reduced the number of
variables from 159 to 21.
Applying PCA to the data reduced by ANOVA con-
firmed that the remaining variables were highly group-
specific. Figures 9 and 10 present the score plots for the
data after ANOVA with and without the pck1D3 sample,
respectively. These score plots were accounting for
86–87% of the total variance and confirmed that the vari-
ables left after ANOVA were highly strain specific, since
data clustered according to the strain. However, in Fig. 9
with all samples including the suspected outlier pck1D3
there were still some divergence among the pck1D samples.
The cluster is not as delimited as for the two other strains.
Strain specific variables are listed in Table 4, which
presents the most significant ions found from the ANOVA.
To gain more specific information regarding the strain
differences, tentative identification of ions was done based
on the ion mass using Table S2, and this resulted in the list
of metabolites that represent the different strains given in
Table 4. The errors listed in Table 4 indicate relatively
poor mass accuracy for a tof instrument. The poor accuracy
Fig. 7 PCA of MS footprinting data excluding the pck1D3 sample.
The score plot shows the first two principal components (PCs)
describing 86% of the data variation
Fig. 8 Distribution of P-values found from analysis of variance
(ANOVA) of footprinting data
Fig. 9 PCA of footprinting data after selection of significant
variables by analysis of variance (ANOVA)
Fig. 10 PCA of footprinting data excluding the pck1D3 sample after
selection of significant variables by ANOVA
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might be caused by all ions in Table 4 have a relatively low
mass compared to the calibration range by PEG, thus the
calibration might not provide optimal accuracy below
200 Da/e. To obtain a more confident identification the
samples should ideally have been reanalyzed by tandem
MS of the significant ions.
The results from the footprinting experiment confirmed
that strain characteristics can be derived from metabolic
footprints (Allen et al. 2003; Kell et al. 2005). This indi-
cated the strength of metabolites as functional markers,
where the genome sets the boundaries for metabolic path-
ways, which will be inherited downstream to the
metabolites and then be detected in the metabolic foot-
prints. Even the initial PCA revealed the presence of major
clusters in the underlying MS data and the clusters were
strain associated (Figs. 6 and 7). The hxk2D strain segre-
gated from the two other strains, which was also expected
based on the physiological knowledge of the strain. HXK2
encodes hexokinase II in S. cerevisiae and plays a role in
carbon catabolite repression (Entian and Mecke 1982). The
hxk2D mutant has a distinct physiology compared to the
reference strain. It grows at a slower rate on glucose
compared to the reference strain and no fermentative
products are formed in the initial exponential phase, which
leads to higher biomass yield. The diauxic shift is also
shorter, which indicates altered carbon catabolite repres-
sion, since the enzymes for respirative growth are not
repressed (Diderich et al. 2001). Although slower growth
of the hxk2D strain, all strains were sampled after
exhaustion of glucose, which was the primary carbon
source. Thus, the considerable differences detected for the
hxk2D strain was not caused by residual glucose.
Variable selection was required to clearly distinguish the
reference and the pck1D strain by PCA. ANOVA suc-
cessfully selected variables (ions), which accounted for
these differences, and led to a complete separation of the
three strains (Figs. 9 and 10). It was expected that the
pck1D strain would be alike the reference strain. PCK1 is
not known to have any regulatory role on any other genes,
but is solely acting as an enzyme. PCK1 encodes for
phosphoenolpyruvate carboxykinase catalyzing the reac-
tion of oxaloacetate to phosphoenolpyruvate. The reaction
is part of the gluconeogenesis and primarily active during
growth on 2-C carbon sources like ethanol and acetate. The
pck1D mutant is not viable on ethanol (McCammon 1996).
As this experiment was carried out on glucose, a high
similarity between BY4741 and the pck1D mutant was
expected, which was also observed. However, minor dif-
ferences seemed to be present, which shows the specificity
and sensitivity of metabolic footprinting for phenotypic
characterization.
9 Metabolic markers
Metabolic footprinting was proposed as a guilt-by-associ-
ation approach for functional genomics (Allen et al. 2003);
but to take footprinting beyond the point of guilt-by-asso-
ciation, information regarding exact metabolic differences
must be extracted from the footprints. In this experiment,
the highly significant ions that were selected by ANOVA
are interesting metabolic markers, which might explain the
genetic and metabolic differences. Many of the ions listed
in Table 4 were contained in the footprinting medium;
however, the uptake of these was different for the different
strains, which resulted in significantly different quantities
in the footprints.
The tentative metabolites were mapped on to the met-
abolic pathways of S. cerevisiae to see if there was
convergence in parts of metabolism. According to KEGG
(http://www.kegg.com) leucine/isoleucine, isopropylma-
late, isopropylmaleate and valine are all associated with the
biosynthesis/degradation of valine, leucine and isoleucine.
Valine and leucine are pyruvate-derived amino acids (Str-
yer 1995), which could point to metabolic differences
around the pyruvate branch point. Thus, the footprints were
found to contain metabolic characteristics for the compared
strains and the results supported the specificity of
Table 4 Highly significant ions (P \ 10-5)
Mass Metabolite Adduct Error (Da)
131.06 Itaconic acid [M ? H]? 0.03
132.09 Leucine/isoleucine [M ? H]? -0.01
150.04 Methionine [M ? H]? -0.02
177.06 Isopropylmalate [M ? H]? -0.02
194.08 Isopropylmalate [M ? NH4]? -0.02
148.03 Glutamate [M ? H]? -0.03
159.06 Isopropylmaleate [M ? H]? -0.01
190.03 Pyridoxal [M ? Na]? -0.02
115.03 Glycerol [M ? Na]? -0.01
118.08 Valine [M ? H]? -0.01
206.03 Pyridoxal [M ? K]? 0.01
158.08 Threonine [M ? K]? 0.06
162.08 Nicotinate [M ? K]? 0.08
119.08 Succinate [M ? H]? 0.05
179.1 Cys–Gly [M ? H]? 0.05
110.07 Glycerol [M ? NH4]? -0.01
230.98 Citrate [M ? K]? -0.01
199.01 Isopropylmalate [M ? Na]? -0.05
147.06 Glutamine [M ? H]? -0.02
190.09 N-Acetyl-glutamate [M ? H]? 0.02
273.88 ?
The ions are assigned with a tentative metabolite suggested based on
the mass ± 0.1 Da (Table S2)
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footprinting. Even deletion of a presumably inactive
enzyme (PCK1) during growth on glucose gave distinct
footprints.
10 Concluding remarks
The building of a spectral library for ESI-MS of microbial
metabolites has been initiated. Although the mass spectrum
library only covers a minor part of the metabolites, still it
represents a core set of metabolites and it can obviously be
expanded in the future. The library contains information
about ion formation in electrospray for a selection of pri-
mary metabolites. The library also contains fundamental
information regarding fragmentation patterns for different
classes of metabolites, which makes it possible to predict
candidate ions for other and similar metabolites. Together
with the theoretical metabolome, it has provided insight to
the biological information contained in metabolic foot-
prints. With this approach metabolic footprinting by ESI-
MS can reach beyond the principle of guilt-by-association
and metabolic markers can be extracted from the high-
throughput data. The findings can be used to setup
hypotheses for further biological experiments that are tar-
geted and more specific.
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Chapter 8
Discussion and perspectives
The metabolomics research is still at its infancy compared to transcriptomics and
proteomics, but continuously new techniques and tools are published and progress
is evident (Dunn, 2008; Mashego et al., 2007). There are a continuously more
articles published and the annual number of publication from 1998 and onwards
still seems to increase.
To conclude the thesis, this final chapter addresses Chapters 5–7 in the context
of the field of metabolomics and some of the most recent publications. Sample
preparation is pivotal for metabolomics and the most recent results from literature
will be discussed in the context of Chapter 5. Furthermore, design of experiments
will be addressed with the ability to conduct multi-parallel experiments. Then
the impact of mass spectrometry (MS) on metabolomics is discussed, and finally
the chapter is ended by a discussion of the dynamic responses and the concept of
dynamic footprinting.
8.1 Sample preparation
Since the publication of Chapter 5 (Publication 1) in 2005 other research groups
have investigated sampling and extraction of microorganisms, and the paper has
been cited numerous times. Bolten et al. (2007) studied the sampling of sev-
eral Gram-positive and Gram-negative bacteria and found that quenching in cold
aqueous methanol lead to unspecific leakage and significant losses of metabo-
lites. Fast filtration was tested as another option and found suited for analysis
of metabolites with low turnover rates (e.g. amino acids and TCA cycle interme-
diates). Further Winder et al. (2008) investigated the quenching and extraction
of metabolites from Escherichia coli with an approach comparable to the study
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for Saccharomyces cerevisiae in Chapter 5. Winder et al. (2008) suggested using
cold aqueous methanol for quenching although leakage occurred and advocated
to monitor the exo-metabolome and supernatants from the quenching step. Loret
et al. (2007) also evaluated quenching of S. cerevisiae in cold aqueous methanol
and estimated the leakage to be in the range of 5%, when the contact time with
methanol was minimized. The results from Bolten et al. (2007), Loret et al. (2007)
and Winder et al. (2008) support the findings in Chapter 5 that quenching in
cold aqueous methanol causes leakage. Bacteria seem more sensitive to methanol
quenching compared to yeasts, but it was shown in Chapter 5 that the cell wall of
S. cerevisiae was damaged. An alternative to cold aqueous methanol quenching
could be quenching in cold saline-glycerol, which was proposed by Villas-Boas and
Bruheim (2007) for both bacteria and yeasts. Glycerol is a cryoprotectant and
often used for strain preservation, thus it is a very reasonable choice of quenching
solution as it might not harm the cells.
Extraction with methanol using freeze-thaw cycles seemed to be the preferred
extraction method for E. coli (Winder et al., 2008) as was found for S. cerevisiae
(Chapter 5) for metabolomics. However, Loret et al. (2007) re-validated the
extraction method for S. cerevisiae using boiling ethanol; and the paper must be
partly considered as a comment to Chapter 5 as they strongly disagree with the
indications that boiling ethanol might not be optimal for metabolome extraction.
The paper (Loret et al., 2007) is rather a defence of extraction by boiling ethanol
than comparison of methods, but Loret et al. (2007) shows that boiling ethanol is
a very valid extraction method for phosphorylated metabolites and some organic
acids. There are only limited loses of these metabolites during boiling in three
minutes in the absence of cells. Furthermore, it is correctly stated by Loret et al.
(2007) that the poor recoveries of sugar phosphates found in Chapter 5 could be
caused by the choice of analytical method (GC-MS), which was already addressed
in the Chapter 5. However, chloroform-methanol-buffer extraction was found to
be the best method for extraction of sugar phosphates in Chapter 5, hence a
comparison between boiling ethanol and chloroform-methanol-buffer extraction
would have been appreciated. Another reason for discrepancies could be the
protocol for extraction, since Loret et al. (2007) showed that it was important to
evaporate the extract with the cells, which was not done in Chapter 5.
It is important to keep in mind that the two studies (Loret et al. (2007) and
Chapter 5) do not have the same scope, since Loret et al. (2007) are pursuing
a targeted approach whereas Chapter 5 is aiming at global metabolite profiling
(metabolomics). Taking the extraction results for E. coli from Winder et al.
(2008) methanol with freeze-thaw cycles and boiling ethanol may work equally
well, and Winder et al. (2008) also conclude that complementary extraction meth-
ods will be needed to cover the whole metabolome.
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In continuation of extraction, I think it is worthwhile to mention that the ulti-
mate goal of metabolomics is to achieve quantification of the full metabolome, and
quantitative rather than qualitative information about the presence of metabo-
lites is essential for microbial metabolomics to succeed. There are several examples
of quantification of intracellular metabolites concentration (e.g. Buchholz et al.,
2002; Lange et al., 2001; Theobald et al., 1993), but it is questionable whether
it is meaningful to talk about an intracellular concentration. The cytosol is not
a well-mixed liquid with diffusion being the primary mass transport for metabo-
lites in the cytosol. Of course some metabolites present in high amounts may
be almost equally distributed in the cell due to evenly distribution of involved
metabolic enzymes in the cytosol. The kinetics of the glycolytic (EMP) pathway
has successfully between modeled based on measured intracellular concentrations,
but this pathway must be considered as the highway in the metabolism. For other
pathways channeling is needed for some reactions to proceed based on thermody-
namic calculations (Stephanopoulos et al., 1998), e.g. the galactose pathway (de
Jongh et al., submitted), and this underlines that the cytosol cannot be consid-
ered as well-mixed. Rather metabolite quantities should be reported relative to
the cell mass.
Metabolome data is highly affected by the actual experimental setup. Not
only the growth conditions are influencing your results, but sampling and sample
preparation are critical parameters for your results (Chapter 5). The choice of
methods will influence the final data sets, and data sets from different experiments
and labs are likely to be confounded, which at present makes inter-laboratorial
comparison of data difficult. Initiatives for microarrays (Brazma et al., 2001) and
protein analysis (Orchard et al., 2003) have already been presented – what is the
minimum experimental information needed to go along with the data to make it
usable for reanalysis by other research groups? Likewise Lindon et al. (2005) have
recommended guidelines for standardization and reporting of metabolic analyzes,
which partly initiated the Metabolomics Standard Initiative. The essence is that
genome sequences are more or less conserved independently of the experimental
setup. However, this is not the case for downstream components such as RNAs,
proteins and metabolites. These are all context-specific and reflect individual ex-
perimental conditions and physiological states. For microbes the Metabolomics
Standard Initiative has materialized into a specific set of requirements for report-
ing of microbial metabolomics (van der Werf et al., 2007b).
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8.2 Experimental design
Metabolites carry integrated information from the surroundings (ecotype) and the
genes (genotype) as discussed by Smedsgaard and Nielsen (2005), and the results
from Chapter 6 show that changing the primary carbon source results in a sig-
nificant change of the exo-metabolome. This clearly illustrates the impact of the
ecotype. The dimension of ecotype for S. cerevisiae has, however, not been studied
extensively using metabolomics; particularly in comparison with functional stud-
ies of genotypes, e.g. in a study by Giaever et al. (2002) who analyzed many single
gene deletion mutants growing on different media. Manipulation of the ecotype
makes it possible to activate different parts of metabolism, which might reveal
pleiotropy of genes. This should definitely have more focus in metabolomics.
The results in Chapter 6 with cultivation in microtiter plates (MTPs) also
show that throughput can be significantly increased by using MTPs compared to
ordinary shake flasks. High-throughput is a prerequisite for screening of several
strains and not only can the genotype be an experimental factor but the ecotype
should be varied by using different growth media as already discussed. Further-
more, MTPs opens up for the possibility of conducting several repetitions of the
same experiment, which is essential to obtain valid results that are statistically
significant. The experimental design is critical for the ability to produce valid
data in metabolomics (Dunn, 2008). The experimental design should cover not
only the biological experiment but also the following analysis to be able to es-
timate the uncertainty of measurements and avoid bias. Problems arising from
improper experimental design are discussed in Section 8.4.
8.3 Mass spectrometry and metabolomics
The central position of MS in metabolomics is clear (Dunn, 2008; Dettmer et al.,
2007; Villas-Boas et al., 2005) and I am confident that the constant improvement
of MS instruments will keep MS in that position for future metabolite studies.
The high-resolution instruments becoming available today can determine the mass
within less than 1 ppm (Breitling et al., 2006). These instruments allow high mass
resolving power (Sleno et al., 2005), which combined with database searches (Kind
and Fiehn, 2006) will continue to drive the research of metabolomics forward. This
should be seen in combination with the continuing improvement of sensitivity and
the ability to cover a large range of dynamic response. Besides improved MS
instruments, there is a need for efficient separation and whether this separation
will be obtained by gas or liquid chromatography (van der Werf et al., 2007a)
or capillary electrophoresis (Montona and Soga, 2007) is hard to say — maybe a
combination of these is needed.
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Enormous amounts of information are available from MS data and at present I
see that the deconvolution and analysis of data determine the pace for metabolomics.
Ute Rossner (personal communication) stated that as a rule-of-thump, one should
expect to use 3 times the data acquisition time to analyze the data. To speed
up the data analysis reference data for metabolites are important. As already
discussed in Chapter 7, there is a long tradition for collection of spectral libraries
for GC-MS, whereas the availability of the spectral libraries for electrospray ion-
ization (ESI)-MS for microbial metabolites is limited. Hence, it is very valuable
to start collecting tandem MS data. Not only does an ESI tandem MS library
contain specific information about the individual metabolites, but it can also be
used to identify characteristic fragmentation patterns, which might be used for
identification of unknown metabolites.
For data analysis theoretical metabolomes are available through genome-scale
metabolic models for various organisms and these represent a set (or subset)
of metabolites that potentially can be detected by metabolome analysis. van der
Werf et al. (2007a) took the union of three microbial in silico metabolomes (E. coli,
Bacillus subtilis, and S. cerevisiae) of which 399 metabolites could be purchased
and used for the evaluation of a platform for metabolome analysis. This platform
enabled analysis of 380 out of 399 metabolites using a combination of GC-MS and
LC-MS methods. In Chapter 7, the in silico metabolome of S. cerevisiae was used
to investigate the capabilities of detecting it by ESI-MS. This theoretical analysis
emphasized why MS has had and still has such a central position in metabolomics:
MS has the specificity required to undertake the challenge of metabolomics.
8.4 Dynamic footprinting
To conclude, this final Section is used to discuss perspectives of investigating
correlations in metabolomics. Correlation between intracellular metabolite pools
has been demonstrated by Arkin et al. (1997), and correlations have even been
observed in cases where the metabolites are far from being directly linked by
metabolic pathways (Steuer et al., 2003). The intracellular metabolite concen-
tration change rapidly and react to environmental changes (de Koning and van
Dam, 1992), and therefore the dynamic behavior of the system have small time
constants, which will require very frequent sampling to appropriately describe the
dynamics of system. E.g. the response of the concentration of intermediates in the
glycolysis on a glucose pulse has been extensively studied in S. cerevisiae. Here,
samples are taken within few seconds to make it possible to access the kinetics of
the pathway (Lange et al., 2001; Theobald et al., 1993, 1997; Visser et al., 2002).
In the research areas of omics, the focus has until now primarily been on
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Figure 8.1 Observations from dynamic footprinting i.e. the evolution of metabolic foot-
prints. From metabolic footprints obtained by ESI-MS the intensity of some ions was found
to change over time as the yeast grew. The present example initially shows an exponential
increase in intensity corresponding to excretion of a metabolite, which is expected from a
shaken batch cultivation. At a later stage in the end of the batch cultivation the intensity
tends to decrease, which indicates that the yeast has started to consume the metabolite after
a metabolic shift.
measurement of concentrations or presence of components, e.g. genes, mRNA
and proteins, to distinguish differences at different steady states. However, life is
mainly driven by fluxes (Nielsen, 2003; Sauer, 2004). Hence, in my opinion the
analysis of data from time series will give insight into the interplay between the
different functional levels in the cell. This will make it possible to reveal cascade
reactions, which are hard to derive from steady-state observations. In this context
dynamic footprinting may be one way to address the dynamics of the metabolome.
The footprinting approach (Kell et al., 2005) has proved it strengths (e.g.
Chapters 6 and 7); but might be sensitive to differences in growth rates and time
of sampling. Allen et al. (2003) showed that the footprints changed over time and
from a principal component analysis (PCA) their trajectory were reproducible.
At the same time Allen et al. (2003) argued that no major changes of the foot-
print would occur when a culture had reached the stationary phase. However,
this may be questionable for e.g. S. cerevisiae grown on glucose, since glucose
is mainly converted to ethanol, which subsequently can be consumed after the
diauxic shift. Although no significant growth might be observed after depletion
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Figure 8.2 Growth-correlated trends from dynamic footprinting. Along with the sampling
for metabolic footprinting the biomass concentration was measured by optical density (OD).
The OD and ion intensity are correlated for some ions, which demonstrates that the changes
observed in the dynamic footprints are related to the growth of yeast. The correlation
is interpreted to correspond to constant yield coefficients on biomass, which represents a
physiological feature that can be extracted from the dynamic footprints.
of glucose, ethanol can slowly be consumed and changes will occur in the culture
broth (footprint). Secondly, if the cells are kept without nutrients for a while, they
might undergo lysis and intracellular metabolites will contribute to the footprint.
To address the changes in metabolic footprints, we propose dynamic metabolic
footprinting by analyzing time series of samples of extracellular metabolites to
identify physiologic characteristics that reaches beyond differences in specific
growth rate. At present the setup for dynamic footprinting is not fully tuned,
which explains why only limited data and details are presented, but preliminary
results indicate the presence of information in the dynamic footprints. We know
from Allen et al. (2003) that footprints change over time, so at first changes
over time were sought to pinpoint the dynamic ions (Figure 8.1). Dependent on
the medium composition a number of metabolites will be taken up and consumed
from the medium, which would result in a declining concentration over time. Also
some metabolites will be excreted over time as seen in Figure 8.1, where the data
points form an S-curve that tends to level off at the end. Here, the metabolite is
first produced and later on consumed during the course of a batch cultivation.
During growth several metabolites will be consumed and excreted as a result
96 CHAPTER 8. DISCUSSION AND PERSPECTIVES
of growth, and the changes are very likely to correlate with growth. Figure 8.2
shows an example of such trends between ion intensity and optical density that is
used to measure the biomass concentration. The plot shows a linear trend with
negative correlation corresponding to uptake of the metabolite. Both positive and
negative correlations between extracellular metabolites and biomass are observed
from batch cultures. These correlations represent constant yield coefficients dur-
ing the batch culture. The yield coefficients (Y ) are defined by the ratio between
two rates (r) of the i’th and j’th component (Nielsen et al., 2002):
Yij =
rj
ri
(8.1)
which for constant yield coefficients also can be derived from concentrations (c):
Yij =
∆cj
∆ci
(8.2)
Similar to the growth correlated ions, pairwise comparison of the individual
ion intensities in Figure 8.3 shows that some of them are linearly correlated. The
plot is an example of consistent observations from three independent biological
replicates.
The data has been acquired by direct infusion MS, which might not be consid-
ered as a quantitative approach by default, but the present results demonstrated
at least semi-quantitative responses in the MS data. The ion intensities were
found to vary as the yeast was growing (Figure 8.2) and showed profiles over time
which could be expected for shaken batch cultures (Figure 8.1). To maintain
the quantitative aspect it is of course important that the sample matrix remains
similar throughout the sampling period, since direct infusion MS is known to be
sensitive to matrix effect.
To develop the concept of dynamic footprinting further there are currently
some challenges that need to be dealt with — or better practices that should be
considered. Design of experiments and randomization is of outmost importance
to enable valid conclusions from this kind of data. Of course this applies for
all experiments, but partly lack of these considerations was a problem for inter-
preting a large data set that I received from post doc Sandrine Mas, who had
worked in the group of Jens Nielsen. Secondly, it is important that the sam-
pling is frequent enough to establish the dynamic response and represent it with
sufficient data points. Another issue is the number of replicates needed in the
data set to extract biological information. There has been a tendency to use
three replicates for biological experiments, but it is questionable whether this is
sufficient to adequately detect outliers. The current data set contains triplicates
of shake flask cultures, and thereby it suffers from having too few replicates to
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Figure 8.3 Correlation between ions. Pairwise correlations between intensities of ions in
the dynamic footprint were identified and these represent yield coefficients between two
metabolites.
identify outliers and obtaining confident statistics, which in general weakens the
data analysis. Furthermore, there are no analytical replicates. Unfortunately, the
sample list was not randomized before analysis, which caused sample groups to be
confounded with instrument drift over time. All in all this has lead to a heavily
biased data set with promising indication without allowing proof of concept.
Instrument drift and bias from the MS analysis will be very likely, when many
samples have to be analyzed, and normalization is needed to correct for these ef-
fects. The normalization is not trivial and both normalization within and between
spectra is needed. Part of the normalization could be accomplished by using an
internal standard, but in the present data set, variation in signal-to-noise ratios
had an impact on the number of ions detected with low intensities, which resulted
in suboptimal performance of the subsequent data analysis.
In conclusion, this data demonstrates that dynamic footprinting will be ex-
citing to pursue further. It is a non-targeted approach for phenotypic feature
extraction, which links to fluxes and flux ratios. Hence, the approach is capable
of depicting physiological changes, which is the key objective in many biological
studies. Dynamic footprinting should be considered as a screening tool that opens
up new possibilities for high-throughput screening.
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Appendix A
Atomic isotopes
The monoisotopic mass of a molecule is calculated based the atomic mass of the
individual isotopes. Table A.1 lists the mass of isotopes that typically are present
in biological molecules. Additionally, the abundances of isotopes are presented
for the calculation of isotope patterns.
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Table A.1 Stable mass isotopes and their natural abundances
Mass Abundance Relative
Atom Isotope (Da) (%) abundance
Hydrogen 1H 1.007825 99.9885 100.0
2H 2.014102 0.0115 0.0
Lithium 6Li 6.015122 7.59 8.2
7Li 7.016004 92.41 100.0
Carbona 12C 12.000000 98.93 100.0
13C 13.003355 1.07 1.1
Nitrogen 14N 14.003074 99.636 100.0
15N 15.000109 0.364 0.4
Oxygen 16O 15.994915 99.757 100.0
17O 16.999132 0.038 0.0
18O 17.999160 0.205 0.2
Sodium 23Na 22.989770 100.00 100.0
Phosphorus 31P 30.973761 100.00 100.0
Sulphur 32S 31.972071 94.99 100.0
33S 32.971458 0.75 0.8
34S 33.967867 4.25 4.5
36S 35.967081 0.01 0.0
Chloride 35Cl 34.968853 75.76 100.0
37Cl 36.965903 24.24 32.0
Potassium 39K 38.963707 93.2581 100.0
40K 39.963999 0.0117 0.0
41K 40.961826 6.7302 7.2
Bromide 79Br 78.918338 50.7 100.0
81Br 80.916291 49.3 97.2
a The mass of the 12C isotope is exactly 12 Da by definition
Reference: de Laeter et al. (2003)
Appendix B
Supplementary material for
Chapter 7
Table S1 contains an index of metabolites analyzed for the mass spectral library.
Table S2 contains the metabolome of yeast based on the in silico model of Sac-
charomyces cerevisiae.
Table S3 summarizes fragmentation by positive tandem MS of metabolites in-
cluded in the mass spectral library.
Table S4 summarizes fragmentation by negative tandem MS of metabolites in-
cluded in the mass spectral library.
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# Compound name KEGG compound ID Formula Monoisotopic mass
00001 4-Aminobutyric acid C00334 C4H9NO2 103.063
00002 Glycine C00037 C2H5NO2 75.032
00003 L-Alanine C00041 C3H7NO2 89.048
00004 L-Arginine C00062 C6H14N4O2 174.112
00005 L-Aspartic acid C00049 C4H7NO4 133.038
00006 L-Asparagine C00152 C4H8N2O3 132.054
00008 L-Cysteine C00097 C3H7NO2S 121.020
00009 L-Glutamic acid C00025 C5H9NO4 147.053
00010 L-Glutamine C00064 C5H10N2O3 146.069
00011 L-Histidine C00135 C6H9N3O2 155.070
00012 L-Homocystine C01817 C8H16N2O4S2 268.055
00014 L-Isoleucine C00407 C6H13NO2 131.095
00015 L-Leucine C00123 C6H13NO2 131.095
00016 L-Lysine C00047 C6H14N2O2 146.106
00017 L-Methionine C00073 C5H11NO2S 149.051
00019 L-Phenylalanine C00079 C9H11NO2 165.079
00020 L-Proline C00148 C5H9NO2 115.063
00021 L-Serine C00065 C3H7NO3 105.043
00023 L-Tryptophan C00078 C11H12N2O2 204.090
00024 L-Tyrosine C00082 C9H11NO3 181.074
00025 L-Valine C00183 C5H11NO2 117.079
00027 O-acetyl-L-serine C00979 C5H9NO4 147.053
00028 O-Phospho-L-serine C01005 C3H8NO6P 185.009
00029 N-Acetyl-L-glutamic acid C00624 C7H11NO5 189.064
00030 Betaine C00719 C5H11NO2 117.079
00031 2-Hydroxyisobutyric acid - C4H8O3 104.047
00032 6-phosphogluconic acid C00345 C6H13O10P 276.025
00033 Apidic acid C06104 C6H10O4 146.058
00034 cis-Aconitic acid C00417 C6H6O6 174.016
00035 Citraconic acid C02226 C5H6O4 130.027
00036 Citramalic acid C00815 C5H8O5 148.037
00037 Citric acid C00158 C6H8O7 192.027
00038 DL-Isocitric acid C00311 C6H8O7 192.027
00039 Fumaric acid C00122 C4H4O4 116.011
00040 Glutaric acid C00489 C5H8O4 132.042
00041 Glyceric acid C00258 C3H6O4 106.027
00042 Glyoxylic acid C00048 C2H2O3 74.000
00043 Itaconic acid C00490 C5H6O4 130.027
00044 Lactic acid C00186 C3H6O3 90.032
00045 Malic acid C00149 C4H6O5 134.022
00046 Myristic acid C06424 C14H28O2 228.209
00047 Oxalacetic acid C00036 C4H4O5 132.006
00048 Oxalic acid C00209 C2H2O4 89.995
00049 Pimelic acid C02656 C7H12O4 160.074
00050 Tartaric acid C00898 C4H6O6 150.016
00051 α-Ketoapidic acid C00846 C6H8O5 160.037
00052 Flavin adenine dinucleotide (FAD) C00016 C27H33N9O15P2 785.157
00054 NAD C00003 C21H28N7O14P2 664.117
00055 ATP C00002 C10H16N5O13P3 506.996
00057 AMP C00020 C10H14N5O7P 347.063
00059 GTP C00044 C10H16N5O14P3 522.991
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# Compound name KEGG compound ID Formula Monoisotopic mass
00061 cGMP C00942 C10H12N5O7P 345.047
00063 Cytosine C00380 C4H5N3O 111.043
00064 Coenzyme A C00010 C21H36N7O16P3S 767.115
00065 Acetyl-DL-carnitine C02571 C9H18NO4 204.124
00066 Fructose 1,6-bisphosphate C00354 C6H14O12P2 339.996
00067 Phospho(enol)pyruvate C00074 C3H5O6P 167.982
00068 3-phosphoglyceric acid C00197 C3H7O7P 185.993
00069 2-phosphoglyceric acid C00631 C3H7O7P 185.993
00071 Glucose 1-phosphate C00103 C6H13O9P 260.030
00072 Galactose 6-phosphate C01113 C6H13O9P 260.030
00074 Uridine 5'-diphospho-glucose C00029 C15H24N2O17P2 566.055
00075 Uridine 5'-diphospho-galactose C00052 C15H24N2O17P2 566.055
00076 Trehalose C01083 C12H22O11 342.116
00079 N-acetyl-D-glucosamine C00140 C8H15NO6 221.090
00081 Riboflavin C00255 C17H20N4O6 376.138
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# KEGG ID Metabolite Formula Monoisotopic mass
1 C00084 Acetaldehyde C2H4O 44.026215
2 C00033 Acetate C2H4O2 60.021129
3 C00164 Acetoacetate C4H6O3 102.031694
4 C00332 Acetoacetyl-CoA C25H40N7O18P3S 851.136338
5 C00900 2-Acetolactate C5H8O4 132.042259
6 C00024 Acetyl-CoA C23H38N7O17P3S 809.125773
7 C00147 Adenine C5H5N5 135.054495
8 C00212 Adenosine C10H13N5O4 267.096754
9 C00224 Adenylylsulfate C10H14N5O10PS 427.019899
10 C00008 ADP C10H15N5O10P2 427.029415
11 C00301 ADPribose C15H24N5O14P2 560.079499
12 C00099 beta-Alanine C3H7NO2 89.047678
13 C00041 L-Alanine C3H7NO2 89.047678
14 C00499 Allantoate C4H8N4O4 176.054555
15 C01551 Allantoin C4H6N4O3 158.04399
16 C04556 4-Amino-2-methyl-5-phosphomethylpyrimidine C6H10N3O4P 219.040892
17 C04409 2-Amino-3-carboxymuconate semialdehyde C7H7NO5 185.032422
18 C11355 4-amino-4-deoxychorismate C10H11NO5 225.063722
19 C04874 2-Amino-4-hydroxy-6-(D-erythro-1,2,3-trihydroxypropyl)-7,8-dihydropteridine C9H13N5O4 255.096754
20 C01300 2-Amino-4-hydroxy-6-hydroxymethyl-7,8-dihydropteridine C7H9N5O2 195.075625
21 C01279 4-Amino-5-hydroxymethyl-2-methylpyrimidine C6H9N3O 139.074562
22 C04454 5-Amino-6-(5'-phosphoribitylamino)uracil C9H17N4O9P 356.073315
23 C01268 5-Amino-6-(5'-phosphoribosylamino)uracil C9H15N4O9P 354.057665
24 C01268 5-Amino-6-(ribosylamino)-2,4-(1H,3H)-pyrimidinedione 5'-phosphate C9H15N4O9P 354.057665
25 C04807 2-Amino-7,8-dihydro-4-hydroxy-6-(diphosphooxymethyl)pteridine C7H11N5O8P2 355.008285
26 C01092 8-Amino-7-oxononanoate C9H17NO3 187.120843
27 C00956 L-2-Aminoadipate C6H11NO4 161.068808
28 C04076 L-2-Aminoadipate 6-semialdehyde C6H11NO3 145.073893
29 C00568 4-Aminobenzoate C7H7NO2 137.047678
30 C00334 4-Aminobutanoate C4H9NO2 103.063329
31 C00555 4-Aminobutyraldehyde C4H9NO 87.068414
32 C05715 gamma-Amino-gamma-cyanobutanoate C5H8N2O2 128.058578
33 C03373 Aminoimidazole ribotide C8H14N3O7P 295.056936
34 C00430 5-Aminolevulinate C5H9NO3 131.058243
35 C02220 2-Aminomuconate C6H7NO4 157.037508
36 C03824 2-Aminomuconate 6-semialdehyde C6H7NO3 141.042593
37 C02229 3-Aminopropanal C3H7NO 73.052764
38 C05714 alpha-Aminopropiononitrile C3H6N2 70.053098
39 C00020 AMP C10H14N5O7P 347.063084
40 C00108 Anthranilate C7H7NO2 137.047678
41 C00652 D-Arabinono-1,4-lactone C5H8O5 148.037173
42 C00216 D-Arabinose C5H10O5 150.052823
43 C00062 L-Arginine C6H14N4O2 174.111676
44 C00152 L-Asparagine C4H8N2O3 132.053492
45 C00049 L-Aspartate C4H7NO4 133.037508
46 C00441 L-Aspartate 4-semialdehyde C4H7NO3 117.042593
47 C00002 ATP C10H16N5O13P3 506.995745
48 C00120 Biotin C10H16N2O3S 244.088163
49 C01159 2,3-Bisphospho-D-glycerate C3H8O10P2 265.959269
50 C04002 But-1-ene-1,2,4-tricarboxylate C7H8O6 188.032088
51 C00169 Carbamoyl phosphate CH4NO5P 140.982709
52 C04692 2-[3-Carboxy-3-(methylammonio)propyl]-L-histidine C11H19N4O4 271.14063
53 C04441 2-(3-Carboxy-3-aminopropyl)-L-histidine C10H16N4O4 256.117155
54 C04236 3-Carboxy-4-methyl-2-oxopentanoate C7H10O5 174.052823
55 C01063 6-Carboxyhexanoyl-CoA C28H46N7O19P3S 909.178203
56 C01302 1-(2-Carboxyphenylamino)-1'-deoxy-D-ribulose 5'-phosphate C12H16NO9P 349.056268
57 C01269 5-O-(1-Carboxyvinyl)-3-phosphoshikimate C10H13O10P 324.024633
58 C00487 Carnitine C7H16NO3 162.113018
59 C00112 CDP C9H15N3O11P2 403.018181
60 C00307 CDPcholine C14H27N4O11P2 489.115156
61 C00570 CDPethanolamine C11H20N4O11P2 446.060381
62 C00114 Choline C5H14NO 104.107539
63 C00588 Choline phosphate C5H15NO4P 184.073869
64 C00251 Chorismate C10H10O6 226.047738
65 C00158 Citrate C6H8O7 192.027003
66 C00327 L-Citrulline C6H13N3O3 175.095691
67 C00055 CMP C9H14N3O8P 323.051851
68 C00011 CO2 CO2 43.989829
69 C00010 CoA C21H36N7O16P3S 767.115208
70 C05768 Coproporphyrinogen I C36H44N4O8 660.315914
71 C00063 CTP C9H16N3O14P3 482.984512
72 C00575 3',5'-Cyclic AMP C10H12N5O6P 329.05252
73 C00941 3',5'-Cyclic CMP C9H12N3O7P 305.041286
74 C00968 3',5'-Cyclic dAMP C10H12N5O5P 313.057605
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# KEGG ID Metabolite Formula Monoisotopic mass
75 C00942 3',5'-Cyclic GMP C10H12N5O7P 345.047434
76 C00943 3',5'-Cyclic IMP C10H11N4O7P 330.036535
77 C01419 Cys-Gly C5H10N2O3S 178.041213
78 C02291 L-Cystathionine C7H14N2O4S 222.067428
79 C00097 L-Cysteine C3H7NO2S 121.019749
80 C00475 Cytidine C9H13N3O5 243.085521
81 C00380 Cytosine C4H5N3O 111.043262
82 C00206 dADP C10H15N5O9P2 411.0345
83 C00360 dAMP C10H14N5O6P 331.06817
84 C00131 dATP C10H16N5O12P3 491.000831
85 C00705 dCDP C9H15N3O10P2 387.023267
86 C00239 dCMP C9H14N3O7P 307.056936
87 C00458 dCTP C9H16N3O13P3 466.989597
88 C00857 Deamino-NAD+ C21H27N6O15P2 665.100962
89 C04691 2-Dehydro-3-deoxy-D-arabino-heptonate 7-phosphate C7H13O10P 288.024633
90 C00966 2-Dehydropantoate C6H10O4 146.057909
91 C00944 3-Dehydroquinate C7H10O6 190.047738
92 C02637 3-Dehydroshikimate C7H8O5 172.037173
93 C02934 3-Dehydrosphinganine C18H37NO2 299.282429
94 C03226 3-Demethylubiquinone-9 C52H78O4 766.590011
95 C00559 Deoxyadenosine C10H13N5O3 251.101839
96 C00881 Deoxycytidine C9H13N3O4 227.090606
97 C00673 2-Deoxy-D-ribose 5-phosphate C5H11O7P 214.024239
98 C00330 Deoxyguanosine C10H13N5O4 267.096754
99 C05512 Deoxyinosine C10H12N4O4 252.085855
100 C01801 Deoxyribose C5H10O4 134.057909
101 C03496 Deoxy-ribose 1-phosphate C5H11O7P 214.024239
102 C00526 Deoxyuridine C9H12N2O5 228.074622
103 C00882 Dephospho-CoA C21H35N7O13P2S 687.148878
104 C01909 Dethiobiotin C10H18N2O3 214.131742
105 C00361 dGDP C10H15N5O10P2 427.029415
106 C00362 dGMP C10H14N5O7P 347.063084
107 C00286 dGTP C10H16N5O13P3 506.995745
108 C01304 2,5-Diamino-6-hydroxy-4-(5'-phosphoribosylamino)-pyrimidine C9H16N5O8P 353.073649
109 C01037 7,8-Diaminononanoate C9H20N2O2 188.152478
110 C00986 1,3-Diaminopropane C3H10N2 74.084398
111 C00415 Dihydrofolate C19H21N7O6 443.155331
112 C05925 Dihydroneopterin phosphate C9H14N5O7P 335.063084
113 C00337 (S)-Dihydroorotate C5H6N2O4 158.032757
114 C00921 Dihydropteroate C14H14N6O3 314.112738
115 C04272 (R)-2,3-Dihydroxy-3-methylbutanoate C5H10O4 134.057909
116 C04332 6,7-Dimethyl-8-(1-D-ribityl)lumazine C13H18N4O6 326.122634
117 C00235 Dimethylallyl diphosphate C5H12O7P2 246.005826
118 C01143 (R)-5-Diphosphomevalonate C6H14O10P2 308.00622
119 C00363 dTDP C10H16N2O11P2 402.022932
120 C00364 dTMP C10H15N2O8P 322.056602
121 C00459 dTTP C10H17N2O14P3 481.989263
122 C01346 dUDP C9H14N2O11P2 388.007282
123 C00365 dUMP C9H13N2O8P 308.040952
124 C00460 dUTP C9H15N2O14P3 467.973613
125 C05400 Epimelibiose C12H22O11 342.116212
126 C01054 (S)-2,3-Epoxysqualene C30H50O 426.386166
127 C01694 Ergosterol C28H44O 396.339216
128 C00279 D-Erythrose 4-phosphate C4H9O7P 200.008589
129 C00469 Ethanol C2H6O 46.041865
130 C00189 Ethanolamine C2H7NO 61.052764
131 C00346 Ethanolamine phosphate C2H8NO4P 141.019094
132 C00016 FAD C27H33N9O15P2 785.157134
133 C01352 FADH2 C27H35N9O15P2 787.172785
134 C00448 trans,trans-Farnesyl diphosphate C15H28O7P2 382.131026
135 C00125 Ferricytochrome c C42H54FeN8O6S2 886.295715
136 C00126 Ferrocytochrome c C42H54FeN8O6S2 886.295715
137 C00061 FMN C17H21N4O9P 456.104615
138 C00067 Formaldehyde CH2O 30.010565
139 C04640 2-(Formamido)-N1-(5'-phosphoribosyl)acetamidine C8H16N3O8P 313.067501
140 C00058 Formate CH2O2 46.005479
141 C02700 L-Formylkynurenine C11H12N2O4 236.079707
142 C00234 10-Formyltetrahydrofolate C20H23N7O7 473.165896
143 C00095 D-Fructose C6H12O6 180.063388
144 C05378 beta-D-Fructose 1,6-bisphosphate C6H14O12P2 339.996049
145 C01094 D-Fructose 1-phosphate C6H13O9P 260.029719
146 C00665 D-Fructose 2,6-bisphosphate C6H14O12P2 339.996049
147 C05345 beta-D-Fructose 6-phosphate C6H13O9P 260.029719
148 C02095 beta-D-Fucose C6H12O5 164.068473
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149 C00122 Fumarate C4H4O4 116.010959
150 C01061 4-Fumarylacetoacetate C8H8O6 200.032088
151 C00124 D-Galactose C6H12O6 180.063388
152 C03384 D-Galactose 1-phosphate C6H13O9P 260.029719
153 C05401 Galactosylglycerol C9H18O8 254.100168
154 C01235 1-alpha-D-Galactosyl-myo-inositol C12H22O11 342.116212
155 C00035 GDP C10H15N5O11P2 443.024329
156 C00096 GDPmannose C16H25N5O16P2 605.077153
157 C00341 Geranyl diphosphate C10H20O7P2 314.068426
158 C01722 L-Glucitol C6H14O6 182.079038
159 C01236 D-Glucono-1,5-lactone 6-phosphate C6H11O9P 258.014068
160 C00329 D-Glucosamine C6H13NO5 179.079373
161 C06156 D-Glucosamine 1-phosphate C6H14NO8P 259.045703
162 C00352 D-Glucosamine 6-phosphate C6H14NO8P 259.045703
163 C00267 alpha-D-Glucose C6H12O6 180.063388
164 C00221 beta-D-Glucose C6H12O6 180.063388
165 C00103 D-Glucose 1-phosphate C6H13O9P 260.029719
166 C00668 alpha-D-Glucose 6-phosphate C6H13O9P 260.029719
167 C01172 beta-D-Glucose 6-phosphate C6H13O9P 260.029719
168 C00025 L-Glutamate C5H9NO4 147.053158
169 C01165 L-Glutamate 5-semialdehyde C5H9NO3 131.058243
170 C00064 L-Glutamine C5H10N2O3 146.069142
171 C03734 alpha-D-Glutamyl phosphate C5H10NO7P 227.019488
172 C00669 gamma-L-Glutamyl-L-cysteine C8H14N2O5S 250.062342
173 C00051 Glutathione C10H17N3O6S 307.083806
174 C00118 D-Glyceraldehyde 3-phosphate C3H7O6P 169.998024
175 C00116 Glycerol C3H8O3 92.047344
176 C00093 sn-Glycerol 3-phosphate C3H9O6P 172.013675
177 C00184 Glycerone C3H6O3 90.031694
178 C00111 Glycerone phosphate C3H7O6P 169.998024
179 C00037 Glycine C2H5NO2 75.032028
180 C00182 Glycogen C24H42O21 666.221858
181 C00266 Glycolaldehyde C2H4O2 60.021129
182 C00048 Glyoxylate C2H2O3 74.000394
183 C00144 GMP C10H14N5O8P 363.057999
184 C00044 GTP C10H16N5O14P3 522.99066
185 C03078 4-Guanidinobutanamide C5H12N4O 144.101111
186 C01035 4-Guanidinobutanoate C5H11N3O2 145.085127
187 C00242 Guanine C5H5N5O 151.04941
188 C00387 Guanosine C10H13N5O5 283.091669
189 C00027 H2O2 H2O2 34.005479
190 C00032 Heme C34H34FeN4O4 618.192948
191 C00135 L-Histidine C6H9N3O2 155.069477
192 C00860 L-Histidinol C6H11N3O 141.090212
193 C01100 L-Histidinol phosphate C6H12N3O4P 221.056542
194 C05330 Homocysteine C4H9NO2S 135.035399
195 C00544 Homogentisate C8H8O4 168.042259
196 C05662 Homoisocitrate C7H10O7 206.042653
197 C00263 L-Homoserine C4H9NO3 119.058243
198 C00283 Hydrogen sulfide H2S 33.987721
199 C06237 (R)-3-Hydroxy-3-methyl-2-oxobutanoate C5H8O4 132.042259
200 C00356 (S)-3-Hydroxy-3-methylglutaryl-CoA C27H44N7O20P3S 911.157467
201 C00632 3-Hydroxyanthranilate C7H7NO3 153.042593
202 C00156 4-Hydroxybenzoate C7H6O3 138.031694
203 C01251 2-Hydroxybutane-1,2,4-tricarboxylate C7H10O7 206.042653
204 C04294 5-(2-Hydroxyethyl)-4-methylthiazole C6H9NOS 143.040485
205 C02794 3-Hydroxykynurenine C10H12N2O4 224.079707
206 C01157 trans-4-Hydroxy-L-proline C5H9NO3 131.058243
207 C06056 4-Hydroxy-L-threonine C4H9NO4 135.053158
208 C01024 Hydroxymethylbilane C40H46N4O17 854.285796
209 C01179 3-(4-Hydroxyphenyl)pyruvate C9H8O4 180.042259
210 C00262 Hypoxanthine C5H4N4O 136.038511
211 C00104 IDP C10H14N4O11P2 428.01343
212 C01267 3-(Imidazol-4-yl)-2-oxopropyl phosphate C6H9N2O5P 220.024908
213 C04666 D-erythro-1-(Imidazol-4-yl)glycerol 3-phosphate C6H11N2O6P 238.035473
214 C00130 IMP C10H13N4O8P 348.0471
215 C02693 Indole-3-acetamide C10H10N2O 174.079313
216 C00954 Indole-3-acetate C10H9NO2 175.063329
217 C00954 Indoleacetate C10H9NO2 175.063329
218 C02938 3-Indoleacetonitrile C10H8N2 156.068748
219 C03506 Indoleglycerol phosphate C11H14NO6P 287.055874
220 C00294 Inosine C10H12N4O5 268.08077
221 C00137 myo-Inositol C6H12O6 180.063388
222 C01245 D-myo-Inositol 1,4,5-trisphosphate C6H15O15P3 419.962379
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223 C01177 1L-myo-Inositol 1-phosphate C6H13O9P 260.029719
224 C00311 Isocitrate C6H8O7 192.027003
225 C00407 L-Isoleucine C6H13NO2 131.094629
226 C00129 Isopentenyl diphosphate C5H12O7P2 246.005826
227 C02504 2-Isopropylmalate C7H12O5 176.068473
228 C04411 3-Isopropylmalate C7H12O5 176.068473
229 C02631 2-Isopropylmaleate C7H10O4 158.057909
230 C00490 Itaconate C5H6O4 130.026609
231 C00531 Itaconyl-CoA C26H40N7O19P3S 879.131252
232 C00081 ITP C10H15N4O14P3 507.979761
233 C00328 L-Kynurenine C10H12N2O3 208.084792
234 C00424 (S)-Lactaldehyde C3H6O2 74.036779
235 C00256 (R)-Lactate C3H6O3 90.031694
236 C00186 (S)-Lactate C3H6O3 90.031694
237 C03451 (R)-S-Lactoylglutathione C13H21N3O8S 379.104935
238 C01724 Lanosterol C30H50O 426.386166
239 C00123 L-Leucine C6H13NO2 131.094629
240 C00248 Lipoamide C8H15NOS2 205.059505
241 C00047 L-Lysine C6H14N2O2 146.105528
242 C00711 Malate C4H6O5 134.021523
243 C00383 Malonate C3H4O4 104.010959
244 C00083 Malonyl-CoA C24H38N7O19P3S 853.115602
245 C00208 Maltose C12H22O11 342.116212
246 C00392 D-Mannitol C6H14O6 182.079038
247 C00644 D-Mannitol 1-phosphate C6H15O9P 262.045369
248 C00936 alpha-D-Mannose C6H12O6 180.063388
249 C03812 alpha-D-Mannose 1-phosphate C6H13O9P 260.029719
250 C00275 D-Mannose 6-phosphate C6H13O9P 260.029719
251 C05399 Melibiitol C12H24O11 344.131862
252 C05402 Melibiose C12H22O11 342.116212
253 C01438 Methane CH4 16.0313
254 C00409 Methanethiol CH4S 48.003371
255 C00445 5,10-Methenyltetrahydrofolate C20H22N7O6 456.163156
256 C00073 L-Methionine C5H11NO2S 149.051049
257 C00141 3-Methyl-2-oxobutanoate C5H8O3 116.047344
258 C04752 2-Methyl-4-amino-5-hydroxymethylpyrimidine diphosphate C6H11N3O7P2 299.007223
259 C04327 4-Methyl-5-(2-phosphoethyl)-thiazole C6H10NO4PS 223.006815
260 C00143 5,10-Methylenetetrahydrofolate C20H23N7O6 457.170982
261 C00546 Methylglyoxal C3H4O2 72.021129
262 C03460 2-Methylprop-2-enoyl-CoA C25H40N7O17P3S 835.141423
263 C00440 5-Methyltetrahydrofolate C20H25N7O6 459.186632
264 C04489 5-Methyltetrahydropteroyltri-L-glutamate C25H36N8O12 640.245269
265 C00170 5'-Methylthioadenosine C11H15N5O3S 297.08956
266 C05103 4alpha-Methylzymosterol C28H46O 398.354866
267 C00418 (R)-Mevalonate C6H12O4 148.073559
268 C06424 Myristic acid C14H28O2 228.20893
269 C04302 N-(5-Phospho-D-ribosyl)anthranilate C12H16NO9P 349.056268
270 C03406 N-(L-Arginino)succinate C10H18N4O6 290.122634
271 C01152 N(pai)-Methyl-L-histidine C7H11N3O2 169.085127
272 C03883 N1-(5-Phospho-D-ribosyl)-AMP C15H25N5O14P2 561.087324
273 C00612 N1-Acetylspermidine C9H21N3O 187.168462
274 C02567 N1-Acetylspermine C12H28N4O 244.226312
275 C00437 N2-Acetyl-L-ornithine C7H14N2O3 174.100442
276 C03794 N6-(1,2-Dicarboxyethyl)-AMP C14H18N5O11P 463.074043
277 C00449 N6-(L-1,3-Dicarboxypropyl)-L-lysine C11H20N2O6 276.132136
278 C00140 N-Acetyl-D-glucosamine C8H15NO6 221.089937
279 C04256 N-Acetyl-D-glucosamine 1-phosphate C8H16NO9P 301.056268
280 C00357 N-Acetyl-D-glucosamine 6-phosphate C8H16NO9P 301.056268
281 C00624 N-Acetyl-L-glutamate C7H11NO5 189.063722
282 C04133 N-Acetyl-L-glutamate 5-phosphate C7H12NO8P 269.030053
283 C01250 N-Acetyl-L-glutamate 5-semialdehyde C7H11NO4 173.068808
284 C02714 N-Acetylputrescine C6H14N2O 130.110613
285 C00003 NAD+ C21H28N7O14P2 664.116947
286 C00004 NADH C21H29N7O14P2 665.124772
287 C00006 NADP+ C21H29N7O17P3 744.083277
288 C00005 NADPH C21H30N7O17P3 745.091102
289 C00438 N-Carbamoyl-L-aspartate C5H8N2O5 176.043321
290 C00014 NH3 H3N 17.026549
291 C00153 Nicotinamide C6H6N2O 122.048013
292 C00253 Nicotinate C6H5NO2 123.032028
293 C01185 Nicotinate D-ribonucleotide C11H15NO9P 336.048443
294 C04145 all-trans-Nonaprenyl diphosphate C45H76O7P2 790.506628
295 C02571 O-Acetylcarnitine C9H18NO4 204.123583
296 C01077 O-Acetyl-L-homoserine C6H11NO4 161.068808
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297 C00979 O-Acetyl-L-serine C5H9NO4 147.053158
298 C06055 O-Phospho-4-hydroxy-L-threonine C4H10NO7P 215.019488
299 C01102 O-Phospho-L-homoserine C4H10NO6P 199.024574
300 C00077 L-Ornithine C5H12N2O2 132.089878
301 C00295 Orotate C5H4N2O4 156.017107
302 C01103 Orotidine 5'-phosphate C10H13N2O11P 368.025696
303 C00009 Orthophosphate H3O4P 97.976895
304 C01118 O-Succinyl-L-homoserine C8H13NO6 219.074287
305 C00036 Oxaloacetate C4H4O5 132.005873
306 C05533 Oxaloglutarate C7H8O7 204.027003
307 C05379 Oxalosuccinate C6H6O7 190.011353
308 C00127 Oxidized glutathione C20H32N6O12S2 612.151962
309 C06054 2-Oxo-3-hydroxy-4-phosphobutanoate C4H7O8P 213.987854
310 C00322 2-Oxoadipate C6H8O5 160.037173
311 C00109 2-Oxobutanoate C4H6O3 102.031694
312 C00026 2-Oxoglutarate C5H6O5 146.021523
313 C00141 2-Oxoisovalerate C5H8O3 116.047344
314 C00007 Oxygen O2 31.989829
315 C01260 P1,P4-Bis(5'-adenosyl) tetraphosphate C20H28N10O19P4 836.048265
316 C01261 P1,P4-Bis(5'-guanosyl) tetraphosphate C20H28N10O21P4 868.038094
317 C00249 Palmitate C16H32O2 256.24023
318 C00154 Palmitoyl-CoA C37H66N7O17P3S 1005.344874
319 C01134 Pantetheine 4'-phosphate C11H23N2O7PS 358.096358
320 C00522 (R)-Pantoate C6H12O4 148.073559
321 C00864 (R)-Pantothenate C9H17NO5 219.110673
322 C02505 2-Phenylacetamide C8H9NO 135.068414
323 C07086 Phenylacetic acid C8H8O2 136.05243
324 C00079 L-Phenylalanine C9H11NO2 165.078979
325 C00166 Phenylpyruvate C9H8O3 164.047344
326 C00053 3'-Phosphoadenylyl sulfate C10H15N5O13P2S 506.986229
327 C00119 5-Phospho-alpha-D-ribose 1-diphosphate C5H13O14P3 389.951815
328 C00345 6-Phospho-D-gluconate C6H13O10P 276.024633
329 C00631 2-Phospho-D-glycerate C3H7O7P 185.992939
330 C00197 3-Phospho-D-glycerate C3H7O7P 185.992939
331 C00236 3-Phospho-D-glyceroyl phosphate C3H8O10P2 265.959269
332 C04751 1-(5-Phospho-D-ribosyl)-5-amino-4-imidazolecarboxylate C9H14N3O9P 339.046766
333 C04896 5-(5-Phospho-D-ribosylaminoformimino)-1-(5-phosphoribosyl)-imidazole-4-carboxamide C15H25N5O15P2 577.082238
334 C00074 Phosphoenolpyruvate C3H5O6P 167.982374
335 C03082 4-Phospho-L-aspartate C4H8NO7P 213.003838
336 C01107 (R)-5-Phosphomevalonate C6H13O7P 228.039889
337 C03232 3-Phosphonooxypyruvate C3H5O7P 183.977289
338 C03492 D-4'-Phosphopantothenate C9H18NO8P 299.077003
339 C04352 (R)-4'-Phosphopantothenoyl-L-cysteine C12H23N2O9PS 402.086188
340 C04823 1-(5'-Phosphoribosyl)-5-amino-4-(N-succinocarboxamide)-imidazole C13H19N4O12P 454.073709
341 C04677 1-(5'-Phosphoribosyl)-5-amino-4-imidazolecarboxamide C9H15N4O8P 338.06275
342 C04734 1-(5'-Phosphoribosyl)-5-formamido-4-imidazolecarboxamide C10H15N4O9P 366.057665
343 C03090 5-Phosphoribosylamine C5H12NO7P 229.035138
344 C03838 5'-Phosphoribosylglycinamide C7H15N2O8P 286.056602
345 C04376 5'-Phosphoribosyl-N-formylglycinamide C8H15N2O9P 314.051517
346 C01005 3-Phosphoserine C3H8NO6P 185.008924
347 C12144 Phytosphingosine C18H39NO3 317.292994
348 C02656 Pimelic acid C7H12O4 160.073559
349 C00931 Porphobilinogen C10H14N2O4 226.095357
350 C00254 Prephenate C10H10O6 226.047738
351 C00148 L-Proline C5H9NO2 115.063329
352 C02191 Protoporphyrin C34H34N4O4 562.258006
353 C01079 Protoporphyrinogen IX C34H40N4O4 568.304956
354 C01168 Pseudouridine 5'-phosphate C9H13N2O9P 324.035867
355 C00134 Putrescine C4H12N2 88.100048
356 C03722 Pyridine-2,3-dicarboxylate C7H5NO4 167.021858
357 C00250 Pyridoxal C8H9NO3 167.058243
358 C00018 Pyridoxal phosphate C8H10NO6P 247.024574
359 C00534 Pyridoxamine C8H12N2O2 168.089878
360 C00647 Pyridoxamine phosphate C8H13N2O5P 248.056208
361 C00314 Pyridoxine C8H11NO3 169.073893
362 C00627 Pyridoxine phosphate C8H12NO6P 249.040224
363 C00013 Pyrophosphate H4O7P2 177.943226
364 C04281 L-1-Pyrroline-3-hydroxy-5-carboxylate C5H7NO3 129.042593
365 C03912 (S)-1-Pyrroline-5-carboxylate C5H7NO2 113.047678
366 C00022 Pyruvate C3H4O3 88.016044
367 C00492 Raffinose C18H32O16 504.169035
368 C01684 D-Rhamnose C6H12O5 164.068473
369 C00255 Riboflavin C17H20N4O6 376.138284
370 C00121 D-Ribose C5H10O5 150.052823
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371 C00442 alpha-D-Ribose 1-phosphate C5H11O8P 230.019154
372 C00620 D-Ribose 1-phosphate C5H11O8P 230.019154
373 C00117 D-Ribose 5-phosphate C5H11O8P 230.019154
374 C00199 D-Ribulose 5-phosphate C5H11O8P 230.019154
375 C04425 S-Adenosyl-4-methylthio-2-oxobutanoate C15H20N5O6S 398.113429
376 C00021 S-Adenosyl-L-homocysteine C14H20N6O5S 384.121588
377 C00019 S-Adenosyl-L-methionine C15H23N6O5S 399.145064
378 C01137 S-Adenosylmethioninamine C14H23N6O3S 355.155234
379 C00447 Sedoheptulose 1,7-bisphosphate C7H16O13P2 370.006614
380 C00281 Sedoheptulose 7-phosphate C7H15O10P 290.040283
381 C00065 L-Serine C3H7NO3 105.042593
382 C01031 S-Formylglutathione C11H17N3O7S 335.078721
383 C00493 Shikimate C7H10O5 174.052823
384 C03175 Shikimate 3-phosphate C7H11O8P 254.019154
385 C05778 Sirohydrochlorin C42H46N4O16 862.290881
386 C03172 S-Methyl-L-methionine C6H14NO2S 164.074524
387 C00794 D-Sorbitol C6H14O6 182.079038
388 C01452 Sorbose C6H12O6 180.063388
389 C00315 Spermidine C7H19N3 145.157898
390 C00750 Spermine C10H26N4 202.215747
391 C00836 Sphinganine C18H39NO2 301.29808
392 C01120 Sphinganine 1-phosphate C18H40NO5P 381.26441
393 C00751 Squalene C30H50 410.391252
394 C01530 Stearate C18H36O2 284.27153
395 C00042 Succinate C4H6O4 118.026609
396 C00232 Succinate semialdehyde C4H6O3 102.031694
397 C00091 Succinyl-CoA C25H40N7O19P3S 867.131252
398 C00089 Sucrose C12H22O11 342.116212
399 C00059 Sulfate H2O4S 97.967379
400 C00094 Sulfite H2O3S 81.972465
401 C03785 D-Tagatose 1,6-bisphosphate C6H14O12P2 339.996049
402 C01097 D-Tagatose 6-phosphate C6H13O9P 260.029719
403 C02593 Tetradecanoyl-CoA C35H62N7O17P3S 977.313574
404 C00101 Tetrahydrofolate C19H23N7O6 445.170982
405 C04144 Tetrahydropteroyltri-L-glutamate C24H34N8O12 626.229619
406 C00378 Thiamin C12H17N4OS 265.112307
407 C00068 Thiamin diphosphate C12H19N4O7P2S 425.044968
408 C01081 Thiamin monophosphate C12H18N4O4PS 345.078637
409 C03028 Thiamin triphosphate C12H20N4O10P3S 505.011298
410 C00188 L-Threonine C4H9NO3 119.058243
411 C00214 Thymidine C10H14N2O5 242.090272
412 C00178 Thymine C5H6N2O2 126.042927
413 C01083 alpha,alpha-Trehalose C12H22O11 342.116212
414 C00689 alpha,alpha'-Trehalose 6-phosphate C12H23O14P 422.082542
415 C00078 L-Tryptophan C11H12N2O2 204.089878
416 C00082 L-Tyrosine C9H11NO3 181.073893
417 C01967 Ubiquinone-9 C54H82O4 794.621311
418 C00015 UDP C9H14N2O12P2 404.002197
419 C00052 UDP-D-galactose C15H24N2O17P2 566.05502
420 C00029 UDPglucose C15H24N2O17P2 566.05502
421 C00203 UDP-N-acetyl-D-galactosamine C17H27N3O17P2 607.081569
422 C00105 UMP C9H13N2O9P 324.035867
423 C03543 Undecaprenyl diphosphate C55H92O7P2 926.631828
424 C00106 Uracil C4H4N2O2 112.027277
425 C00086 Urea CH4N2O 60.032363
426 C01010 Urea-1-carboxylate C2H4N2O3 104.022192
427 C00603 (S)-Ureidoglycolate C3H6N2O4 134.032757
428 C00299 Uridine C9H12N2O6 244.069536
429 C01051 Uroporphyrinogen III C40H44N4O16 836.275231
430 C00075 UTP C9H15N2O15P3 483.968527
431 C00183 L-Valine C5H11NO2 117.078979
432 C00385 Xanthine C5H4N4O2 152.033425
433 C01762 Xanthosine C10H12N4O6 284.075684
434 C00655 Xanthosine 5'-phosphate C10H13N4O9P 364.042015
435 C00181 D-Xylose C5H10O5 150.052823
436 C06814 D-Xylose-5-phosphate C5H11O8P 230.019154
437 C00310 D-Xylulose C5H10O5 150.052823
438 C05437 Zymosterol C27H44O 384.339216
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00001 4-Aminobutyric acid 104.07 87.04 NH3
86.06 H2O
69.03 NH3 + H2O
00003 L-Alanine 90.06 62.06 CO
00004 L-Arginine 175.14 116.08 CH5N3
60.06 C5H9NO2
158.11 NH3
70.07 CH5N3 + CHOOH
130.11 CO + NH3
157.13 H2O
72.08 C4H9NO2
112.1 CHOOH + NH3
00005 L-Aspartic acid 134.06 88.04 CHOOH
74.02 CH3COOH
116.04 H2O
00006 L-Asparagine 133.0766 87.06 CHOOH
116.04 NH3
74.02 CH3CONH2
88.04 CHONH2
00008 L-Cysteine 122.04 76.02 CHOOH
105.01 NH3
86.99 NH3 + H2O
00009 L-Glutamic acid 148.08 130.06 H2O
102.06 CHOOH
84.04 CHOOH + H2O
00010 L-Glutamine 147.09 130.06 NH3
84.04 CHONH2 + H2O
101.08 CHOOH
00011 L-Histidine 156.0958 110.08 CHOOH
95.06
00012 L-Homocystine 269.09 136.06 C4H7NO2S
134.04 C4H9NO2S
118.04 C4H7NO2S + H2O
00014 L-Isoleucine 132.12 86.1 CHOOH
58.066
00015 L-Leucine 132.12 86.1 CHOOH
69.07 N?
00016 L-Lysine 147.13 130.1 NH3
84.085 CHOOH + NH3
00017 L-Methionine 150.0775 104.0614 CHOOH
133.05 NH3
102.0634 CH4S
56.05 CH4S + CO + H2O
61.01
00019 L-Phenylalanine 166.1 120.094 CHOOH
149.08 NH3
131.0636 NH3 + H2O
00021 L-Serine 106.0618 60.04 CHOOH
88.04 H2O
70.03 2H2O
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00023 L-Tryptophan 205.1241 188.0925 NH3
159.11 CHOOH
146.08
00024 L-Tyrosine 182.1039 165.07 NH3
136.0941 CHOOH
123.0598
147.063 NH3 + H2O
119.0647 CHOOH + NH3
00025 L-Valine 118 72.0827 CHOOH
00027 O-acetyl-L-serine 148.06 88.04 CH2CO + H2O
106.05 CH2CO
60.05 CH2CO + CO + H2O
70.03 CH2CO + 2H2O
102.05 CHOOH
00028 O-Phospho-L-serine 186.04 88.0436 H3PO4
00029 N-Acetyl-L-glutamic acid 190.0951 130.07 CH2CO + H2O
172.08 H2O
148.08 CH2CO
144.08 CHOOH
102.06 CH2CO + CHOOH
84.05 CH2CO + CHOOH + H2O
00030 Betaine 118.1003 59.07 CH3COOH
00033 Apidic acid 147.08 129.0698 H2O
101.07 CHOOH
111.06 2H2O
83.05 CHOOH + H2O
00034 cis-Aconitic acid 175.03 139 2H2O
157.01 H2O
111.01 CHOOH + H2O
00035 Citraconic acid 131.05 113.037 H2O
85.032 CHOOH
00036 Citramalic acid 149.06 103.05 CHOOH
131.05 H2O
85.03 CHOOH + H2O
00037 Citric acid 193.06 175.04 H2O
157.02 2H2O
129.03 CHOOH + H2O
139.03 3 H2O
147.05 CHOOH
00038 DL-Isocitric acid 193.06 129.03 CHOOH + H2O
175.05 H2O
157.04 2H2O
147.05 CHOOH
00040 Glutaric acid 133.07 115.05 H2O
87.05 CHOOH
00043 Itaconic acid 131.04 113.03 H2O
85.03 CHOOH
00045 Malic acid 135.05 89.03 CHOOH
117.033 H2O
71.01 CHOOH + H2O
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00049 Pimelic acid 161.1 143.09 H2O
125.08 2H2O
97.07 CHOOH + H2O
115.09 CHOOH
69.07 2CHOOH
00051 α-Ketoapidic acid 161.05 143.09 H2O
00052 Flavin adenine dinucleotide (FAD) 786.16 348.07
00054 NAD 664.1 542.07
524.03
428.03 C9H10N5O3
00057 AMP 348.07 136.06
213.01
330.06 H2O
00059 GTP 524.01 152.06
00061 cGMP 346.06 152.06
00063 Cytosine 112.0627 95.03 NH3
69.05
94.05 H2O
00065 Acetyl-DL-carnitine 204.12 85.03
145.05
60.09
00066 Fructose 1,6-bisphosphate 440.11 100.12
323.02
341.03
00067 Phospho(enol)pyruvate 168.99 150.98 H2O
122.99 CHOOH
80.98
00069 2-phosphoglyceric acid 0 98.99
140.99
00071 Glucose 1-phosphate 261.05 98.98 C6H10O5
163.06 H3PO4
00076 Trehalose 343.17 325.15 H2O
163.09 C6H12O6
181.0961 C6H10O5
00079 N-acetyl-D-glucosamine 222.1 204.09 H2O
138.06
186.08 2H2O
168.07 3 H2O
126.07 CH3COOH + 2H2O
00081 Riboflavin 377.1902 243.11 C5H10O4
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00001 4-Aminobutyric acid 102.05 n.d.
00002 Glycine 74.03 n.d.
00003 L-Alanine 88.04 n.d.
00005 L-Aspartic acid 132.03 88.03 CO2
115 NH3
00006 L-Asparagine 131.04 114.01 NH3
70.04 NH3 + CO2
113.04 H2O
00008 L-Cysteine 120.01 n.d.
00009 L-Glutamic acid 146.04 102.06 CO2
128.04 H2O
00010 L-Glutamine 145.05 127.03 H2O
109.04 2H2O
00011 L-Histidine 154.06 n.d.
00012 L-Homocystine 267.05 n.d.
00017 L-Methionine 148.04 n.d.
00019 L-Phenylalanine 164.07 147.05 NH3
103.05 NH3 + CO2
72.01 C7H8
00020 L-Proline 114.05 n.d.
00021 L-Serine 104.03 74.02 CH2O
00023 L-Tryptophan 203.08 n.d.
00024 L-Tyrosine 180.06 n.d.
00025 L-Valine 116.06 n.d.
00027 O-acetyl-L-serine 146.04 n.d.
00028 O-Phospho-L-serine 183.99 96.97 C3H5NO2
00029 N-Acetyl-L-glutamic acid 188.04 128.03 CH3COOH
102.05
144.06 CHOCH3 or CO2
59.02 C5H7NO3
170.04 H2O
100.04 CHOCH3 + CO2
146.04
00031 2-Hydroxyisobutyric acid 103.04 57.04 CO + H2O
00032 6-phosphogluconic acid 275 96.96 C6H10O6
177.04 H3PO4
256.98 H2O
78.95 C6H12O7
00033 Apidic acid 145.04 101.06 CO2
83.05 CO2+ H2O
00034 cis-Aconitic acid 173 85.03 2CO2
129.01 CO2
111 CO2+ H2O
00035 Citraconic acid 129.02 85.02 CO2
00036 Citramalic acid 147.02 87.01 CH3COOH
85.02 CO2+ H2O
129.02 H2O
57.05
103.04 CO2
59.02 2CO2
00037 Citric acid 191 157.11
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115.07
143.09
129.09
00038 DL-Isocitric acid 191 157.11
115.07
143.09
129.09
00039 Fumaric acid 115 n.d.
00040 Glutaric acid 131.03 87.04 CO2
00041 Glyceric acid 105.02 n.d.
00042 Glyoxylic acid 73 n.d.
00043 Itaconic acid 129.02 n.d.
00044 Lactic acid 89.02 n.d.
00045 Malic acid 133.01 n.d.
00046 Myristic acid 227.19 n.d.
00047 Oxalacetic acid 131 87.01 CO2
00048 Oxalic acid 89 n.d.
00049 Pimelic acid 159.06 97.07 CO2+ H2O
141.05 H2O
115.07 CO2
00050 Tartaric acid 149 87.01 CO2+ H2O
73
59.02
103 CHOOH
130.97 H2O
00051 α-Ketoapidic acid 159.02 59.03
115.04 CO2
87.05
00052 Flavin adenine dinucleotide (FAD) 784.13 n.d.
00054 NAD 662 540.04
00055 ATP 505.99 426.02
00057 AMP 346.04 n.d.
00059 GTP 522 n.d.
00061 cGMP 344.05 n.d.
00064 Coenzyme A 766.1 n.d.
00066 Fructose 1,6-bisphosphate 338.98 96.97 C6H11O8P
241 H3PO4
00067 Phospho(enol)pyruvate 166.97 78.96 2CO2
00068 3-phosphoglyceric acid 184.98 96.97 2CO2
78.96 2CO2+ H2O
00069 2-phosphoglyceric acid 184.98 96.97 2CO2
78.96 2CO2+ H2O
00071 Glucose 1-phosphate 259.01 241.01 H2O
96.96 C6H10O5
00072 Galactose 6-phosphate 259.02 n.d.
00074 Uridine 5'-diphospho-glucose 565.03 n.d.
00075 Uridine 5'-diphospho-galactose 565.03 n.d.
00076 Trehalose 341.11 n.d.
00079 N-acetyl-D-glucosamine 220.08 n.d.
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